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Abstract 
Granaticin is a structurally unique member of the benzoisochromane quinone (BIQ) family of 
antibiotics. The molecule and its derivative exhibit a sugar moiety fusted to the naphthazarin 
core, only exhibited by one other natural compound, by a C-C glycosidic bond and an aldol 
like bond. The mechanism of enzymatic attachment of this substituent is currently unknown.  
This project aimed to devise a novel and elegant synthesis towards the granaticin aglycone and 
other benzoisochromane quinone natural compounds with the long term aim of discerning the 
mechanism of glycosylation. 
This thesis shows a novel route for the synthesis of highly substituted isochromane and 
isochromane quinone compounds towards the eventual synthesis of the desired natural 
molecules. 
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Abbreviations   
(DHQD)2-PHAL – (dihydroquinidine)2-phalizine 
Ac – acetate 
AD – asymmetric dihydroxylation 
AIBN – azobisisobutylnitrile 
Ar – aromatic 
BAIB – bisacetoxyiodobenzene 
BINAP – binaphthalene 
BIQ – benzoisochromanequinone 
Bn – benzyl 
Bz – benzoyl 
C – Celsius   
Calc. – calculated 
CAN – ceric ammonium nitrate (ceriumIV ammonium nitrate) 
1CBz – carboxybenzyl 
cm – centimeters 
CoA – coenzyme A 
Conc. – concentrated 
CSA – camphor sulfonic acid 
d – doublet 
dba – dibenxylideneacetone 
DBU – 1,8-diazabicycloundec-7-ene 
DCC – N,N’-dihcyclohexylcarbodiamide 
DDQ – 2,3-dichloro-5,6-dicyanoquinone 
DIBAL – diissobutylaluminium 
2 
 
DIPEA – diisopropylethylamine 
DMAP – N,N-dimethylpyridine 
DMF – dimethylformamide 
DMSO – dimethylsulfoxide 
dppf – 1,1’-bis(diphenylphosphino)ferrocene 
ESI – electron spray ionisation 
Et – ethyl 
g – gram 
HMBC – heteronuclear multiple bond correlation 
HRMS – high resolution mass spectrometry  
hrs. – hours 
HSQC – heteronuclear singular quantum correlation 
imid. – imidazole 
Ipc – isopinocamphyl 
i
Pr – isopropyl 
IR – infra red 
LCMS – liquid chromatography mass spectrometry 
LDA – lithium diisopropylamine 
LRMS – low resolution mass spectrometry 
m – meta 
M – molar 
m – multiplet 
m.p. – melting point 
MALDI – matrix assisted laser desorption/ionisation 
mCPBA – metachloroperbenzoic acid 
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Me – methyl 
mg – miligram 
mins. – minutes 
mL – mililitre 
mmol – milimole 
MOM – methoxymethylene 
Ms – mesyl 
Mz – megahertz 
NBS – N-bromosuccinamide 
n
Bu – normal butyl 
NMO – N-methylmorpholine oxide 
NMR – nuclear magnetic resonance 
NOE – nuclear Overhauser effect 
NOSY – nuclear Overhauser effect spectroscopy  
n
Pr – normal propyl 
o – ortho 
p – para 
PCC – piridiniumchlorochromate 
PG – protecting group 
Ph – phenyl 
pin – pinicol 
Piv – pivaloyl 
PMA – phosphomolybdic acid 
PMB – paramethoxybenzyl 
PPM – parts per million 
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pTSA – paratoluene sulfonic acid 
Py. – pyridine 
q – quartet 
R – rectus 
r.t. – room temperature 
s – singlet 
S – sinister 
s
Bu – secondary butyl 
t – triplet 
TBAB – tetran-N-butylammonium bromide 
TBAF – tetrabutylammonium fluoride 
TBDPS – tertiarybutyldiphenylsilyl 
TBS – tertiarybutyldimethylsilyl (TBDMS) 
t
Bu – tertiary butyl 
TEMPO – 2,2,6,6-tetramethylpipridin-1-yl oxide 
TES – triethylsilyl 
Tf – trifluorosulfonyl 
TFA – trifluoroacetic acid 
TFAA – trifluoroacetic anhydride 
THF – tetrahydrofuran 
TLC – thin layer chromatography 
TMEDA – tetramethylethylenediamine 
TMS – trimethylsilyl 
TMTU – tetramethylthiourea 
UV – ultra violate 
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1. Introduction  
1.1 Natural Products 
The term natural product is used to describe a chemical compound produced by living 
organisms. Natural products are classified depending on whether their biological activity is 
intended to affect the organism that produced the compound – primary metabolites; or an 
extraneous organism – secondary metabolites. Secondary metabolites are a main focus of 
many biological and chemical sciences due to their use as therapeutic agents. Natural products 
and natural product derived molecules account for almost 60% of all therapeutic agents (1981 
- 2002) particularly as antibiotic (78%) and anticancer (66%) agents.
[1,2]
 
Natural products and their synthesis form a major part of modern organic chemistry. Since the 
first total synthesis of urea in 1828 by Wohler
[3]
 total synthesis has evolved into a complex and 
exact science which now employs a vast array of techniques and methodologies as varied as 
the molecules they are used to construct. Over the past 100 years organic chemistry has 
witnessed many landmark syntheses of highly complex natural products such as strychnine 1 
(R. B. Woodward, 1954),
[4]
  prostaglandin 2 (G. Stork, 1976),
[5]
 erythronolide B 3 (E. J. 
Corey, 1978),
[6]
 hirsutine 4 (D. P. Curran, 1986),
[7]
 calicheamicin γI 5 (K. C. Nicolaou, 
1992),
[8]
 and taxol 6 (K. C. Nicolaou, 1994)
[9]
 as well as many more. With the increasing 
occurrence of antibiotic resistant strains of bacteria, natural products total synthesis is an 
important discipline in organic chemistry and a necessity for the medicinal and biological 
sciences.   
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Figure 1. 
2.1 Benzoisochromane quinones  
Benzoisochromane quinone (BIQ) compounds, also referred to as pyranonaphthoquinones, are 
a common class of bioactive molecule usually isolated from the Streptomyces genus but have 
been isolated from a wide variety of other bacteria. BIQ compounds usually exhibit one of 
three skeletal forms. A pyranonaphtho-5,10-dione system is present in all three and frequently 
contain a γ-lactone ring (3S, 4R)-8 and (3R, 4S)-8 present at C3, C4 which always exhibit a 
cis fused ring system or as a dihydro analogue exhibiting a carboxylic acid chain 9 at the C3 
position
[10]
. 
 
Figure 2: Skeletal structures of common BIQ compounds and ring numbering. 
These BIQ natural products are biosynthesised by a type II polyketide synthase. This is an 
iterative process involving multiple acetyl-CoA and malonyl-CoA units to form a long chain 
polyketone. This then undergoes a series of eliminations to aromatize the compound and form 
the naphthoquinone back bone.
[11, 12]
 
7 
 
Many BIQ molecules contain a 5,8-hydroxylated naphthoquinone component, commonly 
referred to as naphthazarin 10. This, in most cases, exhibits tautomerism
[13, 14]
 (scheme 1) but 
is commonly drawn with the quinone ring on the right. 
 
Scheme 1: Tautomerism of naphthazarin. 
The simplest known benzoisochromane quinone is pychorubin 11 which exhibits cytotoxic 
activity against KB cancer cells.
[15]
 Isolated in 1987
[16]
 from Psycotria rubra, this compound 
simply contains a hydroxyl group at the C3 position giving the molecule a hemiacetal motif. 
Another simple example of this class of molecule is eleutherin 12 (cis) and isoeleutherin 
(trans) which were isolated in 1950
[17]
 and 1951
[18]
 respectively from Eleutherine bulbosa. 
Both of these compounds exhibit activity against Pycococcus aureus and Streptococcus 
haemolyticus.
[17, 18]
 Another hemiacetal containing BIQ antibiotic is the highly oxygenated 
compound fusarubin. Unlike most BIQ natural compounds the more favored tautomer of this 
molecule exhibits the quinone ring of the naphthazarin core to the left of the molecule. This is 
due to electronic effects of the 7-methoxy substituent. Like other hemiacetal containing BIQ 
molecules, tautomerism occurs between the closed hydroxpyran ring and opened isomers.
[14]
  
 
Figure 3. 
A class of BIQ antibiotic containing this naphthazarin motif are the martinicins 13, 14 isolated 
from Fusarium martii in 1963
[19]
. These again exhibit a C6 methoxy group but contain a 
dioxobicyclic ring system present at C1 and C3 of the pyran ring. 
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Figure 4. 
Many pyranonaphthoquinone natural compounds contain only one hydroxyl group on the 
naphthoquinone ring system. This is normally present at the C9 position as is the case with the 
antibiotic kalafungin 15. This tetracyclic molecule was first isolated in 1968 by Beregy et 
al.
[20]
 and exhibits activity against a wide variety of bacteria, fungi, protozoa and yeast 
pathogens.
[21]
 Like many compounds of this nature it has a cis relationship between the lactone 
ring present at C3/C4 and the C1 methyl substituent which is the more thermodynamically 
stable diastereoisomer as it reduces pseudo 1,3-diaxial interactions.  
 
Figure 5. 
A series of natural compounds similar to kalafungin are the nanaomycins 16-20 isolated from 
Streptomyces rosa.
[22-25]
 Five analogues have been isolated of this class all exhibiting 1S, 3R 
(4R) stereochemistry. Nanaomycin A 16 and C 17 do not contain the lactone ring observed in 
kalafungin but a free carboxylic acid chain (A, R1 = CO2H) and primary amide chain (C, R1 = 
CONH2). Nanaomycin B 18 also lacks the presence of a lactone ring but differs as it has a 
hydroxylated quinone ring with the tertiary alcohol group present at the ring junction. 
Nanaomycin E 20 also contains a free carboxylic acid chain but, like some other BIQ natural 
molecules, has an epoxidised quinone ring. All the nanaomycins show broad spectrum 
antibiotic activity against gram positive bacteria.
[26]
 The frenolicins 21, 22 isolated from 
Streptomyces fradiae
[27-30]
 also exhibit similar structural analogues. These molecules contain 
the same 1R, 3S (4S) stereogenicity as kalafungin but differ by the presence of a C1 n-propyl 
substituent as opposed to a methyl group. 
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Figure 6: Nanaomycins A-E. 
 
Figure 7: Frenolicin and deoxyfrenolicin. 
A unique group of benzoisochromane quinone compounds are the griseusins 23, 24 isolated in 
1976 from Streptomyces griseus. These molecules contain a 1,7-dioxaspiro[5,5]undecane 
around the C1 position. The griseusins have only mild activity against gram positive 
bacteria.
[30, 31] 
 
Figure 8: The grisusins. 
Other than the granaticins 34-37, there are few carbohydrate derived BIQ natural products. 
Medermycin 25, isolated in 1976 from Streptomyces tanashienis,
[32]
 contains a tertiary amino 
pyran ring attached at the C7 position to the juglone core of the molecule via a glycosidic 
bond. This antibiotic exhibits strong activity against gram positive bacteria and leukemia.
[33]
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Figure 9: Merdermycin. 
Several dimeric and pseudodimeric benzoisochromane quinones have also been reported. The 
actinorhodins are one class of such dimers isolated from Streptomyces coelicolor and 
Streptomyces lividens. These highly coloured pigments are connected at the C7 position of the 
naphthazarin core. There are six individual actinorhodin analogues however 26 is the most 
common.
[34-36]
  
 
Figure 10: γ-actinorhodin. 
One class of structurally simplistic dimers are the cardinalins 27-29. Originally isolated from 
the toadstool Dermocybe cardinalis, these compounds show potent inhibition of leukemia 
cells. Only cardinalin 3 29 is a true dimer exhibiting 1S, 3S methyl substituents, a C6 methoxy 
group and C8 hydroxyl moiety. Cardinalin 1 27 contains hydrogenated quinone rings and a 
single reduced C5 carbonyl whereas cardinalin 2 28 contains only a single hydrogenated 
quinone group. The cardinalins do not exhibit rotation around the centre of the molecule and 
are only isolated as the R enantiomer.
[37]
 
 
Figure 11: Cardinalin 1 27, 2 28 and 3 29. 
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Another C2 symmetric group of BIQ dimers are the crisamicins. One of the more recently 
isolated benzoisochromane quinone compounds (1986)
[38]
 these natural compounds exhibit 
strong activity against melanoma cells and herpes simplex along with excellent activity against 
gram positive bacteria.
[39]
 Crisamicin A 30 contains a pyranolactone bicyclic ring system  with 
a methyl substituent present at the C1 position in the more thermodynamically favored trans 
configuration with regards to the γ-lactone. This pyran ring is fused to a juglone moiety which, 
unusually, has a hydroxyl group present at the C6 position unlike most BIQ compounds where 
the hydroxyl group is normally present at the C9 position the compound is dimerised by a 
carbon-carbon bond at the C8 position similar to many BIQ dimers. 
 
Figure 12: Crisamicin A. 
More unusual dimer like benzoisochromane quinones have also been isolated such as the red 
pigment phenocyclinone 31, isolated from Streptomyces coelicolor which has yet to have its 
absolute stereochemistry determined,
[40]
 the rhododactynaphins 32 and xanthodactynaphins 33 
isolated from the aphid Dactynotusjacae.
[41] 
 
Figure 13: Pseudodimeric BIQs phenocyclinone 31, rhododactynaphins 32 and 
xanthodactynaphins 33. 
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2.1 Granaticin 
Granaticin is a structurally unique member of the benzoisochromane quinone family of 
antibiotics as it has a fused D-glucose derived sugar moiety attached at the C7 and C8 
positions of the naphthazarin core. This sugar molecule is attached via a C-C glycosidic bond 
and aldol like bond. Granaticin exists as four analogues. Granaticin 34 and dihydrogranaticin 
A 36 contain a 2,6-dideoxyglucose substituent whereas granaticin 35 and dihydrogranaticin B 
36 exhibit an L-rhodinose molecule attached by an O-glycosidic bond to the dideoxyglucose. 
 
Figure 14: The granaticins and dihydrogranaticins.  
This unusual fused sugar motif has only ever been observed in one other natural compound. 
The quinone containing polyketide sarubicin A 15 (Figure 15). 
 
Figure 15: Sarubicin A 
The enzymatic mechanism of glycosylation has yet to be elucidated but it is assumed that the 
gene cluster gra14 is responsible.
[42]
 Two possible routes have been proposed by Ichinose et 
al.
[43]
 (Scheme 2). 
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Scheme 2: Proposed enzymatic glycosylation routes. 
The granaticins were first isolated in 1957 from Streptomyces olivaceus,
[44, 45]
 but has since 
been isolated from many others such as Streptomyces litmogenes,
[46]
 Streptomyces 
thermoviolaceus
[47]
 and Streptomyces violaceoruber.
[48]
 Granaticin has been shown to exhibit 
strong activity against gram positive bacteria with a minimal inhibitory concentration of 0.25 
to 1.75 µg/100mL. It has also been shown to have activity against lymphocytic leukemia and 
cytotoxicity against KB cancer cells.
[44-46]
  
3. Total synthesis of benzoisochromane quinones 
3.1 The first total synthesis of (±)-granaticin 
The first total synthesis of racemic granaticin A was completed in 1987 in twenty two steps 
with an overall yield of 2% by Yoshii et al.
[49]
 The group originally attempted to synthesise 
the BIQ target starting from a naphthalene derivative, however, the group could not install the 
final oxygen to generate the tetra oxygenated naphthazarin core in the final stages of the 
synthesis.
[50]
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Scheme 3: i) Methoxyvinyllithium, THF, −60 °C then HCl, MeOH (90%). ii) NaBH4, 
i
PrOH 
r.t. (100%). iii) Ac2O, py., r.t. then SOCl2, py., r.t. then KOH, MeOH, r.t. (65%). iv) Me3N(O), 
OsO4, 
t
BuOH, H2O, 60 °C (65%). v) AIBN, NBS, CCl4, 40 °C. vi) AgClO4, THF, r.t. (65% 2 
steps). vii) 2-methoxypropene, CSA, THF, r.t. (97%). 
The modified synthesis (scheme 3) began with addition of the unsaturated organolithium 
reagent methoxyvinyllithium to ketone containing bicyclic starting material 42, synthesized in 
seven steps from 1,4-dimethoxybenzene. Treatment of this methyl enol ether with methanolic 
hydrochloric acid cleaved the methyl protecting substituent to give ketone (±)-43 in good yield 
(90%). Reduction of this compound with sodium borohydride in isopropanol gave the diol as a 
9:1 mixture of diastereoisomers of (±)-44 with the major compound as the desired isomer. 
Treatment with acetic anhydride acetylated the secondary hydroxyl group only allowing for 
thionyl chloride induced β-elimination of the tertiary hydroxyl substituent. Potassium 
hydroxide was then used to remove the acetate protecting substituent in 65% yield over the 
three transformations. Dihydroxylation of the unsaturated position with osmium tetraoxide, 
using triethylamine N-oxide as a reoxidant, produced a 25:1 diastereomeric mixture of triol 
(±)-46 in modest (60%) yield and recrystalisation allowed access to the major pure epimer. 
AIBN induced radical bromination at the benzyl position provided the cyclisation precursor 
and treatment with silver perchlorate gave the oxabicyclic ring system of the sugar substituent 
in excellent yield (65% over two steps). The two remaining hydroxyl groups were then 
protected as the dimethylacetal using 2-methoxypropene to give (±)-49.  
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Scheme 4: i) 
n
BuLi, THF, −100 °C then ClCONEt2, −70 °C (70%). ii) 
t
BuLi, DMF, THF, −75 
°C (96%). iii) TMSCN, KCN, 18-crown-6, CH2Cl2, r.t. then AcOH, r.t. then 2-
methoxypropene, CSA, THF, r.t. (84%). iv) LiCH2SO2Me, 56, THF, 
t
BuOH, −78 °C (87%). v) 
Me2SO4, K2CO3, Me2CO, 56 °C (77%). vi) LiAlH4, Et2O, −15 °C then pTSA, MeCN, 0 °C 
then DBU, PhMe −10 °C ((a = 1S, 3S 32%) (b = 1R, 3S 26%) (c/d = 1S, 3R/1R, 3R 8%). 
The synthesis continued (scheme 4) with metallation of the aromatic (±)-49 ring with n-
butyllithium at low temperature and quenching with N,N-diethylcarbamoyl chloride provided 
the tertiary amide (±)-50 in good yield (70%) and a second lithiation followed by formylation 
with DMF of the remaining aromatic carbon gave cyclisation precursor (±)-51 in almost 
quantative yield (96%). Addition of potassium cyanide to the aldehyde carbonyl in the 
presence of trimethylsilyl cyanide and 18-crown-6 gave five membered lactone (±)-52 but also 
resulted in deprotection of the acetal requiring reprotection with 2-methoxypropene in 84% 
over the two steps.  
 
Figure 16: Michael acceptor 56. 
Deprotonating with LiCH2SO2Me followed by the addition of Michael acceptor 56 resulted in 
annulation to the tetra oxygenated naphthalene (±)-56 via the mechanism shown below 
(scheme 5) in excellent yield (87%).  
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Scheme 5: Mechanism for the generation of the tetraoxygenated core of granaticin. 
The generated free hydroxyl groups were then methylated with dimethyl sulfate. The carbonyl 
was then reduced with lithium aluminium hydride and exposure to pTSA deprotected the 
acetal and tertiary butyl group giving α,β-unsaturated lactone (±)-54. DBU induced oxa-
Michael addition to the lactone gave the pyran ring as all four diastereoisomers rac-55 a-d 
with the desired enantiomer (1S, 3R) isolated in 26%.  
 
Scheme 6: i) 2-methoxypropene, CSA, THF, r.t. (97%). ii) CAN, MeCN 35 °C. iii) AlCl3, 
SMe2, CH2Cl2, r.t. iv) 1% HCl, H2O, r.t. (82% over three steps). 
Reaction with 2-methoxypropene reprotected the sugar diol groups as the acetal and ceric 
ammonium nitrate oxidation gave a 1:1 regiomeric mixture of the naphthaquinone core. 
Demethylation with aluminium trichloride and dimethylsulfide accessed the deprotected 
naphthazarin centre of the molecule. A final HCl depotection of the acetal yielded (±)-
granaticin A (±)-34 in 82% over four steps.  
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 3.2 The first enantioselective total synthesis of (±)-granaticin 
The same group then reported a stereocontrolled synthesis of granaticin A in 1989
[51]
 using the 
same key steps but using an enantiopure dihydropyranone as a Michael acceptor.  
 
Scheme 7: i) CH2C(OMe)OTBS, BF3
.
Et2O, PhMe, −78 °C then 1% KOH, MeOH, r.t. (64%). 
ii) MsCl, Et3N, CH2Cl2, 0 °C (87%). iii) SiO2, (100%). iv) Me2AlNMe2, CH2Cl2, 0 °C then 
PCC, NaOAc, CH2Cl2, −10 °C (82%). 
The group started from diacetoxydihydropyran (±)-61, exposing it to boron triflouride 
eliminated an acetoxy group and forming an oxonium intermediate of (±)-61. Ketene methyl t-
butyldimethylsilyl acetal was then used as a nucleophile in the presence of boron trifluoride 
etherate complex for addition onto the oxonium generating a 3:2 mixture of separable 
diastereoisomers of (±)-62. The free hydroxyl group was then mesylated with MeSO2Cl 
resulting in lactonisation of the methyl ester and elimination of the mesyl group upon 
chromatography generating (±)-64. Ring opening of this lactone to generate the amide with 
dimethylaluminiumdimethylamide followed by pyridinium chlorochromate oxidation gave 
access to the pyranone Michael acceptor (±)-65 in a total of 46% yield over three steps. A 
modified phthalide was synthesised in seven steps in a similar fashion to (±)-69 in 32 % 
overall yield. 
 
Scheme 8: i) OsO4, Me3N(O), 
t
BuOH, H2O, r.t. ii) NBS, AIBN, CCl4, 40 °C then AgClO4, 
THF, r.t. iii) 2-methoxypropane, CSA, THF, r.t. iv) 
n
BuLi, THF, −100 °C then Et2NCOCl, −78 
°C - r.t. v) 
t
BuLi, −78 °C, DMF, 0 °C, vi) Me3SiCN, 18-crown-6-KCN complex, CH2Cl2, 0 °C 
then AcOH, r.t. vii) 2-methoxypropane, CSA, THF, r.t. 
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With the modified cyanophthalide in hand the group could couple (±)-69 with Michael 
acceptor (±)-65. 
 
Scheme 9: i) LiCH2Ms, (±)-65, 
t
BuOH, THF, −78 °C. ii) Me2SO4, K2CO3, MeCO, 57 °C (50% 
over 2 steps). iii) Li
s
Bu3BH, TMSCl, THF, −78 °C (56%). iv) 2-methoxypropene, CSA, THF, 
r.t. v) CAN, MeCN then AlCl3, SMe2, CH2Cl2 r.t (62% over 2 steps). 
(±)-65 then underwent a benzanulation reaction with the phthalide (±)-69 in 50% yield. The 
generated naphthalene hydroxyl groups were then O-methylated with dimethyl sulfate. Pyran 
carbonyl (±)-70 was then reduced stereoselectivly using lithiumtri-s-butylborohydride and the 
addition of trimethylsilyl chloride resulted in lactonisation in moderate yield (56%). This 
transformation, however, resulted in the deprotection of the dihydroxyl substituent of the fused 
sugar system requiring reprotection with 2-methoxypropene. Similarly to the previous 
synthesis, CAN oxidation of the central naphthalene system gave the O,O-
dimethylnaphthazarin core of the BIQ and treatment with aluminium trichloride and 
dimethylsulfate resulted in deprotection of the remaining methyl groups along with the acetal 
to give (±)-granaticin A (±)-34.  
3.3 Towards the total synthesis of (±)-sarubicin A 
The methodology used to synthesise the glycosylated half of granaticin A was based on a 
previous publication by Sammelheck et al.
[52]
 reporting the total synthesis of (±)-sarubicin A 
(±)-41 (scheme 10). Starting from 1,4-dimethoxybenzene the bicyclic ketone 42 was 
synthesized in 26% over seven steps.  
19 
 
 
Scheme 10: i) LDA, TBSCl, THF, r.t. ii) mCPBA, CH2Cl2, 0 °C (57% over 2 steps). iii) 18-
crown-6, KCN(cat.), PhMe, −30 °C then TMSCN, r.t. (100%, 86:14 dr). iv) DIBAL-H, 
NH4Cl/H2SO4, PhMe, r.t. v) AcOH, HCl, H2O, THF, 65 °C (84% over 2 steps). vi) 
TiMe(O
i
Pr)3, THF, r.t. (80%). vii) cyclohexene oxide, AIBN, Br2, NBS, CCl4, 10 °C. viii) 
AgClO4, THF, 0 °C (53% over 2 steps). ix) Pd(PPh3)2Cl2, 2,4-dimethoxybenzylamine, CO(g), 
90 °C (71%). x) (imid.)2CO, K2CO3, EtOAc, 120 °C.  xi) CAN, H2O, MeCN, r.t. xii) NaOH, 
H2O, dioxane, r.t. (56%). 
After generating the silyl enol ether 71 with LDA and TBDMS-Cl the unsaturated bond was 
oxidized with mCPBA to give the α-silyoxyketone 72 in a modest 57% yield over the two 
steps. Addition of trimethylsilyl cyanide to the ketone in the presence of catalytic 18-crown-6 
and potassium cyanide giving 86% conversion to the desired diastereomer of (±)-73 which 
was separated by chromatography. This cyano compound (±)-73 was then hydrolysed to the 
carboxylic acid under acidic conditions, which also cleaved the silyl protecting group, and 
then reduced in situ to the aldehyde (±)-74. Organometallic methyl addition onto aldehyde (±)-
74 occurred using methyltitaniumtriisopropoxide gave the desired diastereoisomer (±)-75 in 
80% yield. Similarly to the total synthesis of (±)-granaticin A by Yoshii
[49, 50]
 the oxobicyclic 
system was formed by AIBN induced radical bromination at the benzylic position followed by 
silver perchlorate induced ether formation which occurred in 53% yield over two steps to give 
(±)-48. A palladium catylised carbonylation reaction was then employed using 2,4-
dimethoxybenzylamine, as ammonia was not successful, to install the amide moiety and give 
(±)-76. This allowed for concomitant oxidative removal of the 2,4-dimethoxybenzyl 
substituent and conversion to quinone (±)-77 with ceric ammonium nitrate. The group, 
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however, did not report the terminal step for the installation of the remaining amine to give 
sarubicin A 41 in 13 steps. 
3.4 Synthesis of kalafungin via tandem Michael-Diekmann approach 
In 2007 Christopher Donner synthesized (+)-kalafungin 15 using a tandem Michael-Diekmann 
approach as the key step.
[53]
 
 
Scheme 11: i) KBr, NaNO2, H2SO4, H2O, 0 °C (91%). ii) BH3
.
THF, THF, −30 °C (97%). iii) 
TBSCl, imid., CH2Cl2, r.t. (98%). iv) methyl propiolate, 
n
BuLi, BF3
.
Et2O, THF, −78 °C (72%). 
v) MeONa, MeOH, r.t. (80%). 
The synthesis involved generating epoxide 81 from enantiopure (S)-aspartic acid 78
[54]
 by 
treating it with sodium nitrite to generate the diazonium salt under acidic conditions resulting 
in formation of the β-lactone. Potassium bromide was then used to open the lactone, retaining 
the stereochemistry at the C2 position in high yield. This was then reduced with borane and 
treatment with sodium hydride and TBDMSCl yielded the desired epoxide 81 in 85% total 
yield. Lewis acid induced ring opening with methyl propiolate and n-butyllithium gave the 
corresponding secondary alcohol 82. Sodium methoxide was then used for conjugate addition 
onto the alkyne then as a base to induce intramolecular lactonisation forming 83 in good 
overall yield (62%).  
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Scheme 12: i) LDA, THF, −60 °C (52%). ii) MeMgBr, THF then TFA, Et3SiH, CH2Cl2, −78 
°C then HCl, THF, r.t. (64% over 2 steps). iii) NBS, DMF, r.t. then CAN, H2O, MeCN, r.t. 
(82% over 2 steps). iv) AlCl3, CH2Cl2, r.t. (92%). v) PhI(OAc)2, TEMPO, CH2Cl2, r.t. then 
NaClO2, NaH2PO4, 
t
BuOH, H2O, r.t. (80% over 2 steps). vi) O2, MeOH, py., 60 °C then 
BF3
.
Et2O, Et3SiH, CH2Cl2, −45 °C (65% over 2 steps). vii) H2SO4, PhH (80%). 
Methyl-(2-methoxy-6-methyl)benzoate 84, in the presence of LDA resulted in a Michael 
addition onto 83, by deprotonation of the methyl group, followed by Dieckmann condensation 
and aromatization to generate the naphthalene backbone 85 in modest yield (52%). This 
lactone was then treated with methyl magnesium bromide to install the C1 methyl substituent 
and deoxygeneation with triethylsilane and TFA produced the desired pyran ring 86. Only the 
opposite enantiomer of kalafungin was generated as hydride delivery occurs from the opposite 
side to the substituent present at C3 due to steric hindrance. Subjecting this molecule to 
hydrochloric acid 2M resulted in silyl deprotection. The quinone core of 87 was installed by 
aromatic bromination using NBS followed by ceric ammonium nitrate oxidation in high 
overall yield. The aromatic hydroxyl group was then deprotected using aluminium trichloride 
to give 88 followed by double oxidation of the primary alcohol with PhI(OAc)2 then a Pinnick 
oxidation
[54]
 with NaClO2 to give the free carboxylic acid 89. Exposure to pyridine and 
atmospheric oxygen resulted in a mixture of the desired lactonised molecule, however, 
addition of methanol to C1 also occurred to give an unsymmetrical acetal. Fortuitously 
treatment with triethyl silane and boron trifluoride etherate complex gave only desired 
compound 89 as a single enantiomer. Epimerisation (+)-kalafungin occurred when the 
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compound was exposed to concentrated sulfuric acid yielding (+)-kalafungin (+)-15 in 
eighteen steps (5.2% overall yield). 
3.5 Synthesis of the (±)-γ-actinorhodin monomer via ceric ammonium nitrate induced 
oxidative rearrangement 
In 1997, Margret Brimble
[55]
 synthesised the (±)-γ-actinorhodin monomer utilizing three key 
steps. A benzyne cycloaddition with furan/2-methoxyfuran, a Fries rearrangement
[56]
 and a 
ceric ammonium nitrate induced oxidative rearrangement to form the pyran ring.  
 
Scheme 13: i) NaNH2, THF, 50 °C then conc. HCl, MeOH, −78 °C (76% over 2 steps, R = H). 
ii) Et3N, Ac2O, DMAP, CH2Cl2, r.t. (72% R = H). iii) BF3
.
Et2O, Et2O, r.t. (70% R = H). iv) 
CAN, H2O, MeCN, r.t. (40% R = H). v) 2-(trimethylsilyloxy)furan, MeCN, H2O, 0 °C (66%). 
vi) CAN, H2O, MeCN, r.t. (75%). vii) TFA, Et3SiH, CH2Cl2, r.t. then CH2N2 (68%). viii) 
BBr3, CH2Cl2, −78 °C (82%). 
Treatment of 1-bromo-2,5-dimethoxybenzene 90 with sodium amide and furan followed by 
reflux in the presence of concentrated hydrochloric acid gave 1-hydroxy-5,8-
dimethoxynaphthalene 91 (R = H) in good yield (76%) following previously described 
methodology.
[57]
 Using 2-methoxyfuran as the diene, 1-hydroxy-4,5,8-trimethoxynaphthalene 
91 (R = OMe) could be generated but only in poor yield. Subjecting either of these compounds 
to triethylamine and acetic anhydride with catalytic DMAP converted the free naphthol group 
to the corresponding acetate 92. Exposure to boron trifluoride etherate complex resulted in a 
Fries rearrangement
[57]
 to install the acetate group at the C2 position generating 93. CAN was 
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then used to form the O,O-dimethylnaphthazarin core 94 on either molecule in low yield. 
Reaction of this naphthoquinone with 2-(trimethylsiloxy)furan via conjugate addition at C5 of 
the furan to C3 of the quinone followed by Michael addition of the C4 oxygen onto the newly 
formed α,β-unsaturated lactone gave the desired cyclisation precursor (±)-95 in a modest 66% 
yield. Oxidative rearrangement using CAN provided the cis fused pyranolactone (±)-96 in 
75%. This was then treated with triethylsilane in the presence of TFA to reduce the hemiacetal 
to the desired pyran ring (±)-97. The group discovered that increasing the reaction time and 
the addition of diazomethane would also generate the free carboxylic acid chain giving the C1 
epimer of the protected γ-actinorhodin monomer. Fortuitously, exposure of this compound to 
boron tribromide not only cleaved the O-methyl protecting substituents but resulted in 
epimerization at the C1 position to generate the desired (±)-γ-actinorhodin monomer (±)-98 in 
a total of nine steps (4.2% overall yield). This strategy was also used for the synthesis of the 
lactone containing actinorhodin monomer by using only two equivalents of CAN and limiting 
reaction time in step vi) preventing lactone opening. 
3.6 Synthesis of (±)-deoxyfrenolicin via Dötz benzannulation 
 
Scheme 14: i) 
n
BuLi, Cr(CO)6, Et2O, −78 °C then Me4NBr, H2O, r.t. ii) AcCl, −20 °C, CH2Cl2 
then (±)-108, CH2Cl2, r.t. (88% over 2 steps). iii) DDQ, Et2O, MeCN, 35 °C (51%). iv) H2SO4, 
MeOH, r.t (95%). v) NaBH4, THF, r.t. then DDQ, MeOH, 0 °C. vi) PdCl2(MeCN)2, CuCl2, 
MeOH, CO, r.t. (70% over 2 steps). vii) BBr3, CH2Cl2, −78 °C (84%). viii) KOH, MeOH, r.t. 
(97%). 
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Another common method for the synthesis of benzoisochromane quinones is utilizing a Dötz 
benzanulation
[58, 59]
 as a key step. In 1982 Sammelheck et al.
[60]
 reported the total synthesis of 
(±)-deoxyfrenolicin (±)-107 using this approach. Starting from 2-bromomethoxybenzene 99 
the group synthesized the necessary chromium carbene complex by metallating with n-
butyllithium, quenching with chromium hexacarbonyl and isolating 100 as the 
tetramethylammonium salt. This hydroxide group was then acetalated with acetal chloride and 
displaced with 2-(non-5-yl-4-yloxy)ethanol (±)-108 to give the cyclisation precursor 90 in 
excellent yield (88% over two steps). Heating this carbene complex resulted in formation of 
the trioxygenated naphthalene backbone followed by exposure to DDQ gave the 
naphthoquinone (±)-102 in modest yield. Treatment of this compound with sulfuric acid 
resulted in removal of the 2-hydroxyethylene group, oxidizing the secondary alcohol to the 
corresponding ketone (±)-103 and reducing the quinone ring to the para hydroxylated 
aromatic analogue in almost quantitative yield (95%). Sodium borohydride was then used to 
reform the secondary alcohol followed by a second DDQ oxidation to yield the central 
quinone ring. Palladium catalysed alkoxycarbonylation, in methanol, under an atmosphere of 
carbon monoxide produced the pyran ring and gave the carboxylic acid chain rac-105 as a 3:1 
mixture of trans:cis diastereoisomers in excellent overall yield (84%). Cleavage of the O-
methyl substituent fortuitously resulted in epimerization of the C3 position to give only the 
more thermodynamically stable trans isomer (±)-106 in 84% yield. The final step was then to 
saponify the methyl ester using potassium hydroxide which occurred in almost quantative 
yield (97%) to give (±)-deoxyfrenolicin (±)-107 in 24% total yield over eight steps. 
3.7 Biomimetic approaches to benzoisochromane quinone synthesis  
Another interesting approach to BIQ synthesis is to a biomimetic synthesis of the 
hydroxylated naphthalene core via double Claisen condensation with a gluterate ester 
derivative, such as diethyl-3-hydroxygluterate, followed by base induced aromatization. One 
example of such a biomimetic approach was used by Harris et al. in 1977
[61]
 to synthesise (±)-
eleutherin (±)-114 but has since been used for the synthesis of several BIQ compounds and 
naphthalene based molecules.
[62]
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Scheme 15: i) LDA, 2,4-diketopentane, THF, −78 °C (24%). ii) TFA, EtOH, r.t. iii) Pd/C, H2, 
EtOH, r.t. iv) CH2N2, Et2O, r.t. v) (KSO3)2NO, H2O, r.t. vi) H3PO4.    
In this synthesis by Harris et al., LDA was employed to generate the dianion of penta-2,4-
dione, which was used in excess, followed by the addition of diethyl-3-pyrrolidinylgluterate 
(±)-108 to affect dual Claisen condensation and generate a hexaone intermediate. Increasing 
the temperature from −78 °C to −35 °C, still under basic conditions, resulted in the formation 
of the highly substituted dihydroxynaphthalene derivative (±)-109 in 24% yield. 
Trifluoroacetic acid was then used to induce ring closure and elimination to give 
isochromanone (±)-110 followed by palladium catylised hydrogenation to give the racemic 
naphthopyran core of the molecule 111. Methylation of the C9 hydroxyl group with 
diazomethane gave rac-112 followed by oxidation with Fremy’s salt provided the O-
methoxyjuglone ring system (±)-113. Exposure to phosphoric acid epimerized the C1 carbon 
to generate the more stable trans isomer giving (±)-eleutherin (±)-114. Since this synthesis in 
the late 70’s the biomimetic approach has been optimised[62] using 3-hydroxygluterate and a 
calcium acetate to induce aromatization producing the naphthalene backbone of many 
molecules in much higher yield (≈50%).  
3.8 Synthesis of (−)-frenolicin B via regioselective Diels-Alder cycloaddition 
A common method for the synthesis of BIQ targets is by a late stage regioselective Diels-
Alder cycloaddition. This methodology was pioneered by Kraus et al.
[63]
 for the synthesis of 
elutherin 14 in 1981 and used again in several synthesis particularly by Kraus in 1993 for the 
first total synthesis of frenolicin B.
[64]
 The group employed an alkoxycarbonylation similarly 
to the method of Sammelheck et al.
[52]
 in 1985 as a key step to form the pyran ring and γ-
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lactone ring and used their previously devised Diels-Alder reaction/Jones oxidation
[65]
 to 
install the juglone like core of the molecule.  
 
Scheme 16: i) (+)-Ipc2BCl, CH2Cl2, r.t. (100%, 93% ee). ii) 
n
BuLi, acrolein, THF, −78 °C 
(56%, 89% ee). iii) Pd(OAc)2, CO,  THF, r.t. (65%). iv) HNO3, AgO, r.t. (95%) v) 1-
trimethylsiloxy-1,3-butadiene, CH2Cl2, −78 °C. vi) Jones reagent, Me2CO, r.t. (81% over 2 
steps). 
Starting from 1,4-dimethoxybenzene-2-butyl ketone 115, the synthesis involved an 
asymmetric Brown reduction
[66]
 using (+)-Ipc2BCl followed giving 93% of the (R) enantiomer 
of 116 (determined by analysis of the Mosher ester) by ortho lithiation and quenching with 
acrolein to give a mixture of diols of 117 in high enantiomeric excess (89%, (S)) but only in 
56% total yield due to meta and para metallation compounds. Altering the solvent system to a 
1:10 ether:pentane improved the yield but lowered the enantiomeric selectivity of the reaction. 
Palladium catalysed carbonylation of this diol, under an atmosphere of carbon monoxide, 
afforded the formation of both pyran and lactone ring systems 118 in modest yield (65%). A 
seldom used Rapoport oxidation
[67]
 with silver oxide and nitric acid then gave the 
cycloaddition precursor 119 in excellent yield (95%). Diels-Alder reaction with 1-siloxy-1,3-
butadiene at low temperature followed by immediate exposure of 120 to Jones reagent yielded 
the target compound (–)-24 with excellent conversion from the quinone (81%) observing the 
presence of only one regioisomer. The rationale for this observed selectivity is the presence of 
the lactone ring. When the silyl containing diene overlaps with the quinone substituent the 
trimethylsilyl group forces the lower quinone carbonyl group towards the towards the lactone 
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oxygen thus making this the disfavored orientation. Therefore, reaction occurs preferentially 
with the silyl enol ether positioned at the top of the molecule (Figure 17). 
 
Figure 17: Diene overlap with 119. 
3.9 Synthesis of (±)-crisamicin via regioselective Diels-Alder cycloaddition 
Zhen Yang et al. in 2008
 
also used a Diels-Alder cycloaddition followed by a Jones oxidation 
for the synthesis of the dimeric benzoisochromane quinone (±)-crisamicin A
[68]
 (±)-30. Again, 
a palladium catalysed carbonalytive lactonisation was used, similarly to that reported by Kraus 
et al.
[65]
, then the group wanted to employ a homocoupling step to generate the dimer which, 
to the best of this author’s knowledge, was the first example of dimerisation at the C8 position.  
 
Scheme 17: i) SOCl2, 75 °C then Et2NH, CH2Cl2, r.t. (93%). ii) 
t
BuLi, TMEDA, DMF, THF, 
−78 °C (92%). iii) MeMgCl, THF r.t. then pTSA, PhMe, r.t. (89%). iv) LiAlH4, THF, 0 °C 
then TEMPO, BAIB, CH2Cl2, r.t. (79%). v) vinylmagnesium chloride, THF, 40 °C (59%). vi) 
Pd(OAc)2, TMTU, CO, CuCl2, propylene oxide, NH4OAc, THF, 50 °C (88%). vii) CAN, H2O, 
MeCN, v10 °C (89%). viii) 1,1-dimethyl-3-silyoxy-1,3-butadiene then Jones reagent, Me2CO, 
r.t. (85%). 
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The group began the synthesis from 2,5-dimethoxybenzoic acid 121 converting it to the 
corresponding diethyl amide 122 with thionyl chloride and diethylamine. This allowed for 
directed ortho lithiation using t-butyllithium in the presence of TMEDA and subsequent 
formylation with dimethylformamide in excellent yield (85% over two steps) to give 123. 
Addition of methyl magnesium chloride to the generated aldehyde followed by pTSA induced 
cyclisation gave the five membered lactone (±)-124 in good yield (89% over two steps). 
Reduction with lithium aluminium hydride resulted in the ring opened diol and exposure to 
TEMPO in the presence of BIAB (PhI(OAc)2) reformed the ring as the hemiacetal 125 in high 
yield. Diastereoselective ring opening with vinyl magnesium chloride generated the 
alkoxycarbonylation precursor (±)-126 in a modest 59% yield. Installing the pyran and lactone 
rings proved to be a challenge with various additives screened to optimize the reaction. The 
group eventually discovered that the use of a TMTU ligand, addition of copper
II
 chloride 
along with ammonium acetate and propylene oxide gave the desired carbonylation compound 
(±)-127 in 88% yield. This isochromane compound was then subjected to standard ceric 
ammonium nitrate oxidation conditions to yield the corresponding quinone (±)-127 (89%). 
Diels-Alder cycloaddition with the diene ((4,4-dimethoxybuta-1,3-dien-2-
yl)oxy)trimethylsilane gave a 20:1 regioisomeric mixture with the desired compound being the 
major isomer. This is attributed to hydrogen bonding between the lower quinone carbonyl, the 
lactone oxygen and a methyl proton of the diene favoring this orientation for the pericyclic 
reaction as opposed to previously observed results were the orientation of the diene favors the 
more sterically hindered substituents at the top of the isochromane quinone.
[69]
 Exposure to 
Jones’ reagent then provided the crisamicin monomer (±)-128 in 85% yield with an aromatic 
hydroxyl group as a functional handle to achieve homocoupling. 
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Scheme 18: i) Tf2O, DMAP, py., r.t. (78%). ii) Na2S2O4, Bu4NBr, THF, H2O, r.t. then 
MOMCl, DMAP, DIPEA, CH2Cl2, r.t. iii) PdCl2(dppf), (Bpin)2, dioxane, 85 °C (76% over 2 
steps). iv) Catalyst 126, Ag2CO3, DMSO, H2O (87%). v) TMSBr, CH2Cl2, −78 °C then SiO2 
(93%). vi) BCl3, CH2Cl2, −78 °C (91%). 
Triflation of the hydroxyl group of (±)-128 using trifluoromethanesulfonic anhydride in the 
presence of catalytic DMAP and pyridine gave the Suzuki coupling precursor (±)-129 in good 
yield, however several protection steps were required to achieve this transformation. The 
addition of sodium sulfate and tetrabutylammonium bromide reduced the central quinone ring 
to the corresponding dihydroxybenzene substituent which was then protected with 
methoxymethylene chloride to give (±)-130 using Hünig’s base and catalytic DMAP. The 
aromatic triflate group was then converted to the boronic pinacol ester using PdCl2(dppe)2 and 
homocoupling was achieved using palladium complex 134 in the presence of silver carbonate 
in excellent yield (87%). Treatment with trimethylsilyl bromide under basic conditions 
allowed for cleavage of the MOM substituents followed by silica gel chromatography induced 
oxidation to produce the quinone centre of compound (±)-133. Then treatment with boron 
trichloride gave crisamicin A (±)-30 in a total of 10% yield over twenty steps. 
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3.10 Synthesis towards the granaticin aglycone via Sharpless asymmetric 
dihydroxylation and benzyne cycloaddition 
In 2012 and 2013 Ulrich Koert et al.
[70, 71]
 published two articles towards the total synthesis of 
granaticin A with the long term aim of using a benzyne cycloaddition to fuse the two sections 
of the natural compound together forming the central aromatic ring.  
 
Scheme 19: i) vinylmagnesium bromide, THF, −60 °C (95%). ii) Ac2O, py., 0 °C (90%). iii) 
Pd2(dba)3, CO, PPh3,DIPEA, NaBr, MeOH, 50 °C (99%). AD-mix-α, NaHCO3, MeSO2NH2, 
t
BuOH, H2O, 0 °C (87%). v) MeCH(OMe)2, BF3
.
Et2O TFA, 80 °C (41%, 14:1 dr). vi) CAN, 
MeCN, −20 °C (59%). vii) Pd/C, H2, EtOAc, 20 °C (99%). viii) O3, CH2Cl2, DMF, −110 °C 
(42%). 
The synthesis of the protected aglycone
[70]
 began with the addition of vinyl magnesium 
bromide to 2,5-dimethoxybenzaldehyde 134 to give unsaturated alcohol (±)-135 in almost 
quantative yield. The secondary hydroxyl group was then acetylated with acetic anhydride in 
the presence of pyridine in 90% yield forming (±)-136. A palladium catalysed carbonylation 
reaction using Pd2-(dba)3, triphenylphosphine, Hünigs base and sodium bromide as a 
methanolic solution under an atmosphere of carbon monoxide yielded β,γ-unsaturated ester 
(E)-137 in high yield. This compound was not purified due to its high instability towards 
chromatography. Sharpless asymmetric oxidation
[72, 73]
 with AD-mix α gave the cyclised (4R, 
5S)-hydroxylactone 138 in excellent yield (87%) and enantiomeric excess (95%). The group 
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then attempted an oxa-Pictet-Spengler cyclisation in ethereal solvent using boron trifluoride 
etherate complex as a Lewis acid. This, however, only generated the undesired cis enantiomer, 
albeit in high yield (88%). The group eventually devised a method to achieve this 
transformation producing an enantioenriched mixture of diastereoisomers in a 14:1 trans:cis 
ratio. This reaction involved the addition of the lactol 138 to an 80 °C TFA solution of 
BF3
.
Et2O and 1,1-dimethoxyethane followed by quenching with base at 0 °C after 60 seconds 
to yield 41% of the diastereomeric mixture of 127. This isochromane 127 was then treated 
with cerium
IV
 ammonium nitrate to remove the phenolic O-methyl substituents, generating the 
corresponding quinone 128.  
 
Scheme 20: i) TFAA, CHCl3, 20 °C. ii) Li(O
t
Bu)3AlH, THF, 0 °C (42% over 2 steps). iii) 
DIBAL-H, CH2Cl2, −78 °C. iv) HCl, H2O, 0 °C. v) BF3
.
Et2O, MeOH, 40 °C (55% over 3 
steps). vi) 1-bromo-2,5-dimethoxybenzene, LDA, THF, −78 °C (100%). vii) BF3
.
Et2O,, 
MeOH, 65 °C then H2SO4, Me2CO, 57 °C. viii) Jones reagent, Me2CO, 20 °C (26% over two 
steps).   
The group then investigated a series of Diels-Alder reactions based on the method of Kraus
[65]
 
to form the naphthoquinone back bone of granaticin 34, however, only elimination reactions 
were observed to give the naphthoquinone substituent with no incorporation of oxygen at 
either the C6 or C8 possition. The group then revised the synthesis to include a benzyne 
cycloaddition. The quinone 128 was then reduced to the para diol using a palladium catalysed 
hydrogenation in 59% over two steps. Ozonolysis of this aromatic gave the α,β-unsaturated 
dicarboxylic pyran 139 in high yield (82%). The diacid 140 (scheme 18) was then converted to 
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the anhydride 141 using TFAA in excellent yield (97%). Nucleophilic addition to the 
anhydride with ortho lithiated 1,4-dimethoxybenzene gave the desired compound as a mixture 
of regioisomers and generation of the methyl ester with MeI in the presence of cesium 
carbonate occurred in modest yield (50%). However, formation of the quinone ring by 
aromatic substitution could not be achieved. The group then attempted a Diels-Alder reaction 
using 1-acetoxy-1,3-butadiene but only observed a non-hydroxylated naphthoquinone as a 
result of elimination of the acetoxy group. Finally, the group converted the pyranoanhydride to 
a furan derivative 144 in an attempt to generate the granaticin aglycone via a benzyne 
cycloaddition. Using lithium tri-t-butoxyaluminium hydride the anhydride was reduced to a 
regiomeric mixture of unsaturated lactones 142, 143. DIBAL-H reduction of both γ-lactones 
gave the ring opened product. Exposure to aqueous hydrochloric acid followed by reaction 
with a methanolic solution of boron trifluoride etherate complex not only generated the furan 
diene but protected the pyran lactone as an unsymmetrical acetal. Two equivalents of this 
diene 144 were then subjected to a benzyne cycloaddition with 1,4-dimethoxybenzyne to give 
the desired adduct in almost quantative yield. Exposure of this compound to BF3
.
Et2O gave a 
mixture of ring opened regioisomers which were then oxidized in very low yield (26%) under 
Jones conditions to give the O,O-methyl granaticin aglycone 146 in a total of 1.6% over 17 
linear steps. To date the group has not succeeded in performing a regioselective benzyne 
cycloaddition on fused sugar aromatic bromide. 
3.11 Synthesis of kalafungin and nanaomycin via Sharpless asymmetric dihydroxylation 
A similar methodology to Koert et al. was used by Rodney Fernandes and Reinhard Brückner 
for the synthesis of both kalafungin 15 and nanaomycin D 19 in 2005
[74]
. Again, employing a 
Sharpless asymmetric dihydroxylation
[72, 73]
 to form the γ-lactone ring of both natural 
compounds and an oxa-Pictet-Spengler cyclisation to give the pyran ring as the key steps of 
the synthesis using either AD-mix-α or AD-mix-β. The synthesis of kalafungin 15 is shown in 
schemes 19 and 20 The main difference in the synthetic strategy was to begin with a 
naphthalene derivative.  
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Scheme 21: i) Ac2O, Et3N, DMAP, CH2Cl2, r.t. (87%). ii) NBS, AcOH, H2O, 55 °C (92%). iii) 
Na2S2O4, TBAB, THF, H2O, r.t. then KOH, r.t. then Me2SO4, r.t. (80%). iv) 
n
BuLi, acrolein, 
THF, −85 °C (70%). v) Ac2O, Et3N, DMAP, CH2Cl2, r.t. (85%). vi) Pd2(dba)3
.
CHCl3, PPh3, 
NBr, EtN
i
Pr2, CO, MeOH, 50 °C (83%). vii) (DHQD)2-PHAL, K3Fe(CN)6, K2CO3, NaHCO3, 
MeSO2NH2, K2Os2(OH)4, 
t
BuOH, H2O, 0 °C then r.t. (82%). vii) BF3
.
Et2O, MeCH(OMe)2, 
Et2O, THF, r.t. (92%) 
Compound 148 was synthesised from commercially available 1,5-dihydroxynaphthalene 147 
by bis acetylating with acetic anhydride and achieving an in situ bromination/oxidation using 
N-bromosuccinamide in acetic acid to give O-acetate protected 6-bromojuglone. In turn this 
was reduced and methylated to give the trimethoxynaphthalene derivative 149. Lithiation with 
n-butyllithium, trapping with acrolin and converting the secondary alcohol to an acetoxy 
leaving group (±)-150 with acetic anhydride gave the Tsuji carbonylation precursor (E)-155 in 
38% over five steps. The carbonylation generated a 95:5 mixture of inseperable β,γ:α,β-
usaturated esters in 83% combined yield which were subjected to Sharpless asymmetric 
dihydroxylation conditions using AD-mix-α towards the total synthesis of kalafungin 156a 
(4S, 5R) or AD-mix-β towards the total synthesis of nanaomycin 156b (4S, 5R) (79% and 82% 
respectively).  
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Scheme 22: i) CAN, MeCN, H2O, r.t. (87%). ii) BBr3, CH2Cl2, −50 °C (82%). iii) conc. 
H2SO4, r.t. (87%). 
Oxa-Pictet-Spengler cyclisation of 156a/156b with boron trifluoride etherate complex and 1,1-
dimethoxyethane followed by ceric ammonium nitrate oxidation and boron tribromide 
deprotection gave either 159a (72:28 mixture of diastereoisomers at the C1 position) or 159b 
(67:33 mixture of diastereoisomers at the C1 position). Enantiopurity could be enriched by 
exposure to concentrated sulfuric acid followed by recrystalisation to give the pure desired 
diastereoisomer. Thus the total synthesis of kalafungin 15 and nanaomycin 19 had been 
achieved in eleven steps in 15% overall yield for both natural compounds. 
3.12 Synthesis of demethoxycardinalin via oxa-Pictet-Spengler cyclisation 
In 2010 Rodney Fernandes et al. reported the total synthesis of the dimeric benzoisochromane 
quinone demethoxycardinalin
[76]
 using three key steps. A Fischer chromium carbene synthesis, 
Dötz benzanulation
[58]
 and oxa-Pictet-Spengler. Similarly to many synthetic strategies of 
dimeric BIQ molecules
[77, 78]
 two simultaneous reactions are performed building the molecule 
from the centre outwards.  
 
Scheme 23: i) Baker’s yeast, DMSO, EtOH, r.t. (69%) or [NEt2H2]-[{RuCl(S)-BINAP}2(µ-
Cl3)], MeOH, H2, 50 °C (100%). ii) TBSCl, imid. CH2Cl2, r.t. (98%). iii) DIBAL-H, CH2Cl2, 
−78 °C (97%). iv) CBr4, PPh3, CH2Cl2, 0 °C then 
n
BuLi, THF, −78 °C (80%). 
The group began with the synthesis of the benzanulation alkyene starting from ethyl 
acetoacetate and performing an asymmetric reduction to the (S) enantiomer either using 
Baker’s yeast (69%) or by a Noyori hydrogenation (100%).[79, 80] Protection of this hydroxyl 
with TBDMSCl gave 161 in 98% yield. This was followed by reduction of the ethyl ester to 
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aldehyde 162 with DIBAL-H which occurred in excellent yield (97%). Treatment of this 
aldehyde carbon tetrabromide and triphenyl phosphine followed by the addition of n-
butyllithium to affect a Corey-Fuchs reaction
[81]
 gave the desired alkyne 163 in 80% over two 
steps. 
 
Scheme 24: i) 
n
BuLi, Et2O, −78 °C then Cr(CO)6, 0 °C then Me3OBF4, CH2Cl2, r.t. (58%). ii) 
152, THF, 45 °C (65%). iii) NaH, MeI, THF, 80 °C (88%). iv) TBAF, THF, r.t. (93%). v) 
MeCH(OMe)2, HCl(g), Et2O, r.t. (55%). 
Attention was then focused on the Fischer carbene synthesis, taking the diaryl dibromide 164 
and metallating with 
n
BuLi followed by the addition of chromium hexacarbonyl and in situ 
protection of the generated hydroxyl group with trimethyloxonium tetrafluoroborate. After 
optimising the reaction times of all three additions and solvent systems the reaction gave a 
modest 59% yield of the dimer. Dötz benzanulation
[58]
 gave the desired substituted (S, S’)-
naphthalene dimer 166 with two equivalents of the previously synthesised alkyne in modest 
yield (65%) followed by protection of the newly formed hydroxyl group with methyl iodide 
generating 167. Silyl cleavage occurred in almost quantative yield to give the cyclisation 
precursor 168. The group then discovered that the use of a Lewis acid and the dimethyl acetal 
of acetaldehyde the oxa-Pictet-Spengler reaction only yielded the less thermodynamically 
stable cis:cis adduct or cis:trans adduct. Using a protic acid (HCl gas) in aprotic solvent gave 
the desired cis:cis stereochemistry of 169 (55%) at the C1/C1’ position which the group 
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attributes to the formation of the E-oxocarbenium with protic acid and predominantly the Z-
oxocarbenium compound with a Lewis acid.  
 
Scheme 25: i) CAN, MeCN, H2O, r.t. (74%), ii) AlCl3, CH2Cl2, 0 °C (77%). 
A ceric ammonium nitrate oxidation installed the quinone ring to give 170 and a simple 
aluminium trichloride deprotection of the two remaining methyl groups gave 
demethoxycardinalin 171 in a total of 17% over six steps. 
3.13 Synthesis of (±)-deoxyfrenolicin via oxa-Pictet-Spengler cyclisation 
Another synthetic strategy that utilized an oxa-Pictet-Spengler was that devised by Xu et al.
[82]
 
in 1999 for the total synthesis of (±)-deoxyfrenolicin 96. However, their strategy involved a 
DDQ induced C-C coupling of the n-propyl C1 substituent to generate only the desired trans 
isomer using allyltriphenyltin.  
 
Scheme 26: i) CH2(OMe)2, BF3
.
Et2O, Et2O, r.t. (85%). ii) Ph3SnCH2CHCH2, DDQ, CH2Cl2, 
r.t. (94%). iii) Pd/C, H2, EtOH, r.t. (77%). iv) Cr(O)3, AcOH, Me2CO, H2O, r.t. then MeOH, 
H2SO4, r.t. (43% over 2 steps). v) BBr3, CH2Cl2, −78 °C (85%). vi) KOH, MeOH, r.t. (97%). 
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Again, a Dötz benzanulation
[58]
 gave the desired substituted naphthalene followed by a series 
of protecting group transformations produced the oxa-Pictet-Spengler precursor (±)-172 in 
good overall yield. Starting from allyl alcohol this, precursor was generated in 31% yield over 
8 steps. Cyclisation of (±)-172 with dimethoxymethane in the presence of boron trifluoride 
etherate complex gave the pyran ring unsubstituted at the C1 position (±)-173. The addition of 
DDQ and allyltriphenyltin installed the allyl substituent in excellent yield (94%) only 
observing the trans diastereoisomer (±)-174. This is attributed to the bulky stannane reagent 
preventing the formation of the more sterically hindered and less thermodynamically favored 
cis isomer. Concomitant hydrogenation of the allyl group to give then n-propyl chain and 
cleavage of the benzyl protecting moiety, exposing the primary hydroxyl group to give (±)-
176, occurred in good yield (77%). This was followed by chromium
VI
 oxide global oxidation 
to give the free carboxylic acid and quinine ring. Esterification using methanol under acidic 
conditions provided the methyl ester (±)-106 in 47% over two steps. The remaining methyl 
ether was then deprotected with boron tribromide and saponification of the ester with 
potassium hydroxide yielded deoxyfrenolicin (±)-107 in 82% over two steps with an overall 
yield of 7% over fifteen steps.  
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4. Aims 
The long term aim of this project is the elucidation of the enzymatic mechanism of 
glycosylation of the granaticin aglycone, the role of gra14 in this glycosylation and the 
potential of the enzyme to glycosylate unnatural substrates.  
The primary aim off this research is to devise a novel, elegent and divergent synthesis of the 
dihydrogranaticin aglycone and analogues of the aglycone. As there have been many 
previously reported total syntheses of benzoisochcromane quinone antibiotics we have placed 
an importance on step economy, attempting to avoid multiple protection/deprotection steps 
and oxidations.  
We also wish to apply the devised methodology towards the total synthesis of other 
benzoisochromane quinone antibiotics such as eleutherin 114, nanaomycin A 16, frenolicin 22 
and kalafungin 15.  
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5. Results and discussion  
5.1 Previous research 
Previous work conducted within this laboratory
[83]
 attempted to synthesise the desired 
naphthamide 180 from 1,4,5,8-tetrametehoxynaphthalene 179. This was achieved by O-
methylation of commercially available 1,5-dihydroxynaphthalene 147 to give 177 and para 
dibromination to generate 178. This allowed for copper mediated coupling with sodium 
methoxide generating the tetra oxygenated precursor 179 in modest yield according to the 
method of Terada et al.
[84]
     
 
Scheme 27: i) MeI, K2CO3, Me2CO, 56 °C (99%). ii) Br2, CCl4, 70 °C (54%). iii) MeONa, 
CuI, DMF, MeOH, 70 °C (49%). 
It was, however, observed that this species underwent rapid oxidation to 
dimethoxynaphthazarin 168 when exposed to Lewis acids preventing Friedel-Crafts 
substitution
[85]
 with isopropylisocyanate. 
 
Scheme 28: Oxidation of 179 to O,O-dimethoxynaphthazarin 181. 
 
Scheme 29: i) AlCl3, 
i
PrNCO, CH2Cl2, 0 °C (182 = 0%, 183 = 1.3%, 184 = 54%) 
40 
 
Attempts at Friedel-Crafts aromatic substitutions on the dibromodimethoxy species (scheme 
29), to allow for later oxidation, resulted in complete degradation of the naphthalene starting 
material 178. Regressing back through the synthetic methodology, Friedel-Crafts substitution 
was next attempted on 1,5-dimethoxynaphthalene 177 (scheme 28) which yielded 1.3% of the 
desired ortho substituted naphthamide 183 and 57% of the para substituted regioisomer 184. 
This can be attributed to the cross-conjugation of the cationic intermediate. Reaction with 
isopropylisocyanate was then examined as a method to perform nucleophilic substitution by 
ortho lithiation of 1,5-dimethoxynaphthalene 177. However, deuterium quenching studies 
showed only low levels of lithiation even with multiple equivalents of 
t
BuLi. 
4.1 Synthetic protocol 1 
 
Scheme 30: i) MOM-Cl, NaH (99%) ii) 
i
PrNCO, 
t
BuLi, TMEDA (78%) iii) 
t
BuLi, TMEDA, 
184. iv) CSA. v) MeLi, TFA, Et3SiH. vi) Br2. vii) MeONa, CuI, then BBr3. viii) CAN. ix) 
NaClO2. x) H2SO4. 
Methoxymethylene was selected for protection of the hydroxyl groups in order to aid ortho 
lithiation and allow for concomitant cleavage in the desired acid mediated cyclisation later in 
the synthesis. The treatment of compound 185 with 
t
BuLi and quenching with 
isopropylisocyante would hopefully lead to the desired naphthamide 186. It was predicted that 
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further treatment of this species with 
t
BuLi (2 eq.) would result in lithiation at the C3 position, 
as opposed to the C6 position, as the deprotonated amide would be a stronger ortho director 
than the C5 MOM substituent. Quenching this intermediate with (S)-t-butyl-(2-(oxiran-2-
yl)ethoxy)diphenylsilane (S)-197 would give the cyclisation precursor 187. Utilising 
previously described methodology
[53, 83]
 the lactone could then be converted into the methyl 
substituted tetrahydropyran 188 by treatment with methyllithium followed by TFA and 
triethylsilylane which has been shown to give the less stable, undesired, cis diastereoisomer 
189. This is most likely due to hydride delivery to the generated oxonium intermediate 
occurring from the least hindered side with regards to the substituent (R) at C3 (Scheme 30). 
However, this has not yet been mechanistically proven. 
 
Scheme 31: Suspected hydride delivery to generated oxonium species of tetrahydropyranone. 
Oxidation of 189 to the tetra oxygenated substituent could then be achieved by bromination to 
give 190 following an established methodology
[53, 83]
 and substitution via copper mediated 
coupling with sodium methoxide
[83, 84]
. Treatment with boron tribromide would then generate 
the desired tetrahydroxynaphthalene moiety 191, and ceric ammonium nitrate oxidation would 
give the naphthazarin core, if oxidation was not spontaneous as had been previously observed 
with simpler systems. Finally, oxidation of the primary alcohol 192 with NaClO2 to form the 
carboxylic acid would give the C1 epimer of the dihydrogranaticin aglycone and acid 
mediated inversion, which has precedence in previous synthesis
[53, 55]
 of similar BIQs would 
yield the desired molecule 38. This synthetic route was devised due its divergent potential. 
The addition of different epoxides in the third step would allow access to varying chain 
lengths and functionality from the C3 carbon and, depending on stereogenicity of the epoxide, 
allow for generation of all four diastereoisomers. Also, the addition of alternative 
Grignard/organolithium reagents would allow for the synthesis of other BIQ analogues such as 
frenolicin 22. 
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The silyl protected epoxide 197 could be synthesized in three steps as either enantiomer or in 
racemic form using literature methods
[53, 54]
 from (R), (S) or (±)-aspartic acid (scheme 32).  
 
Scheme 32: i) H2SO4, KBr, NaNO2. ii) BH3
.
THF (71% over 2 steps) iii) NaH, then TBDPS-Cl 
(61%). 
Epoxide 197 was, however, synthesized as a racemate. Treatment of (±)-asapartic acid with 
sodium nitrite and sulfuric acid resulted in the formation of the diazonium salt at C2 followed 
by intramolecular nucleophilic substitution of the carboxylic acid to form the β-lactone. A 
second substitution then occurs at the C2 position from the bromide salt, allowing for retention 
of stereochemistry. Borane reduction gave diol (±)-196 in good yield (70% over 2 steps). 
Finally, treatment with excess sodium hydride resulted in intramolecular epoxide formation 
which was followed by in situ silyl protection to provide epoxide (±)-197 in modest yield 
(60%). 
1
H/
13
C NMR concurred with literature spectra through all steps
[53, 54]
 showing distinct 
signals for the alkyl chain at 1.79 (2 H), 2.50 (1 H), 2.78 (1 H), 3.10 (1 H) and 3.89 (2 H) 
along with the TBDPS moiety at 1.09 (9 H, 
t
Bu), 7.45 (6 H, Ar) and 7.70 (4 H, Ar).  
Protection of both hydroxyl groups of 1,5-dihydroxynaphthalene to yield 185 was achieved in 
quantitative yield using a large excess of sodium hydride followed by the slow addition of 
methoxymethylene chloride as a 2.1 M solution in toluene with no need for further 
purification after extraction. Distinctive MOM peaks at 3.54 (6 H) and 5.39 (4 H) ppm in the 
1
H NMR spectrum confirmed the presence of these CH3 and CH2 groups respectively for the 
bis protected compound 182. Treatment of naphthalene derivative 185 with TMEDA and 
t
BuLi at −30 °C followed by the dropwise addition of isopropylisocyanate at −55 °C gave the 
desired naphthamide 186 in modest yield (60%). Three equivalents of TMEDA and 
t
BuLi 
were needed to affect complete lithiation due to aggregation of the organolithium base with 
the MOM substituents. This, however, resulted in the remaining 
t
BuLi reacting with the highly 
elcetrophilic isocyanate to generate N-isopropylpivalamide, therefore, an excess of isocyanate 
was also used. The naphthamide 186 was observed by 
1
H NMR spectroscopy showing the 
expected 
i
Pr peaks at 1.29 (6H, d) and 4.30 (1H, m) ppm along with the presence of a third 
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quaternary aromatic carbon and carbonyl signals at 153.4 and 165.4 ppm respectively in the 
13
C NMR spectrum. Attempted ring opening of commercially available racemic propylene 
oxide using 
t
BuLi and TMDEA resulted in degradation of the starting naphthamide. Primarily, 
the loss of a MOM group was observed in the 
1
H NMR spectra. This was confirmed as the C1 
MOM by HMBC and HSQC 
1
H NMR. Deuterium quenching experiments (D2O) using 
multiple equivalents of base showed no incorporation of deuterium but also exhibited the loss 
of a MOM substituent indicating that the deprotonation of the secondary amide may be 
hindering aromatic lithiation. In an attempt to circumvent this issue, the N,N-dimethylamide 
analogue 194 was synthesized following the same procedure and quenching with 
dimethylcarbamoylchloride.  
 
Figure 18: N,N-dimethyl-1,5-bismethoxymethyleneoxy-2-naphthamide. 
Although the reaction occurred in poor yield, the expected product was verified by the 
presence of two methyl signals observed in the 
1
H NMR spectrum at 2.89 and 3.14 ppm, 
indicative of the desired amide. Ortho lithiation with two equivalents of 
t
BuLi followed by 
addition of D2O showed not only observed the loss of the C1 MOM group but showed a 2:1 
incorporation of deuterium at C6 and C3 respectively (figure 20).  
 
Figure 19: Deuterium quenched compounds of lithiated 194. 
In order to improve lithiation at the C3 position, 1-methoxymethyleneoxy-5-
methoxynaphthalene was synthesised (scheme 33) as it was hoped that the N,N-dimethylamide 
would be a stronger ortho director than an OMe group.  
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Scheme 33: i) NaH, MOM-Cl, DMF (99%) ii) NaH, MeI, THF (99%). 
Treatment of dihydroxynaphthalene 147 with 1 equivalent of NaH followed by 1 equivalent of 
MOM-Cl (2.1 M in PhMe) generated the mono protected naphthalene 197 in poor yield (99%) 
due to partial formation of the bis protected compound. The molecule was confirmed through 
1
H NMR integrations of the methyl (3.48 ppm, 3H) and methylene (5.38 ppm, 2H) protons 
with the indicative 1,5-disubstituted naphthalene 1H protons. O-Methyl protection with 
sodium hydride and methyl iodide occurred in quantitative yield to give 198 showing a distinct 
3H singlet at 4.01 ppm in addition to previously observed signals for the non-substituted 
naphthalene. However, treatment of this compound with two equivalents of 
t
BuLi/TMEDA 
followed by deuterium quenching (D2O) showed little incorporation of deuterium.  
4.3 Synthetic Protocol 1.1 
 
Scheme 34: i) NaH, MOM-Cl (92%) ii) 
t
BuLi, ClC(O)NMe2 or 
i
PrNCO (189 = 71%, 190 = 
84%) iii) 
t
BuLi, 184. iv) pTSA. v) Et3SiH, MeLi, TFA. vi) CAN. vii) 199, Et3N. viii) NaClO2. 
ix) H2SO4. 
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The key step of our second synthetic strategy was a Diels-Alder cycloaddition (scheme 34, 
step vii) followed by in situ base-mediated rearomatisation, using furan derivative 208. The 
reaction was envisioned mechanistically as shown in scheme 35 and scheme 36. 
 
Scheme 35: Mechanistic rationale for Diels-Alder cycloaddition and base induced 
aromatization with diene 208. 
 
Scheme 36: Second mechanistic rationale for Diels-Alder cycloaddition and base induced 
aromatization with diene 208. 
It was also envisaged that in this synthetic route, global deprotection could be achieved during 
step v) through the addition of excess TFA to improve the step economy of the strategy. 
Therefore, although deuterium quenching studies showed that O-methyl protection of the 
aromatic hydroxyls allowed for efficient lithiation with both 
n
BuLi and 
t
BuLi, 
methoxymethyleneoxy protection was chosen as an acid labile protecting fucnctionality. This 
protocol also maintained the divergent steps of epoxide opening and Grignard addition giving 
the potential for additional analogues of the aglycone to be synthesised. In addition, alternative 
dienes, such as 1-(trimethylsiloxy)-1,3-butadiene, could be employed for the Diels-Alder step 
to synthesise BIQs such as nanaomycin D 19, dihydrofrenolicin and dihydrokalafungin 
utilising previous methodology.
[63, 64]
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Protection of 1,4-dihydroquinone occurred in excellent yield (99%) using an excess of NaH 
and freshly synthesised MOM-Cl (2.1M in PhMe). Compound 200 was characterized by the 
distinct methylene and methyl peaks observed in the 
1
H NMR spectrum at 3.42 and 5.07 ppm 
respectively. Deuteration studies again showed that three equivalents of either 
n
BuLi or 
t
BuLi 
were required to achieve complete lithiation. Therefore, the synthesis of the N-
isopropylbenzamide 201 required the addition of three equivalents of the corresponding 
isocyanate, generating two equivalents of N-isopropylpivalamide or N-isopropyl-n-butylamide 
as side products. The n-butylisomer, however, could not be removed via silica gel 
chromatography due to the two compounds similar retention factor of 0.2 (EtOAc/hexanes 
1:4). 
1
H NMR spectroscopy showed distinct isopropyl peaks at 1.28 (6H, d) and 4.21 (1H, m) 
ppm. Lithiation with four equivalents 
t
BuLi followed by D2O quenching resulted in 80% 
incorporation of deuterium at the C3 position. The need for the excess base was again 
attributed to aggregation with the MOM substituents and deprotonation of the secondary 
amide. Nucleophilic epoxide opening of both propylene oxide and silyl protected epoxide 197, 
however, did not occur and in the case of epoxide 197 resulted in total degredation of the 
epoxide. Boron trifluoride etherate was then employed in an attempt to increase the 
electrophilicity of epoxide 197. Complete degredation was observed with both substrates. The 
N,N-dimethyl analogue 202 was also synthesized in good yield (84%) from the corresponding 
carbomyl chloride using the same methodology devised. Benzamide 202 was confirmed by 
signals in the 
1
H NMR and 
13
C NMR spectra at 1.21 (6H, s, methyl) ppm and 170.84 
(carbonyl) ppm. Attempts at nucleophilic ring opening of propylene oxide again resulted in no 
reaction indicating that the generated organolithium was too sterically hindered to react with 
an epoxide.  
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4.4 Synthetic protocol 2 
 
Scheme 37: i) 
n
BuLi, ethylene oxide (54%) ii) SO3
.
Py. EtN(
i
Pr)2, DMSO (98%) iii) TiCl4, 
EtN(
i
Pr)2, 218, NMO. iv) KOH. v) BF3
.
Et2O, MeCH(OMe)2. vi) CAN. vii) Diene 199, Et3N. 
The next synthetic strategy (scheme 37) employed two key steps: an Evans aldol
[86, 87]
 like 
addition to 2-(2,5-dimethoxyphenyl)acetaldehyde 211 and oxa-Pictet-Spengler reaction to 
form the tetrahydropyran ring. Although this route limited the potential number of analogues 
that could be generated with regards to the substituents at the C3 position, many 
acetals/aldehydes could be employed for the oxa-Pictet-Spengler cyclisation allowing access 
to various analogues and BIQ natural products.  
Lithiation of 1,4-dimethoxybenzene 209 with 
n
BuLi followed by addition of ethylene oxide 
(liquid cooled to −20 °C) resulted in formation of primary alcohol 210 in modest yield (54%). 
This was suggested by an LRMS ion signal at [M+H]
+
 182.02. 
1
H NMR showed a distinct 
geminal triplet at 2H 2.81 ppm observed in along with two distinct 3H OMe signals at 3.69 
and 3.72 ppm. Oxidation of this compound could not be achieved under Swern conditions 
therefore a modified Parikh-Doering was employed. Addition of sulfur trioxide pyridine 
complex in one portion resulted in formation of 1-(2,5-dimethoxyphenyl)-2-ethyl sulfate 
which was suggested by LRMS showing an ion signal at [M]
-
261.20. However, addition over 
30 minutes as a solution in DMSO, gave quantitative conversion to aldehyde 211 with no need 
for purification. Compound 211 was characterised by 
1
H NMR which showed an indicative 
aldehyde triplet at 9.96ppm, benzylic 2H doublet at 3.64 ppm and expected OMe signals at 
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3.79 and 3.80 ppm. The resulting aldehyde, however, proved to be highly air and moisture 
sensitive and would readily degrade/polymerise upon storage, therefore, all aldol reactions 
were performed immediately after synthesis of 211. This instability is believed to be a result of 
a series of aldol reactions/aromatic substitutions and eliminations between two molecules of 
the aldehyde. One example of this has been previously reported (scheme 36).
[88]
 
 
Scheme 38: Possible side reactions of aldehyde 202. 
Three Evans like auxiliaries were synthesized (scheme 37 and scheme 38).  
 
Scheme 39: i) 
n
BuLi, (Ac)2O (99%). 
The first was synthesized from commercially available oxazolidinthione 224 by slow addition 
of 
n
BuLi followed by slow addition of freshly distilled acetic anhydride to give auxiliary 218 
in quantitative yield. The acetalation product was observed by 
1
H NMR which showed a 
distinct α methyl signal at 2.88 ppm (3H, s), along with two 1H doublet of doublets at 2.80 
and 3.32 ppm and a 1H multiplet at 4.69 ppm corresponding to the thiooxazolidinone ring 
protons, in accordance with the literature spectra.
[89]
 A carbonyl carbon was also observed in 
the 
13
C NMR spectrum at 171.08 ppm indicating that N-acetylation had occurred.  
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Scheme 40: i) MeOH, SOCl2 (98%) ii) PhMgBr (44%) iii) Et3N, CS2 (86%) iv) CO(CCl3)2, 
KOH (65%) v) 
n
BuLi, (Ac)2O (229 = 61%, 231 = 98%). 
Oxazolidinthione 229 and oxazolidinone 231 were synthesised in four steps from enantiopure 
valine 225. The methyl ester hydrochloride salt 226 was generated by treatment with thionyl 
chloride in methanol followed by concentration and washing with diethyl ether to give the 
desired compound in almost quantitative yield with no further need for purification. 
1
H NMR 
was consistent with existing literature spectra.
[90, 91]
 The addition of this salt as a solid to an 
excess of freshly synthesised phenyl magnesium bromide gave 1,1-diphenyl-valinol 227 in 
low yield (44%) which was confirmed by a 
1
H NMR signal between 7.19-7.42 ppm (10H, m), 
i
Pr 3H doublets at 0.69 and 0.81 ppm along with an LRMS ion signal at m/z [M + H]
+
: 238.13. 
The observed spectra were consistent with previously reported literature.
[92, 93, 94]
 (4S-
isopropyl-(3,3-diphenyl)-thio-oxo-oxazolidin-3-yl)-ethanone 228 was then generated by 
treatment of the valinol precursor with triethylamine followed by the slow addition of carbon 
disulfide. Chromatography of the resulting mixture gave oxazolidinthione 228 in good yield 
(85%) as a yellow solid. 
13
C NMR displayed a distinct thiocarbonyl signal at 187.9 and LRMS 
observed an ion at [M + H]
+
: 298.07. 
1
H NMR was also consistent with literature precedents 
showing isopropyl signals at 0.70 ppm (3H, d), 0.90 (3H, d) and 1.90 (1H, m) along with the 
thiooxazolidinone ring proton at 4.48 ppm (1H, d).
[89]
 N-acetylation of this compound with 
acetic anhydride and sodium hydride gave only modest conversion to 229 after flash 
chromatography. This is attributed to steric hindrance of the sodium salt intermediate. This 
compound was characterized by the presence of an α methyl signal observed on 1H NMR 
spectrum at 2.69 ppm along with a 
13
C NMR signal at 171.05 ppm indicative of a carbonyl 
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carbon and consistent with literature spectra.
[89]
 Initial attempts to synthesise (4S-isopropyl-
(3,3-diphenyl)-oxazolidin-3-yl)-ethanone 231 using diethyl carbonate or ethyl chloroformate 
in the presence of excess base (NaH or Et3N) resulted in minimal conversion to 230. However, 
treatment with triphosgene and potassium hydroxide followed by recrystalisation from 
cyclohexane gave the oxazolidinone 230 in a reasonable yield (65%). This product displayed a 
broad NH singlet at 5.72 ppm on 
1
H NMR, a 
13
C NMR signal at 196.8 ppm of the 
oxazolidinone carbonyl and a LRMS ion at [M + H]
+
: 282.07 consistent with literature 
values.
[95]
 N-Acetylation with acetic anhydride and sodium hydride again occurred in modest 
yield, however, the use of 
n
BuLi as a base gave almost quantitative conversion to the desired 
auxiliary after recrystalisation to 231. This auxiliary showed 
1
H NMR signal for the α methyl 
group at 2.36 ppm, a 
13
C NMR carbonyl signal at 153.24 ppm and a LRMS ion at [M + H]
+
: 
282.07 consistent with previously reported literature spectra.
[96]
 
Evans aldol reactions with both oxazolidinethiones 218 and 229 were performed under 
literature conditions
[89] 
using titanium tetrachloride as a Lewis acid, Hünigs base and N-methyl 
morpholine oxide. Addition of Lewis acid to a solution of the auxiliary in dichloromethane 
resulted in a distinct bronze mixture, consistent with literature observations, indicating enol 
formation. However, slow addition to the aldehyde resulted in a highly complex mixture of 
inseparable compounds observed in the 
1
H NMR spectrum of the crude mixture and by TLC. 
No starting aldehyde was present in this mixture. The reaction was performed using alternate 
amine bases such as TMEDA but gave similar results. Test aldol reactions using simpler 
aldehydes indicated that complexation of the aromatic aldehyde with the Lewis acid may be 
generating dimerisation/polymerization compounds, a conclusion was confirmed by exposing 
the aldehyde to TiCl4 at −78 °C, therefore, the asymmetric aldol reaction was next attempted 
using a weaker Lewis acid and oxazolidinone 231. Following literature procedures,
[98]
 di-n-
butylboryltriflate was used as the Lewis acid but again caused total degradation of the starting 
aldehyde and no conversion to the desired aldol product, thus the synthetic strategy was again 
revised.  
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 4.5 Synthetic protocol 3 
 
Scheme 41: i) 
n
BuLi, DMF (84%) ii) 233, 
t
BuOK, (MeO)2SO2 (37%) iii) AD-mix-α, 
MeSO2NH2. iv) MeCH(OMe)2, BF3
.
Et2O. v) CAN. vi) 208, Et3N. vii) Pd/C, H2. 
The third strategy that was devised, again employed a Diels-Alder cycloadditon and oxa-
Pictet-Spengler but involved a Sharpless asymmetric dihydroxylation
[72]
 to form a β-hydroxy-
γ-lactone ring 138. This would allow access to granaticin aglycone and hydrogenation of this 
ring in the final step would give the desired dihydrogranaticin aglycone 38. It was envisioned 
that the β ,γ-unsaturated ester precursor 137 could be easily accessed by formylation of 1,4-
dimethoxybenzene and in situ Wittig/esterification with 3-triphenyl phosphonium bromide 
propanoic acid 217. 2,5-dimethoxybenzaldehyde 127 was synthesised in modest yield (50%), 
via lithiation of 1,4-dimethoxybenzene 200 and quenching with DMF. The product concurred 
with literature spectra showing a distinct aldehyde 
1
H NMR singlet signal at 10.44 ppm. The 
13
C NMR spectra also showed an indicative carbonyl signal at 189.6 ppm. This was further 
confirmed by LRMS showing an ion at [M + H]
+
 167.14. 
 
Scheme 42: i) PPh3 (99%). 
3-Triphenylphosphonium bromide propanoic acid 233 was synthesized (scheme 42) as a white 
solid from the corresponding alkyl bromide 232 and triphenylphosphine in quantitative yield 
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by treatment with triphenylphosphiene. 
1
H NMR spectroscopy of the Wittig salt showed two 
distinct multiplets at 3.11 and 3.77 ppm. The complex splitting observed was expected due to 
the nuclear spin of the phosphonium substituent. The γ,β-unsaturated ester 137 was 
synthesised in only a poor yield (37%) despite attempts at optimisation. A solution of 
t
BuOK 
in THF was added dropwise over a one hour period to a mixture of the phosphonium salt and 
the aromatic aldehyde. Two equivalents of Wittig salt 233 and four equivalents of base 
(
t
BuOK) were used to increase the yield to 37% after chromatography. After stirring for 30 
minutes at 0 °C and 2 hours at r.t., three equivalents of dimethyl sulfate was added to give the 
esterified product 137. Analysis of the 
1
H NMR of the crude material showed significant 
conversion to the desired unsaturated ester 137, however, silica gel/alumina gel 
chromatography led to partial isomerisation giving the α,β-unsaturated compound along with 
several degradation products. Therefore, essentially pure ester could only be isolated in low 
yield. This degredation was also observed by Koert et al.
[70]
 Analysis of 
1
H NMR spectra 
showed a doublet of triplets at 6.29 ppm (J  = 16.0, 7.2 Hz) indicative of (E)-alkenes along 
with a third methyl singlet at 3.72 ppm corresponding to the newly installed methyl ester. The 
same experiment was also performed without the addition of the methylating agent to give the 
β,γ-unsaturated acid however this could not be isolated as decarboxylation readily occurs 
during silica/alumina gel chromatography and would subsequently show no conversion under 
Sharpless AD conditions when used as a crude mixture. 
With access to the Sharpless asymmetric dihydroxylation precursor 137 now achieved, 
investigations into the Deils-Alder cycloaddition reaction using 2,5-(trimethylsiloxy)furan 
were performed.  
 
Scheme 43: Synthesis of 2,5-(trimethylsiloxy)furan 199.  
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Silylating agent Base Lewis Acid 
TMS-Cl Et3N - 
TMS-Cl Et3N ZnCl2 
TMSOTf Et3N - 
Table 1: Conditions for i) 
Attempts to generate the desired diene under three separate conditions resulted in mixtures of 
products. The bis-silylenolether 199 rapidly decomposed upon exposure to the atmosphere, 
which has previously been reported.
[97, 98]
 Therefore, test reactions to react the diene with 1,4-
naphthoquinone were performed in situ with diene formation. These attempts at cyclisations 
using all three conditions yielded only oxidized naphthoquinone (1,4-dihydroxynaphthalene); 
therefore, a new strategy was devised for use with the desired diene 199.  
4.5.1 Benzyne cycloadditions 
Recent literature
[99]
 was published forming 1,4-quiones fused to aromatic rings via a benzyne 
cycloaddition followed by PhI(OTf)2-induced oxidation.  
 
Scheme 44. i) LDA, 2-(trimethylsiloxy)furan (99%) ii) [O] 
To a solution of freshly prepared LDA was added excess furan in one portion followed by the 
slow addition of 2-bromo-1,4-dimethoxybenzene 90 over a 1 hour period followed by 
additional stirring for 1 hour to give the desired cycloaddition adduct 235 in quantitative yield. 
1
H NMR spectrum observed two triplets of equal J value at 5.92 and 7.06 ppm and a LCMS 
ion signal at [M + H]
+
 205.06 consistent with literature spectra.
[100]
 It was discovered that, due 
to its high reactivity, generation of the benzyne intermediate could not occur prior to the 
introduction of furan as dimerisation products (namely 2,2’,5,5’-tetramethoxy-1,1’-diphenyl) 
were rapidly generated. Addition of triflic acid to a solution of diacetoxyiodobenzene in DCM 
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formed a dark solution consistent with literature observations.
[100]
 However, addition of the 
cycloaddition adduct 235 followed by stirring at 0 °C for 5 minutes before quenching showed 
total degradation of the starting material. The oxidation was performed again under the same 
conditions using less reactive difluoroacetoxyiodobenzene but showed similar results. In an 
attempt to reduce the acidity of the reaction medium a further experiment was carried out 
using only diacetoxyiodobenzene, under the same conditions, which caused quantitative 
conversion into the acid mediated ring opened product 1,4-dimethoxy-8-hydroxynaphthalene, 
distinguished on the 
1
H NMR spectrum by the distinct 1,4,8-substituted naphthalene signals at 
6.91, 7.27 and 7.62 ppm.  
 
Scheme 45. 
In an attempt to circumvent this problem, 2,5-(trimethylsiloxy)furan 218 was again chosen as 
the diene (scheme 44) for a benzyne cycloaddition. Freshly sublimed succinic anhydride was 
treated with three equivalents of freshly prepared LDA in order to generate the dienolate 
followed by the slow addition of aromatic bromide 90. However, only dimerised compound 
was observed in the 
1
H NMR spectrum of the crude material. In an attempt to synthesise the 
disilylenolether, the anhydride was treated again with three equivalents of LDA but in the 
presence of two equivalents of TMSOTf followed by the slow addition of aromatic bromide to 
allow for in situ cycloaddition. This resulted in no reaction but showed significant conversion 
of the starting aromatic compound 90 into 1,4-dimethoxybenzene 209. This indicated that the 
generated benzyne intermediate had reacted with the silylating agent and the C-Si bond had 
been cleaved upon work up. A further experiment was conducted to generate the diene by 
literature means
[98]
 using trimethylsilyl chloride, triethylamine and ZnCl2 followed by the 
addition of LDA and 2-bromo-1,4-dimethoxybenzene 90 respectively. No sign of conversion 
into the benzyne, however was observed in the 
1
H NMR spectrum of the crude material. 
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Scheme 46: i) LDA, 2-(trimethylsiloxy)furan (77%) ii) CAN or SiO2 (99%). 
A more stable diene was then selected for the cycloaddition. Commercially available 2-
(trimethylsiloxy)furan which was envisaged to undergo acid mediated ring opening to 1,4-
dimethoxy-5,8-dihydroxynaphthalene upon work up (scheme 46).  
 
Scheme 47: Predicted mechanism for the cycloaddition between generated benzyne and 2-
(trimethylsiloxy)furan. 
LDA was prepared from freshly distilled DIPA followed by the addition of the substituted 
furan diene in one portion at −78 °C. The aromatic bromide 90 was then added over 1 hour. 
After quenching with 1M HCl, extraction and chromatography, the desired tetra oxygenated 
naphthalene 236 was isolated in modest yield (57%),
[101]
 characterized by, 1H NMR 
spectroscopy, exhibiting a 2H singlet at 9.08 ppm distinctive to the phenolic OH group as well 
as two 2H aromatic singlets at 6.61 and 6.82 ppm, along with a small quantity of O,O-
dimethoxynaphthazarin 281 which oxidized during chromatography. Complete oxidation was 
observed upon overnight exposure to air or prolonged absorption on silica. Treatment with 
cerium 
IV
 ammonium nitrate resulted in quantitative conversion into the naphthoquinone 168 
within 5 minutes. 
1
H NMR showed three signals at 3.96 ppm (6H, s), 6.78 ppm (2H, s) and 
7.33 ppm (2H, s). 
13
C NMR spectra as consistent with previously reported results
 [83, 102, 103]
 
showing a signal for the quinone carbonyl carbons at 184.9 ppm. Utilising two equivalents of 
diene increased the yield to 77%. Following this success the synthetic route was revised to 
include an aromatic bromide to allow for the benzyne cycloaddition as a final key step. 
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4.6 Synthetic protocol 3.1 
 
Scheme 48: i) Br2 (47%) ii) 
n
BuLi, DMF (90%) iii) 
n
BuLi, DMF (84%) iv) Br2, AcOH (53%). 
The desired 4-bromo-2,5-dimethoxybenzaldehyde 242 was synthesized via two separate 
methods (scheme 48). Treatment of a solution of dimethoxybenzene 208 in chloroform with 
bromine gave the para dibrominated species 241 in modest yield (47%) after 
recrystalisation.
[104]
 
1
H NMR showed a 6H methyl singlet at 3.85 ppm and aromatic 2H singlet 
at 7.11 ppm and the 
13
C NMR observed three aromatic signals at 110.5, 117.1 and 150.5 ppm 
along with a OMe signal at 57.0 ppm, consistent with literature spectra, however, the 
compound could not be ionized using ESI. Lithiation followed by addition of DMF and brief 
reflux in diethyl ether gave benzaldehyde 241 in high yield (89%). 
1
H NMR showed two 
distinct aromatic singlets at 7.19 and 7.27 ppm and two methoxy signals at 8.83 and 3.84 ppm 
along with the characteristic aldehyde peak at 10.33 ppm. The 
13
C NMR also showed a 
characteristic carbonyl peak at 188.79 ppm. In order to improve the yield and avoid reflux 
conditions with n-butyllithium, a second method was devised to synthesise the Wittig 
precursor involving the previously reported fomylation of 1,4-dimethoxybenzene 208 to give 
127 (84%) followed by bromination in acetic acid over 24 hrs allowing alternate access to 242. 
Bromination occurred in similar yield to the para dibromination (51%) resulting in similar 
overall yields. Therefore, the first method was preferred due to time economy. 
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Scheme 49: i) 233, 
t
BuOK, (MeO)2SO2 (51%) ii) AD-mix-α, MeSO2NH2 (90%) iii) 
MeCH(OMe)2, BF3
.
Et2O. iv) 2-(trimethylsiloxyfuran), LDA. v) BBr3. vi) Pd/C, H2. 
The Wittig adduct (E)-243 was synthesised and used crude as decomposition to a complex 
mixture of compounds occurred during silica gel/alumina gel chromatography. Again the 
1
H 
NMR spectrum of the crude material showed significant conversion into the (E)- β,γ-
unsaturated ester, however. The product showed characteristic trans alkene peaks by 
1
H NMR 
spectroscopy at 6.30 ppm (1H, dt, J  = 16.0, 7.1 Hz) and 6.74 ppm (1H, dt, J  = 16.0, 1.5 Hz). 
The carboxylic acid analogue was also synthesized showing distinct trans alkene peaks in the 
1
H NMR spectrum of the crude material but could not be purified due to its high polarity and 
degredation compounds. The β-hydroxylactone 244 was then synthesised in excellent yield 
(90%) after chromatography under standard Sharpless asymmetric dihydroxylation 
conditions
[72]
 using g/mmol of AD-mix-α and 1 equivalent of methane sulfonamide. 1H NMR 
spectrum observed the loss of the methyl ester singlet and distinct non-equivalent α protons at 
2.70 ppm (1H, d, J  = 17.7 Hz) and 2.87 ppm (1H, dd, J  = 5.3 Hz) along with a benzylic 1H 
doublet at 5.68 ppm and CHOH multiplet at 4.80 ppm. This compound was also confirmed by 
HRMS showing indicative bromine containing ion signals at [M + H]
+
 317.0024 and 
319.0032. In order to ascertain enantiomeric excess a diastereoisomer was synthesized 
(scheme 50).  
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Scheme 50: i) DMAP, Py., (Ac)2O (99%) ii) DMAP, DCC, lactone 248(>10%). 
O-Acetylmandelic acid 248 was synthesized from the enantiopure starting material 247. 
Treatment of mandelic acid 247 with catalytic DMAP and freshly distilled acetic anhydride in 
a solution of diethyl ether and pyridine yielded the desired O-acetylated 248 compound in 
quantitative yield.
[105]
 [α]D confirmed no loss of chirality (+149.2° c = 1.00 g/100mL MeOH) 
as the result concurred with previously published results. The presence of a methyl singlet at 
2.13 ppm along with benzylic proton singlet at 5.86 ppm also correlated with literature 
spectra.
[105]
 This pure compound was then treated with catalytic DMAP and DCC in a solution 
of toluene followed by the addition of the β-hydroxylactone 244 dropwise as a solution in 
dichloromethane. Esterification of this compound occurred in very low yield preventing 
isolation of 249, therefore the ee could not be ascertained. No further purification was 
performed.  
With the Sharpless asymmetric dihydroxylation adduct 244 in hand, the next key step was an 
oxa-Pictet-Spengler reaction to form the tetrahydropyran ring. Previously reported literature 
and preliminary test reactions showed that boron trifluoride etherate complex gave the highest 
conversion. However, using a twofold excess of the dimethyl acetal of acetaldehyde with this 
Lewis acid gave no reaction at 0 °C to r.t. Increasing the temperature to reflux in 
dichloromethane caused decomposition of the hydroxylactone ring. The addition of BF3
.
Et2O 
to a mixture of acetaldehyde and lactone at r.t. also gave zero conversion. When the addition 
order was reversed a deep red solution formed upon addition of the Lewis acid to the acetal 
indicating formation of the oxonium ion of the acetal, however, slow addition of a solution of 
lactone in dichloromethane gave again no conversion. Using a 4:1 mixture of Et2O:THF (used 
due to the Sharpless adduct 244 insolubility in diethyl ether) also resulted in no reaction under 
these conditions. A final attempt at cyclisation was performed using ten equivalents of both 
acetal and Lewis acid which resulted in partial degradation after 24 hrs. Several possible 
explanations were postulated for this lack of reactivity. The electron withdrawing capacity of 
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the lactone ring was deactivating the hydroxyl group, reducing the nucleophilicity and thus 
preventing reaction with the oxonium intermediate. Coordination of the lactone carbonyl to 
the boron trifluoride was resulting in enolisation or the combined meta deactivating properties 
of both the bromine and methoxy substituents were preventing aromatic substitution.  
During this period, a publication by Koert et al.
[71]
 showed that the oxa-Pictet-Spengler 
reaction could be achieved under harsh conditions on the non-brominated lactone.  
 
Scheme 51: Ulrich Koert’s oxa-Pictet-Spengler conditions i) BF3
.
Et2O, TFA, MeCH(OMe)2, 
80 °C, 60 sec. (41%) 
The group achieved a 14:1 diastereomeric ratio of trans:cis isomers of 138 by the addition of 
the β-hydroxylactone 139 to a solution of MeCH(OMe)2 (10 equivalents) and boron trifluoride 
diethyl etherate complex (10 equivalents) in trifluoroacetic acid at 80 °C. The reaction time 
was kept under 60 seconds before quenching at 0 °C to reduce compound degradation giving 
the formed pyran ring in 41% yield. It was clear from the publication that the oxa-Pictet-
Spengler cyclisation on the desired brominated species would be extremely difficult to achieve 
due to the added meta deactivating capability of the bromine. An additional complication 
observed by the group was the same instability of the β,γ-unsaturated ester confirming our 
result of degradation during silica gel chromatography. 
In an effort to circumvent this issue, the synthesis was revised to open the lactone ring and 
attempt an oxa-Pictet-Spengler reaction on the β-hydroxycarboxylic acid 251. 
 
Scheme 52: i) Pd/C, H2 ii) MeCH(OMe)2, BF3
.
Et2O. 
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Solvent Temperature Time 
EtOAc r.t. 17 hrs. 
EtOAc 40 °C 30 mins. 
MeOH r.t. 17 hrs. 
MeOH r.t. 2 hrs. 
EtOAc + pTSA (cat.) r.t. 2 hrs. 
Table 2: i) Hydrogenation conditions for 244. 
The β-hydroxylactone 244 was subjected to several hydrogenation conditions (table 2). 
Overnight reaction using ethyl acetate as the solvent and catalytic palladium on carbon 
resulted in no reaction. Increasing the temperature gave total degradation of the lactone ring 
within 30 mins. Using methanol as the solvent resulted in complete isomerisation at the 
geminal position after 17 hours with no opening of the lactone ring. Reducing the reaction 
time and monitoring the reaction by 
1
H NMR showed that partial isomerisation after 2 hours 
and again no lactone hydrogenation. A final attempt to resolve this problem was to perform 
the reaction in the presence of catalytic pTSA. By monitoring by 
1
H NMR spectroscopy, 
degradation products were observed within 2 hrs. The benzylic stereoscrambling is attributed 
to the high electron density of the aromatic ring resulting in opening of the lactone ring. 
 
Figure 20: Possible Pd induced ring opening of 244. 
 
Scheme 53: i) Amberlyst™, MeCH(OMe)2, MeOH (33%) ii) BF3
.
Et2O 
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The second attempt to overcome the lack of reactivity towards oxa-Pictet-Spengler cyclisation 
was to perform the reaction intramolecularly by converting the β-hydroxylactone 224 into the 
corresponding β,γ-ethyl acetal methyl ester 228 and then subjecting the compound to BF3
.
Et2O 
to form the tetrahydropyran ring. Stirring a methanolic solution of lactone with a large excess 
of 1,1-dimethoxyethane in the presence of amberlyst™ resin gave desired compound 228 in 
33.3% yield after three days as a mixture of acetal diastereoisomers. This was characterised by 
1
H NMR spectroscopy showing two acetal methyl doublets at 1.41 and 1.45 ppm (J = 3.0 Hz) 
along with two acetal CH quartets at 5.27 and 5.34 ppm (J = 6, 9 Hz). However, exposure to 
boron trifluoride resulted in the rapid and complete degradation of acetal 228 to a mixture of 
deoxygenated compounds.  
 
Scheme 54: i) LDA, 2-(trimethylsiloxy)furan. ii) MeCH(OMe)2, BF3
.
Et2O. 
The strategy was then rearranged to perform the benzyne cycloaddition on β-hydroxylactone 
244 using an excess of base to deprotonate the hydroxyl group and form the benzyne 
intermediate. However, treatment of lactone 244 with LDA, however, did not lead to benzyne 
formation. This is attributed to the formation of the hydroxyl enolate dianion preventing a 
third deprotonation. 
 
Scheme 55: i) LDA, 2-(trimethylsiloxy)furan. 
The cycloaddition could not be attempted on β,γ-unsaturated ester (E)-243 as it was envisaged 
that benzyne cycloadditions could occur with the unsaturated bond. Therefore, the reaction 
was attempted with 4-bromo-2,5-dimethoxybenzaldehyde 242. This resulted in a complex 
mixture of inseperable compounds..   
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Scheme 56: i) 
n
BuLi, DMF. 
Ortho-lithiation of O,O-dimethoxynaphthazarin 181 at −78 °C did not occur but resulted in 
degredation of 181 producing an inseperable mixture of compounds. This seemed likely to 
contain addition products of the organolithium either by conjugate addition or direct addition 
to the quinone carbonyls.  
4.7 Synthetic protocol 4 
A new divergent strategy was devised to allow for varying chain lengths (R1) at C3 by opening 
a variety of epoxides. This would allow for the synthesis of analogues of BIQ natural 
compounds such as eleutherin 105 by opening propylene oxide as well longer, more 
functionalised carbon chains such as that present in the granaticin by opening epoxides such as 
the previously synthesised TBDPS protected epoxyalcohol 197. Variation at C1 (R2) could be 
achieved by utilizing a range of acetals or aldehydes in an oxa-Pictet-Spengler cyclisation. 
This would allow for analogues of BIQ molecules such as deoxyfrenolicin 107 containing an 
n
Pr chain to be generated. Two alternate starting materials were considered for this synthesis 
to either incorporate a Diels-Alder reaction or a benzyne cycloaddition.  
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Scheme 57: i) 
n
BuLi, BF3
.
Et2O, epoxide. ii) R2CH(OMe)2, BF3
.
Et2O. iii) CAN. iv) 199, Et3N 
then Jones reagent.  
The first cyclisation considered was a Diels-Alder (scheme 57). Starting from 2-bromo-1,4-
dimethoxybenzene 79 and including a ceric ammonium nitrate oxidation as the third step 
would allow for a range of oxidized naphthoquinones to be produced (scheme 58). It is 
believed that the 5,8-dihydroxynaphthoquinone core is essential for the attachment of the 
sugar moiety, thus, this methodology would confirm this hypothesis.  
 
Scheme 58: Potential Diels-Alder adducts. 
Using previously reported methodology,
[74]
 a Diels-Alder reaction with 1-trimethylsiloxy-1,3-
butadiene followed by Jones oxidation would allow for the generation of BIQ molecules such 
as kalafungin 15 and nanaomycin 16. Using the methodology reported by Xu et al.
 
in the total 
synthesis of crisamicin,
[49]
 Diels-Alder reaction with 1,1-dimethoxy-1,3-butadiene followed by 
Jones oxidation could generate unusual BIQ molecules featuring the hydroxyl group at the 6 
position. However, the main focus was to synthesise the naphthazarin core by Diels-Alder 
cycloaddition with 2-(trimethylsiloxy)furan or 2,5-(trimethylsiloxy)furan 207. 
64 
 
Scheme 59: i) 
n
BuLi, BF3
.
Et2O, propylene oxide. ii) MeCH(OMe)2, BF3
.
Et2O, (75% over 2 
steps) . iii) CAN, (99%). iv) 207, Et3N, then Jones reagent.  
The first epoxide selected was commercially available propylene oxide which can be bought 
enantiopure, or the racemic compound can be resolved via a Jacobsen kinetic resolution.
[106, 
107] 
However, for the purposes of devising the methodology, the epoxide was used as a 
racemate. Treatment of 2-bromo-1,4-dimethoxybenzene 90 with 
n
BuLi followed by the 
addition of neat propylene oxide yielded only starting material. However, the slow addition of 
boron trifluoride diethyletherate complex before quenching with the epoxide gave the desired 
secondary alcohol in good yield. However, silica gel chromatography resulted in a complex 
mixture of compounds which is presumed to be a result of elimination and polymerization.  
 
Figure 21: Geminal protons of 3-(2,5-dimethoxyphenyl)isopropanol 239. 
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Therefore, the compound was identified by 
1
H NMR spectroscopy of the crude material 
showing two distinct doublets of doublets at 2.72 and 2.85 ppm (figure 21) and by HRMS [M 
+ H]
+
: 197.1172,
[108]
 and used as a crude mixture for the next step. The impure oil was then 
dissolved in dichloromethane with two equivalents of the dimethyl acetal of acetaldehyde and 
slowly treated with BF3
.
Et2O giving quantitative conversion to the desired isochromane. 
1
H 
NMR NOESY experiments determined the reaction to yield a 2.7:1 mixture of trans:cis 
diastereoisomers of 267. The 
1
H NMR spectrum shows four distinct methyl doublets at 1.25 
and 1.43 ppm (trans) and 1.28 and 1.47 ppm (cis) corresponding to the methyl groups at C1 
and C3. Two distinct tertiary proton signals corresponding to the proton at C1 were also 
observed as a quartet of triplets at 4.90 ppm (cis) and a quartet at 5.01 ppm (trans).
[109]
 
 
Figure 22: C1 tertiary protons of 1,3-dimethyl-5,8-dimethoxyisochromane 267. 
This mixture of diastereoisomers was then treated with ceric ammonium nitrate to give the 
corresponding isochromane quinone in quantitative yield of 268, again as a 2.7:1 mixture of 
diastereoisomers trans:cis. The desired trans isomer was easily isolated by silica gel 
chromatography. This compound was characterised by 
1
H NMR showing loss of both 
methoxy groups, two methyl doublets at 1.31 and 1.45 ppm, two benzylic proton signals at 
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2.12 ppm (ddd) and 2.52 ppm (ddd), a C3 proton multiplet at 3.94 ppm and a doublet of 
quartets at 4.83 ppm corresponding to the tertiary proton at C1. NOE 
1
H NMR confirmed the 
stereogenic configuration by the absence of correlation between the C1 and C3 tertiary protons 
or methyl protons.
[109]
  
With the simple (±)-1,3-dimethylisochromane quinone 268 in hand attempts were made to 
replicate the synthesis using a more complex epoxide.  
 
Scheme 60: i) 
n
BuLi, 273. ii) MeCH(OMe)2, BF3
.
Et2O. iii) CAN. iv) Et3N, diene 199. 
In order to improve step economy, an ester epoxide 273 was chosen rather than a protected 
primary alcohol to avoid oxidation steps later in the synthesis. Also by using a benzyl 
protected ester, concomitant ester cleavage and oxidation to the quinone could be achieved 
allowing for a more elegant synthesis. 
 
Scheme 61. i) CBzCl, Py., (98%). ii) mCPBA, NaHCO3, (36%). iii) Co(Salen). 
The racemic epoxide was synthesised according to literature procedure
[110, 111]
 starting from 
vinyl acetic acid 246. Treatment of this compound with pyridine and benzyl chloroformate, 
via the decarboxylative mechanism described (scheme 62), produced vigorous gas evolution 
upon cloroformate addition, and gave the desired benzyl ester 247 in high yield (98%). After 
chromatography, the compound was confirmed by comparison of 
1
H NMR data with literature 
spectra showing two distinct signals at 3.16 ppm (2H, dt, J = 7.2, 1.4 Hz) and 5.95 ppm (1H, 
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dt, J = 17.4, 9.9 Hz) along with an indicative benzyl 2H singlet at 5.15 ppm. An indicative 
carbonyl ester signal was observed in the 
13
C NMR at 170.6 and HRMS ion at [M + H]
+
: 
193.0857, again concurrent with literature spectra
[110, 111]
 also confirmed this compound. 
 
Scheme 62: Mechanism for the synthesis of but-3-enebenzoate. 
The β,γ-unsaturated ester was then subjected to four equivalents of mCPBA and stirred for 
24hrs. Although conversion was not complete, increasing reaction time resulted in degradation 
of the epoxide yielding the desired compound in 35%. Compound 275 was characterized by 
1
H NMR showing the loss of both vinyl protons and three multiplets at 2.56 ppm (1H), 2.61 
ppm (2H) and 2.80 ppm (1H) along with the expected benzyl signals at 5.20 ppm (2H) and 
735 ppm (5H). HRMS also confirmed this compound with an ion [M + H]
+
: 193.0857 
signal.
[111, 112]
 This compound could then undergo a Jacobsen kinetic resolution
[106]
 to give the 
enantiopure epoxide, following literature precedent, however attempts to optimize the 
methodology of reacting the epoxyester with the aromatic nucleophile were performed on the 
racemic series before using expensive catalysts.  
Several nucleophiles were used in the attempt to ring open the epoxide in the racemic series by 
metallating 1-bromo-2,5-dimethoxybenzene. 
 
Scheme 63: Opened ester 276. 
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Metallating agent Eq. of 
nucleophile 
Temperature of 
addition (°C) 
Lewis acid Addition order 
nBuLi 1 −78 - Epox. to Nucleophile 
nBuLi 3 −78 - Epox. to Nucleophile 
nBuLi 3 −78 - Nucleophile to epox. 
nBuLi 1 −78 BF3
.Et2O Epox. to Nucleophile 
nBuLi 3 −78 BF3
.Et2O Epox. to Nucleophile 
Mg 3 −78 - Epox. to Nucleophile 
nBuLi/CuI 3/1.5 −78 - Epox. to Nucleophile 
nBuLi/CuCN 3/1.5 −78 - Epox. to Nucleophile 
nBuLi/CuI 3/3 −78 - Epox. to Nucleophile 
Table 3: Epoxyester 276 addition conditions. 
Generating the aromatic lithium nucleophile with 
n
BuLi and reacting a solution of electrophile 
to this resulted in only degradation of the epoxide giving a highly complex mixture of 
compounds. This occurred regardless of the addition order and number of equivalents of 
nucleophile used. When boron trifluoride etherate complex was used, again with 
stoichiometric or excess nucleophile, complete degradation was also observed. One compound 
that could be observed by 
1
H NMR spectroscopy, but not isolated, was the opened epoxide via 
α proton abstraction which is assumed to be highly labile to the resonance structures of the 
anionic intermediates (scheme 64).  
 
Scheme 64: degredation of 276. 
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Therefore, a less basic organometallic reagent was required. Using the Grignard reagent of the 
bromoaromatic also resulted in total degradation of the epoxyester 276 so several attempts 
were made to generate the organocuprate. Following literature procedure, the starting aromatic 
was lithiated and added to a solution of copper
I
 iodide or copper
I
 cyanide and allowed to stir at 
−40 °C overnight giving a distinct green/yellow coloured solution. A solution of epoxide was 
then added to this at −78 °C and monitored by 1H NMR. In all cases degradation of the 
epoxyester to the unsaturated ester 276 occurred rapidly. 
The synthesis was then revised to use a protected primary alcohol and include the oxidation of 
this substituent to the required carboxylic acid at the end of the synthesis. It was hoped that a 
protecting group could be used to still include concomitant cleavage in order to maintain some 
step economy. TMS protection was selected due to its high lability in the presence of acid and 
was hoped that this could be cleaved upon quench of the epoxide opening reaction with two 
molar hydrochloric acid. 
 
Scheme 65: i) 
n
BuLi, BF3
.
Et2O, epoxide, then 2M HCl. ii) NaClO2. 
 
Scheme 66: i) NaH, TMSCl. 
Attempts were made to synthesise the trimethylsilyl analogue 286 of the previously 
synthesised epoxide using the same methodology
[54]
 (scheme 32). However, the final step of 
the synthesis (scheme 62) did not achieve the incorporation of the silyl protecting group due to 
its instability towards aqueous extraction TBDPS
[54]
 was then reselected as the protecting 
moiety with the intention of a deprotection at step five. The possibility to again cleave the 
oxygen silicon bond upon quenching, but with a stronger acid, was still plausible, however, it 
was presumed that elimination of the newly formed hydroxyl group could occur. Therefore, 
for the purposes of developing this reaction procedure, this acidic quench was not conducted. .  
70 
 
 
Scheme 67: i) 
n
BuLi, 197, BF3
.
Et2O. ii) MeCH(OMe)2, BF3
.
Et2O. iii) CAN. iv) Et3N, 2-
(trimethylsiloxy)furan. v) TBAF. vi) NaOCl2. 
Metallating 
agent 
Eq. LA Addition Temperature (°C) Result 
nBuLi 1 - −78 No reaction 
nBuLi 1 BF3
.Et2O −78 No reaction 
nBuLi 1 BF3
.Et2O 0 Epoxide degradation 
nBuLi 1 - 0 Epoxide degradation 
nBuLi 1 BF3
.Et2O 0 (inverse addition) Epoxide degradation 
nBuLi 1 - 0 (inverse addition) Epoxide degradation 
Mg 1 - 0 Epoxide degredation 
Mg 1 - −78 Epoxide degradation 
Mg 1 - −78 (inverse addition) Epoxide degradation 
nBuLi /CuI 0.5 - −78 No reaction 
nBuLi /ZnCl2 1 - −78 Epoxide degradation 
Table 4: TBDPS protected epoxide 197 opening conditions. 
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The dropwise addition of the epoxide to a solution of the organolithium at −78 °C resulted in 
no reaction with and without the presence of boron trifluoride, therefore, the temperature was 
increased. In both cases, this led to total degradation of the epoxide even when the addition 
order was reversed to add a solution of the nuclophile to the protected epoxide. These 
reactions gave an complex and inseparable mixture of compounds. These observations can be 
attributed, in part, to abstraction of the three most acidic protons on the epoxide by the highly 
electron rich aromatic lithium reagent (scheme 68). 
 
Scheme 68: β-elimination of epoxide 184. 
In the first two cases (coloured green and red) a proton is abstracted to generate an enolate 
which, upon, quenching results in the aldehyde or ketone respectively. In the third case 
(coloured blue) β-elimination occurs to give the unsaturated alcohol. Another possible 
explanation for the high number of side compounds is cyclisation under Lewis acid conditions. 
 
Scheme 69: α-elimination of epoxide 184. 
The α-elimination product could also be attributed to the complex mixture observed, 
generating the primary carbene of epoxide 184.  
 
Scheme 70: Lewis acid induced cyclisation of epoxide 184. 
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The presence of boron trifluoride could induce the formation of a zwitterionic five membered 
heterocyclic intermediate 296 which is ring opened upon quenching with water to generate the 
1,2-diol 297. It was clear that a less basic nucleophile would be required therefore the 
Grignard reagent was synthesised. At 0 °C, a black solution rapidly formed and complete 
degradation of the starting material was observed by 
1
H NMR. At −78 °C degradation of the 
epoxide was also observed. This was attributed to coordination of magnesium salts to the 
epoxide resulting in similar by products. However, when the addition order was reversed the 
same result was observed indicating that the aromatic organomagnesium was also 
deprotonating the epoxide. The organocuprate was then synthesised, however the dropwise 
addition of the TBDPS protected epoxide at −78 °C warming to 0 °C yielded no reaction. The 
final organometallic reagent synthesised used zinc
II
 chloride to trans metallate with the 
generated aromatic lithium species but its use resulted in degradation of the starting epoxide. 
Therefore, alternative epoxides were considered. 
Para-methoxybenzyl was the next choice for protection as it was hoped that it could be 
removed with ceric ammonium nitrate during step three (scheme 71). 
 
Scheme 71: i) 
n
BuLi, BF3
.
Et2O, 301, (87%). ii) MeCH(OMe)2, BF3
.
Et2O. iii) CAN. iv) Et3N, 
diene. v) NaClO2. 
The PMB protected epoxide 301 was generated in a similar fashion
[113]
 to the previously 
reported TBDPS protected epoxide from (2S)-bromobut-1,4-diol 196 (scheme 67). 
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Scheme 72: i) NaH, PMBBr, (77%). 
Treatment of 2-bromo-1,4-butanediol (S)-196 with sodium hydride followed by the slow 
addition of freshly synthesised p-methoxybenzyl bromide gave the desired epoxide 301 in 
77% yield. The compound was confirmed by comparison of the 
1
H NMR with literature
[113]
 
spectra showing six distinct multiplets for the seven butyl protons at 1.75, 1.85, 2.52, 2.76, 
3.06 and 3.59 ppm (each 2 H) along with the indicative PMB doublets at 6.87 ppm (2 H, d, J = 
9.0 Hz), 7.26 (2 H, d, J = 9.0 Hz). Optical rotation for the (S) enantiomer ([α]25D = +10.5) was 
consistent with literature values
[113]
. A series of reactions were attempted to open the epoxide. 
Metallating 
agent 
Lewis acid Solvent Temp. of 
addition (°C) 
Result 
nBuLi - THF −78 °C No reaction 
nBuLi BF3
.Et2O THF −78 °C Epoxide degradation 
Mg - THF −78 °C Epoxide degradation 
nBuLi/CuI - THF −78 °C No reaction 
nBuLi/ZnBr2
 - THF −78 °C No reaction 
nBuLi BF3
.Et2O  THF (Diluted epoxide) −55 °C 43% 
nBuLi BF3
.Et2O  Et2O (Diluted epoxide) −55 °C 87% 
Table 5: Epoxide opening conditions for PMB protected epoxide. 
Addition of the neat epoxide dropwise to the lithiated 1,4-dimethoxybenzene resulted only in 
the recovery of the starting electrophile. Conducting the reaction in the presence of boron 
trifluoride etherate complex observed degradation compounds after two hours at −78 °C. 
Similarly generating the Grignard reagent of the aromatic bromide and adding the epoxide 
showed decomposition. Transmetallating the lithium species with copper
I
 iodide showed no 
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reaction nor did transmetallation to generate the organozinc nucleophile. A breakthrough was 
finally achieved by increasing the addition temperature to −55 °C and slowly adding the 
epoxide as a dilute solution in THF over forty minutes and quenching the mixture with water 
at 0 °C. This gave the desired ring opened adduct as a clear oil in modest yield (43%) after 
rapid chromatography. Similarly to the propylene oxide analogue, the compound would 
decompose if exposed to silica for a prolonged period of time. Many side compounds were 
observed on TLC but in low quantity. This secondary alcohol was characterised by 
1
H NMR 
showing three 2H multiplets at 1.76 ppm (2) 2.77 ppm (4) and 3.59-3.68 ppm (1) and a 1H 
multiplet at 4.04 ppm (3). Three methoxy peaks were also observed at 3.75, 3.77 and 3.79 ppm 
corresponding to the aromatic OMe groups and the distinctive para substituted doublets at 
6.78 and 7.23 ppm confirmed the presence of the PMB substituent. Due to the modest yield, a 
series of optimistation reactions were conducted, by which it was discovered that simply 
changing the solvent to diethylether doubled the yield to 87%.  
 
Figure 23: Proton labeling for (S)-4-paramethoxybenzyl-1-(2,5-dimethoxyphenyl)butan-2-ol. 
These reaction conditions were then applied to the TBDPS protected analogue 197, however, 
none of the desired opened epoxide was observed.  
Treatment of a dichloromethane solution this compound with the dimethyl acetal of 
acetaldehyde in the presence of boron trifluoride etherate complex did not however give the 
oxa-Pictet-Spengler adduct. Performing this reaction with two equivalents of both the acetal 
and the Lewis acid in a dichloromethane solution at 0 °C gave the desired isochromane as a 
complex mixture of products in very low yield. After extensive chromatography this 
compound was isolated (>2%, 1 mg). 
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Figure 24: 
1
H NMR of PMB protected isochromane 299. 
Only one diastereoisomer was observed on 
1
H NMR, however, due to the small quantity of 
material no further 2D spectra could be obtained to discern the stereogenicity at C1. The 
compound was charcterised by 
1
H NMR showing C1 methyl doublet at 1.34 ppm and proton 
at 4.67 ppm. The PMB substituent remained intact showing indicative signals at 4.09 ppm 
(2H, s). 6.80 ppm (2H, d) and 7.12 ppm (2H, d) along with three methoxy peaks at 3.70, 3.77 
and 3.78 ppm. The two benzylic protons were showed distinct signals at 2.73 and 2.89 ppm. 
The main compound isolated from the reaction mixture was compound 302. 
 
Figure 25: Acetal isolated from oxa-Pictet-Spengler 
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Figure 26: 
1
H NMR of isolated acetal 302. 
This compound was characterised by 
1
H NMR spectroscopy. Similarly, the desired compound 
observed distinctive geminal proton signals at 2.72 and 2.90 ppm. The acetal also gave signals, 
similar to that observed at C1 of the desired compound at, 1.32 ppm (3H, d) and 4.68 ppm 
(1H, q). Labeled aliphatic protons 1 and 3 were almost identical to those of the isochromane 
observed at 1.67 and 4.69 ppm respectively, however, protons labeled 2 showed more well 
defined splitting as a doublet of triplets and a doublet of quartets at 3.70 and 4.04 ppm 
respectively. The aromatic protons integrated as three as a multiplet and 
13
C NMR showed 
only three quaternary aromatic signals indicating that this was the predicted acetal and not the 
deprotected isochromane. Therefore, it was clear that another protecting group was required.  
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Scheme 77. i) 
n
BuLi, BF3
.
Et2O, 303 (88%). ii) MeCH(OMe)2, BF3
.
Et2O, (99%). iii) CAN. iv) 
Et3N, diene. v) H2, Pd/C. vi) NaClO2. 
The next protecting substituent chosen was benzyl. This group was previously not used due to 
foreseen complications with exposure to hydrogenation conditions as the carbon oxygen bond 
at C1 may also be cleaved. However, due to the group’s somewhat inert characteristics 
towards the preceding reactions it was selected as the next logical choice. 
 
Scheme 77: i) NaH, BnBr, (89%). 
The benzyl protected epoxide was synthesised according to previously published literature
[114]
, 
similarly to previous epoxides, from optically pure aspartic acid. The final step involved the 
slow addition of a solution of benzyl bromide in DMF to a THF solution of 2-bromo-1,4-
butanediol (S)-196 to achieve the desired epoxide in modest yield (89%). The compound was 
characterized by 
1
H NMR showing the indicative 5H benzyl multiplet and CH2 singlet at 7.34 
and 4.53 ppm respectively. The aliphatic chain was observed showing six multiplet signals at 
1.81, 1.91, 2.51, 2.78, 3.08 and 3.63 ppm (each 2H) similar to the previously synthesised 
epoxides. Both 
1
H and 
13
C NMR correlated with literature spectra
[114]
 as did the HRMS 
spectrum showing an ion [M + H]
+
: 179.1060. Comparison of the observed optical rotation 
([α]D
25
 = + 15.8) confirmed retention of stereochemistry of 303. Treatment of 1-bromo-2,5-
dimethoxybenzene 90 with 
n
BuLi followed by the slow addition of boron trifluoride then the 
addition of a dilute solution of the benzyl protected epoxide 303 over forty minutes yielded the 
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opened epoxide (88%) 304. As with the PMB analogue, many side compounds were observed 
on TLC but in small quantity. Also, exposure to silica gel more than thirty minutes resulted in 
decomposition of the compound. This can be attributed to β-elimination of the hydroxyl 
substituent to generate a conjugated styrene like analogue. 
 
Figure 27: Proton assignments for 304. 
The 
1
H NMR spectrum showed two aromatic multiplets at 6.76 ppm (3H), 7.30 ppm (5H) 
corresponding to the dimethoxy aromatic and benzyl substituents, and a benzyl CH2 signal at 
4.51 ppm. Three 2H multiplet signals were present at 1.78, 2.79 and 3.70 ppm for protons 1, 2 
and 4 and a 1H multiplet was observed at 4.11 ppm for tertiary proton 3. An oxa-Pictet-
Spengler cyclisation using two equivalents of 1,1-dimethoxyethane and BF3
.
Et2O in a 
dichloromethane solution gave isochromane 205.  
 
Figure 28: Mixture of trans(1.00):cis(0.37) isomers observed in the crude 
1
H NMR spectrum. 
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Again 
1
H NMR NOE experiments showed a 2.7:1 mixture of trans:cis isomers. The major cis 
isomer could be partially isolated by silica gel chromatography and showed 1H NMR signals 
at 1.50 ppm (3H) and 4.91 ppm (1H) corresponding to the C1 methyl group and tertiary 
proton. A 5H multiplet at 7.25 ppm and 2H singlet at 4.50 ppm confirmed that the benzyl 
protecting group was still present. Indicative geminal signals were observed at 2.34 and 2.72 
ppm. The stereogenic assignment of this diastereoisomer was confirmed by NOESY (figure 
29) experiments showing no correlation between the tertiary protons at C1 (5.00 ppm) and at 
C3 (4.07 ppm).  
 
Figure 29: 
1
H NMR NOESY showing no correlation between C1 and C3 tertiary protons for 
the cis diastereoisomer of 305. 
In an effort to isomerise the diastereoisomers mixture, the isochromane mixture was exposed 
to H2SO4 as a solution in benzene according to literature procedures.
[53]
 However, within two 
minutes at 0 °C the solution had become black and 
1
H NMR of the mixture after work up 
showed no starting material remained. This was also reported by Koert et al.
[71]
 on similar 
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compounds. Whilst the epimerization of BIQ molecules is well known via this method and 
others,
[53, 115]
 simple isochromane quinones are not stable towards these conditions.  
With access to this isochromane 305 and the previously synthesised 1,3-dimethylisochromane  
quin0ne 268, attempts were made to perform the Diels-Alder cycloaddition and base induced 
aromatization. The diene selected for the reaction was the previously synthesised 2,5-
(trimethylsiloxy)furan 208 along with the dimethoxy and diacetoxy analogues generated by 
literature procedures from succinic anhydride. Due to the sensitivity of this molecule, 
generation of the diene and Diels-Alder reactions were carried out in situ.  
 
Scheme 78: Dihydroxylated diene synthesis. 
R Electrophile Base Lewis acid 
TMS TMSCl Et3N - 
TMS TMSCl Et3N ZnCl2 
Me MeI Et3N - 
Ac (Ac)2O Et3N - 
Table 6: Diene formation conditions. 
 
Scheme 79: Diels-Alder cycloaddition. 
The diene was generated in an etherial solution at 0 °C then cooled to −78 °C before the 
dropwise addition of the isochromane quinone as a solution in diethylether and the reaction 
was monitored by 
1
H NMR. The methyl and acetate analogues showed no reaction with the 
quinone but 
1
H NMR did not show the presence of any succinic anhydride indicating that the 
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dienol had formed. The TMS analogues, both with and without the presence of a Lewis acid, 
gave a highly complex mixture of inseparable compounds, which exhibited a variety of 
yellow, orange and red colours after attempted chromatography. No characteristic signals 
above 12 ppm were seen in the 
1
H NMR spectrum which would be indicative of a 
naphthazarin like core. However, analysis by MALDI-TOF showed one ion signal at 266.13 
which is believed to be one of the isochromanes (figure 30). 
 
Figure 30: Suspected isochromanes from Diels-Alder reactions. 
A mechanistic rationalisation for this observation is due the symmetrical nature of the diene 
(scheme 80). 
 
Scheme 80: Proposed rearomatisation mechanism. 
After undergoing the initial Diels-Alder reaction the intermediate can undergo two 
symmetrical pericyclic reactions to aromatize the dione and transfer the silyl protecting groups 
to the now phenolic oxygens whilst forming maleic anhydride in the process. As the driving 
force for this reaction will be the aromatization of the quinone, loss of the ring junction 
protons to aromatize to give the less stable naphthazarin core is less likely. However, as no 
compound could be isolated pure and fully characterized, this cannot be certain.  
As the rationale for this was due to the symmetry of the diene, the same reaction was 
attempted with 2-(trimethylsiloxy)furan which was expected to occur via the mechanism in 
scheme 81. 
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Scheme 81: Expected mechanism for cycloaddition of 2-(trimethylsiloxy)furan. 
It was hoped that quenching the reaction with acid would result in ring opening of the Diels-
Alder adduct followed by tautomerisation of the dione to give a tetra substituted naphthalene 
along with removing the TMS protecting group. Then, as previously observed, exposure to 
oxygen or silica gel chromatography would result in the desired naphthazarin core. Quenching 
the reaction with either water or aqueous NH4OH resulted in the isochromane, however, 
quenching with 1M HCl or saturated NH4Cl gave a highly complex mixture of non-isolable 
compounds. A possible explanation of the observed mixture is through the rearomatisation of 
the quinone ring shown in scheme 31. As presumed with 2,5-(trimethylsiloxy)furan 312, after 
the [4+2] cyclisation, aromatisation of the quinone ring is preferential to formation of the 
naphthazarin bicyclic structure. However, is can be envisaged mechanistically that two 
regioisomers can be generated when the Diels-Alder is performed with 1,3-
dimethylisochromane 267 (figure 31).   
 
Scheme 31: Possible rearomatisation mechanism. 
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Figure 32: Possible side products of the Diels-Alder cycloaddition of isochromane 268 and 2-
(trimethylsiloxy)furan. 
Therefore, focus was shifted to the benzyne cycloaddition methodology previously devised.  
Starting from 1,4-dibromo-2,5-dimethoxybenzene, the same methodology could be applied to 
generate the benzyne cycloaddition precursor in two steps by litiation followed by the addition 
of an epoxide then an oxa-Pictet-Spengler reaction to produce the brominates isochromane. It 
was envisaged that upon deprotection of the methoxy groups that oxidation to the 
naphthazarin core of the aglycone would be spontaneous as previously observed with similar 
systems. 
.  
Scheme 82: i) 
n
BuLi, 326, BF3
.
Et2O. ii) MeCH(OMe)2, BF3
.
Et2O. iii) LDA, 2-
(trimethylsiloxy)furan. iv) KOH, H2O. v) BBr3. vi) NaClO2.  
It was envisaged that the synthesis of the granaticin aglycone could be realized in six steps. 
Three key steps to form the tricyclic core ending with the deprotection of both methoxy 
groups using boron tribromide, cleavage of the pivaloyl group with potassium hydroxide and 
finally oxidation of the primary alcohol to give the carboxylic acid chain. Pivaloyl was chosen 
as the protecting group for this synthesis as it can be easily removed with sodium hydroxide 
and does not require hydrogenation. 
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Scheme 83: i) NaH, PivCl, (83%). 
The epoxide 326 was synthesized enantiopure from (S)-aspartic acid 194, similarly to the 
previous epoxides. Treatment of 2-bromo-1,4-butanediol with sodium hydride followed by the 
dropwise addition of pivaloyl chloride gave the desired compound in 83% yield 326. The 
compound was characterized by 
1
H NMR showing the large 9H tertiary butyl peak at 1.24 
consistent with the pivaloyl group. Also observed was the butyl chain showing five expected 
aliphatic signals at 1.86 ppm (2H, m), 2.55 ppm (1H, dd), 2.82 ppm (1H, m), 3.05 ppm (1H, 
ddd), 4.25 ppm (2H, t). 
13
C NMR also showed the pivaloyl carbonyl signal at 178.4 ppm. The 
optical rotation ([α]D
25
 = +4.4) of 326 was comparable to the previously synthesized epoxides 
indicating that stereochemistry was retained. Previously devised methodology showed a 
dramatic increased yield when the epoxide opening were conducted in diethylether, however, 
the dibrominated aromatic 241 was insoluble below 0 °C therefore THF was the chosen 
solvent. Lithiating with 
n
BuLi followed by the dropwise addition of a THF solution of the 
pivaloyl protected epoxide did not however generate the desired secondary alcohol.  
 
Figure 33: 
1
H NMR of crude opened pivaloyl epoxide. 
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Analysis of the crude 
1
H NMR spectrum (figure 33) showed five multiplets and two doublets 
of doublets similar to what is expected from the ring opened compound. It is suspected that the 
presence of boron trifluoride resulted in ring opening of the compound upon quenching the 
reaction with water generated the 1,2-diol. However, this compound could not be isolated. 
 
Scheme 84: i) 
n
BuLi, 326, BF3
.
Et2O. ii) MeCH(OMe)2, BF3
.
Et2O. iii) LDA, 2-
(trimethylsiloxy)furan. iv) H2, Pd/C. v) BBr3. vi) NaClO2.  
The benzyl protected analogue was then reselected for study, as it had been previously 
successful for these reactions, with the ambition to remove the protecting functionality by 
hydrogenation as the penultimate step of the synthesis. Again THF was used as the solvent due 
to the insolubility of the dibromobenzene compound 241. This resulted in the same complex 
mixture of compounds showing the suspected diol as the main product. 
 
Scheme 84: i) 
n
BuLi, BF3
.
Et2O, propylene oxide. ii) MeCH(OMe)2, BF3
.
Et2O. iii) LDA, 2-
(trimethylsiloxy)furan. iv) BBr3. 
The synthesis was then attempted with racemic propylene oxide. Again THF was the chosen 
solvent. Lithiating with normal butyllithium followed by the dropwise addition of neat 
propylene oxide gave the desired secondary alcohol in good yield. This compound was 
observed in the 
1
H NMR spectrum of the crude material (figure 34) showing the two 
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distinctive benzylic protons at 3.29 and 3.43 ppm and a methyl doublet at 1.23 ppm. The 
tertiary proton was also visible as an expected multiplet at 3.92 ppm along with two OMe 
singlets at 3.69 and 3.70 ppm. HRMS observed a ion at [M - OH + H]
+
: 259.0151.
[116]
 This 
compound was not stable towards silica or alumina gel chromatography therefore no further 
purification or spectral analysis was conducted. The instability of the secondary alcohol is 
attributed to elimination of the hydroxyl group to produce an unsaturated molecule with a 
styrene motif which can then polymerise due to the increased electron density within the 
aromatic ring.   
 
Figure 34: 
1
H NMR of crude 330. 
The brominated secondary alcohol 330 was then treated with boron trifluoride etherate 
complex and 1,1-dimethoxyethane to affect the oxa-Pictet-Spengler cyclisation. However, no 
reaction of the crude material was observed by 
1
H NMR spectroscopy when attempted at 0 °C 
or ambient temperature. Increasing the temperature to reflux resulted in decomposition giving 
a highly complex mixture of compounds. This lack of reactivity is attributed to the presence of 
the meta bromine substituent preventing aromatic substitution. Attempts were then made to 
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protect the secondary hydroxyl group and perform the benzyne cycloaddition before 
deprotecting and forming the tetrahydropyran ring by an oxa-Pictet-Spengler reaction. 
 
Scheme 85: i) NaH, PG-X. ii) LDA, diene. 
Triethylsilyl was chosen as a protecting substituent as it was hoped that it could be cleaved 
upon the addition of 2M hydrochloric acid during the quench of the benzyne cycloaddition. 
However, treatment of the free hydroxyl group with sodium hydride followed by the dropwise 
addition of a THF solution of TESCl at −78 °C which was then allowed to warm to 0 °C 
before the addition of H2O resulted in a highly complex mixture of compounds with no 
incorporation of the silyl group observed in the 
1
H NMR spectrum. This can be attributed to 
elimination of the formed siloxy substituent to again generate a compound with a styrene 
motif which can then undergo polymerization reactions. An attempt to O-methylate the 
hydroxyl group by treatment with sodium hydride followed by the slow addition of methyl 
iodide again resulted in a complex mixture of compounds.  
 
Scheme 86: i) LDA, 2-(trimethylsiloxy)furan, then 
n
BuLi, MOMCl, (28% over 2 steps). ii) 
n
BuLi, BF3
.
Et2O, propylene oxide. iii) MeCH(OMe)2, BF3
.
Et2O. iv) BBr3. 
The synthesis was then reorganised to begin with the benzyne cycloaddition and, as previous 
studies had illustrated 1,4,5,8-tetramethoxynaphthalene 179 to be unstable, protect the two 
generated hydroxyl protons with methoxymethylene substituents as compound 334. This 
naphthalene derivative could then be used to form the secondary alcohol, undergo an oxa-
Pictet-Spengler reaction and then it was hoped that exposure to boron tribromide would result 
in global deprotection of all hydroxyl groups. Using the previously devised benzyne 
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cycloaddition conditions 1,4-dihydroxy-5,8-dimethoxynaphthalene 236 was synthesized. The 
reaction was quenched, extracted and solvent removed before being dissolved in THF. 
Treatment of the resulting diol with sodium hydride did not result in deprotonation of the 
hydroxyl protons, therefore, a stronger base was required. This is likely due to hydrogen 
bonding between the methoxy oxygens and the hydroxyl protons. Treatment with 
n
BuLi and 
the addition of freshly synthesized 2.1M MOMCl in toluene generated the desired compound 
334 in 28% yield over the two steps. This product was characterized by 
1
H NMR showing five 
distinct singlets at 3.53 ppm (6H, CH3), 3.82 ppm (6H, CH3), 5.08 ppm (4H, CH2), 6.75 ppm 
(2H, Ar), 6.97 ppm (2H, Ar). However, similarly to the tetramethoxy analogue, the product 
underwent rapid oxidation to O,O-dimethylnaphthazarin 181 therefore the subsequent reaction 
was conducted immediately after isolation. The addition of this compound with n-butyllithium 
resulted in total degradation of the naphthalene derivative.  
As the synthesis of 1,3-dibromo-2,5-dimethoxybenzene would prove to be a three step and 
costly synthesis, the synthesis was again rearranged to incorporate the bromine later. This 
would allow for the oxa-Pictet-Spengler cyclisation but increase the synthesis by one step. 
Attempts were made to install the bromine substituent at either C6 or C7 (as this would not 
affect the generation of the benzyne intermediate in the subsequent reaction) by subjecting the 
previously synthesised isochromane (as a mixture of diastereoisomers) to 
n
BuLi and 
quenching the generated organolithium with  1,2-dibromoethane.  
 
Scheme 87: 
n
BuLi induced ring opening. 
Instead of deprotonating ortho to either methoxy group, the benzylic proton was abstracted 
resulting in ring opening of the pyran ring (scheme 87). This compound was characterised as a 
mixture of diastereoisomers by 
1
H NMR (figure 35) showing a distinctive doublet of doublets 
at 6.21ppm and by HRMS showing two ion signals at m/z [M + H]
+
: 222.1485 and [M - OH]
+
: 
205.1221. 
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Figure 35: 
1
H NMR of opened pyran ring 336. 
 
Scheme 88: i) Br2, AcOH (75%). 
The brominated compounds 337 and 338 was synthesized by an aromatic substitution via the 
dropwise addition of molecular bromine to a solution of the isochromane 267 in acetic acid. 
This produced a 1:1 mixture of regioisomers. 
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Figure 36: 
1
H NMR of brominated isochromane regioisomers. 
These compounds were characterised by HRMS which showed isotopic pattern m/z [M + H]
+
: 
301.0434, 303.0305 and by 
1
H NMR. Signals were observed for the major isomers as two 
quartets for the C1 quaternary protons at 4.95 and 5.01 ppm along with two sets of geminal 
proton doublets of doublets at 2.16, 2.35, 2.62 and 2.80 ppm. These isomeric compounds were 
then subjected to benzyne cycloaddition conditions by the slow addition of a solution of the 
brominated material to freshly synthesised LDA and 2-(trimethylsiloxy)furan. However, no 
cycloaddition product was observed by 
1
H NMR spectrum. A complex mixture of compounds 
was produced which can be attributed to deprotonation of a geminal proton and ring opening 
the pyran ring. The use of lithium hexamethyldisilamide also produced a complex mixture 
indicating that the benzyne intermediate could not be generated for this substituent.   
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5. Conclusions 
In conclusion, we have developed a novel synthetic strategy for the synthesis of functionalised 
isochromanes and isochromane quinones. This divergent strategy can be used to generate a 
range of compounds by altering the epoxide used in the first step and by using varying acetals 
for an oxa-Pictet-Spengler cyclisation.  
Although the final Diels-Alder step has yet to be realized, this strategy has the potential to 
provide a quick and inexpensive route to a variety of benzoisochromane quinone compounds.  
In addition, we have also developed, to the best of this authors knowledge, a novel method for 
the synthesis of naphthazarin analogues in a single step from inexpensive reagents via a 
benzyne cycloaddition and acidic reaction quench. 
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6. Future work 
 
Scheme 89: i) 
n
BuLi, BF3
.
Et2O, 303. ii) MeCH(OMe)2, BF3
.
Et2O. iii) Pd/C, H2. iv) Cr(O)3, 
AcOH. v) Et3N, 353. vi) Jones reagent. vii) BBr3. 
Building on the previously described isochromane synthesis, it is hoped that the benzyl 
protecting substituent can be cleaved by hydrogenation in the presence of catalytic Pd/C to 
generate primary hydroxyl 339. Utilising methodology developed by Xu et al.,
[76]
 global 
oxidation to give the quinone ring and carboxylic acid 340 can be achieved using chromium 
trioxide under acidic conditions. In order to avoid ring opening degredation side products 
during the Diels-Alder reaction with the previously used furan derivatives (208 and 2-
(trimethylsiloxy)furan), an acyclic tetraoxygenated diene may be required. 1,4-
trimethylsiloxy-1,4-ethoxybuta-1,3-diene can be synthesized in a single step (scheme 90) from 
diethylsuccinate
[117, 118]
. This intermediate 350 can then be treated with Jones reagent 
following similar literature methodology
[63, 64]
 to the synthesis of eleutherin 107 and frenolicin 
22 by Kraus et al. to give the naphthazarin core. The remaining ethyl protecting substituents 
can then be cleaved to give the aglycone 37.  
 
Scheme 90: i) TMSCl, Et3N. 
An alternative strategy is to protect the quinone ring as the tetramethyl diacetal (scheme 91) 
according to literature methods
[119, 120]
 by anodic methoxylation of dimethoxy isochromane 
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267 using Pt or Ti plate electrodes. This would prevent rearomatisation during the subsequent 
Diels-Alder cycloaddition with 2-(trimethylsiloxy)furan allowing for generation of protected 
aglycone 357. 
 
Scheme 91: i) MeOH, KOH, Pt or Ti electrode. ii) Et3N, 2-(trimethylsiloxy)furan. iii) BBr3. 
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7. Experimental  
Chemicals of reagent grade were used as purchased unless stated otherwise. When mentioned 
as distilled, THF, Et2O were freshly distilled from sodium benzophenone ketyl. CH2Cl2, and 
acetonitrile were distilled from calcium hydride. Toluene was distilled from sodium. All non-
aqueous reactions were carried out under oxygen-free nitrogen or argon using flame-dried 
glassware. Flash column chromatography was carried out using Davisil LC60A 40-63 micron 
silica (amorphous silicon dioxide). Thin layer chromatography was carried out using 
commercially available Macherey-Nagel pre-coated TLC-sheets (ALUGRAM
®
 SIL 
G/UV254silica plates) and visualised under UV or stained with PMA or KMnO4. Proton and 
carbon NMR spectra were recorded on a Varian Gemini 300 MHz with a 5 mm Inverse detect 
broad band z-gradient probe. A Varian UNITYplus 400 MHz spectrometer with a 5 mm 
Inverse detect broad band z-gradient probe A Bruker Avance III nanobay 400 MHz 
spectrometer with a 5 mm broad band observe BBFO
plus
 probe fitted with an actively shielded 
z-gradient coil. A Bruker Avance III 500 MHz spectrometer with a 5mm broad band observe 
BBFO
plus
 smart probe
TM
 fitted with an actively shielded z-gradient coil. NMR signals were 
measured using the residual non-deuteriated NMR solvent signal as a reference. For 
1
H NMR, 
CHCl3 at 7.27ppm, MeOH at 3.31ppm H2O at 4.79ppm and DMSO at 2.50ppm ppm. For 
13
C 
NMR, CDCl3 at 77.0 ppm was used. Infra-red spectra were recorded on a PerkinElmer 
Spectrum 100FT-IR spectrometer. The specific rotations were measured on aADP 440 
polarimeter from Bellingham + Stanley. Chemical ionisation and high resolution mass spectra 
were measured at the EPSRC Mass Spectrometry Centre at the University of Wales, Swansea. 
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1,5-Bismethoxymethyleneoxynaphthalene 185
[121]
  
 
Scheme 92. 
1,5-Dihydroxynaphthalene 147 (5.00 g, 31 mmol) was slowly added to a suspension of sodium 
hydride 95% (3.75 g, 156 mmol) in anhydrous DMF (100 mL) under an atmosphere of argon 
at 0 °C, resulting in a dark purple slurry. MOMCl (44 mL, 94 mmol, 2.1 M in toluene) was 
introduced dropwise resulting in the mixture gradually becoming yellow. The reaction mixture 
was slowly allowed to rise to r.t. After stirring for 3 hrs the reaction mixture was quenched 
with H2O (150 mL) and extracted into Et2O (5 x 50 mL). The combined organic extracts were 
washed with NaHCO3 (2 x 80 mL) and dried using MgSO4. Evaporation of solvent resulted in 
a yellow solid of 1,5-bismethoxymethyleneoxynaphthalene 185 (99%, 1.41 g). Rf = 0.25 
(EtOAc/hexanes, 1:9). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 3.54 (6 H, s, OCH3), 5.39 (4 H, s, 
CH2), 7.11 (2 H, d, J = 8.4, 4,8-HAr), 7.38 (2 H, t, J = 8.4, 3,7-HAr), 7.90 (2 H, d, J = 8.4, 2,6-
HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 56.7, 95.3, 109.1, 115.9, 125.9, 127.6, 153.3.  IR 
(ATR): υ (cm-1) 1389, 1418, 1594, 2993. HRMS calcd. for C14H16O4 [M + H]
+
: 249.1121 
found: 249.1123. mp: 77-80 °C.  
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N-isopropyl-1,5-bismethoxymethyleneoxynaphthamide 186 
 
Scheme 93. 
TMEDA (1.8 mL, 12.1 mmol) was added under argon at −30 °C to a solution of 185 (1.00 g, 
4.03 mmol) in anhydrous THF (100 mL). 
t
BuLi (7.11 mL, 12.1 mmol, 1.7 M in pentane) was 
slowly added resulting in a dark red solution, consistent with the presence of ortho-lithiated 
aromatics. After stirring at −55 °C for 20 mins., isopropylisocyanate (1.2 mL, 12.1 mmol) was 
introduced dropwise causing the solution to return to a pale yellow colour. The reaction 
mixture was slowly brought to r.t. over 30 mins followed by addition of H2O (50 mL) and 
extraction into ethyl acetate (3 x 50 mL). The combined organic fractions were washed with 
NaHCO3 (50 mL) and the solution was dried (MgSO4) then filtered and concentrated under 
reduced pressure. Chromatography on alumina (EtOAc/hexanes, 1:4) produced N-isopropyl-
1,5-bis(methoxymethyleneoxy)-2-naphthamide 186 as a yellow solid (82%, 879 mg). Rf = 
0.20 (EtOAc/hexanes, 1:4). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.29 (6 H, d, J = 6.6, CH3), 
3.53 (3 H, s, OCH3), 3.60 (3 H, s, OCH3), 4.30 (1H, m, CH) 5.19 (2 H, s, CH2), 5.38 (2 H, s, 
CH2), 7.17 (1 H, d, J = 7.4, 8-HAr), 7.44 (1 H, t, J = 8.4, 7-HAr), 7.55 (1 H, br d, J = 6.8, NH), 
7.78 (1 H, d, J = 8.4, 6-HAr), 8.00 (1 H, d, J = 8.8, 4-HAr), 8.10 (1 H, d, 8.8, 3-HAr). 
13
C NMR 
(100 Mz, CDCl3): δ (ppm) 23.03, 42.08, 56.64, 58.89, 95.06, 101.78, 109.91, 116.53, 119.15, 
124.46, 126.45, 127.08, 128.95, 129.65, 151.58, 153.39, 165.41. IR (ATR): υ (cm-1) 1249, 
1369, 1459, 1540, 1632 (C=O stretch), 3275 (N-H stretch), 3330. HRMS calcd. for C18H24NO5 
[M + H]
+ 
: 334.1649 found 334.1650. mp: 54-56 °C.  
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N-Isopropyl-1-hydroxy-5-methoxymethyleneoxy-2-naphthamide 358 
 
Scheme 94. 
Under an atmosphere of nitrogen, TFA (0.023 mL, 0.3 mmol) was added to an anhydrous 
solution of 186 (89 mg, 0.3 mmol) in CH2Cl2 (20 mL) at 0 °C and stirred for 3 hrs. H2O (20 
mL) was then added and mixture was extracted into CH2Cl2 (2 x 20 mL) which was washed 
with NaHCO3 (2 x 10 mL). After drying (MgSO4) solvent was removed to give N-isopropyl-1-
hydroxy-5-methoxymethyleneoxy-2-naphthamide 358 as a yellow solid. (99%, 86 mg). Rf = 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.27 (6 H, d, J = 6.5, CH3), 3.50 (3 H, s, OCH3), 4.30 (1 
H, m, CH), 5.34 (2 H, s, CH2), 6.16 (1H, br d, J = 7.3, NH), 7.17 (1 H, d, J = 7.7, 6-HAr), 7.26 
(1 H, d, J = 9.0, 4-HAr), 7.38 (1 H, t, J = 7.7, 7-HAr), 7.61 (1 H, d, J = 9.0, 4-HAr), 8.01 (1 H, d, 
J = 9.0, 3-HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 23.3, 42.0, 56.3, 95.5, 107.7, 111.3, 
113.4, 117.5, 120.3, 126.1, 127.0, 128.9, 152.0, 162.9, 170.0. IR (ATR): υ (cm-1) 1245, 1371, 
1444, 1540, 1630 (C=O stretch), 3275 (O-H stetch), 3403 (N-H stetch). HRMS calcd. for 
C16H19NO4 [M + H]
+
: 290.1387 found: 290.1384. mp: 112-114 °C. 
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N,N-dimethyl-1,5-bismethoxymethyleneoxy-2-naphthamide 194 
 
Scheme 95. 
TMEDA (1.8 mL, 12.1 mmol) was added under nitrogen at −55 °C to a solution of 1,5-
bismethoxymethyleneoxynaphthalene 185 (1.00 g, 4.00 mmol) in THF (100 mL) followed by 
dropwise addition of 
t
BuLi (7.1 mL, 12.1 mmol, 1.7 M in pentane) resulting in a dark red 
solution. After stirring for 20 mins N,N-dimethylcarbamyl chloride (0.29 mL, 4.00 mmol) was 
slowly added and reaction mixture stirred for 1 hr resulting in a pale yellow solution. Reaction 
was quenched using H2O (50 mL), extracted into ethyl acetate (3 x 40 mL) and washed with 
NaHCO3 (2 x 40 mL). After drying (MgSO4), solvent was removed and purification by 
alumina gel chromatography (EtOAc/hexanes, 1:2) gave desired naphthamide 194 as a pink 
solid (38%, 485 mg). Rf = 0.20 (EtOAc/hexanes, 1:2) 
1
H NMR (400 Mz, CDCl3): δ (ppm) 
2.89 (3 H, s, NCH3), 3.14 (3 H, s, NCH3), 3.51 (3 H, s, OCH3), 3.53 (3 H, s, OCH3), 5.14 (2 H, 
s, CH2), 5.36 (2 H, s, CH2), 7.11 (1 H, d, J = 8.0, 8-HAr), 7.31 (1 H, d, J = 8.6, 4-HAr), 7.41 (1 
H, t, J = 8.0, 7-HAr), 7.80 (1 H, d, J = 8.0, 3-HAr), 8.05 (1 H, d, J = 8.6, 6-HAr). 
13
C NMR (400 
Mz, CDCl3): δ (ppm) 34.9, 38.5, 56.3, 57.7, 94.9, 100.5, 108.5, 116.0, 118.9, 124.2, 125.4, 
126.7, 126.7, 129.5, 149.2, 153.0, 169.7. IR (ATR): υ (cm-1) 1260, 1371, 1545, 1574, 1665 
(C=O stretch), 3133. HRMS calcd. for C17H21NO5 [M + H]
+
: 320.1498 found: 320.1492. mp: 
81-83 °C. 
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1-Methoxymethyleneoxy-5-hydroxynaphthalene 197 
 
Scheme 96. 
Under an atmosphere of nitrogen, sodium hydride 60% (250 mg, 6.25 mmol) was added to a 
solution of 1,5-dihydroxynaphthalene 147 (1.00 g, 6.25 mmol) in anhydrous DMF (50 mL) at 
r.t. resulting in a purple slurry. After 15 mins MOMCl (3 mL, 6.25 mmol, 2.1M in toluene) 
was added and solution stirred for 17 hrs. The resulting yellow mixture was quenched with 
water and extracted into ethyl acetate (5 x 50 mL) and washed with H2O (5 x 50 mL). The 
combined organic fractions were dried (MgSO4), filtered and solvent evaporated to give the 
mono-substituted compound 197 as a light brown solid (95%, 350 mg). Rf = 0.43 
(EtOAc/hexanes, 1:4). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 3.48 (3 H, s, OCH3), 5.32 (2 H, s, 
CH2), 5.61 (1 H, br s, OH),  6.76 (1 H, d, J = 7.4, 4-HAr), 7.03 (1 H, d, J = 7.4, 8-HAr), 7.23 (1 
H, t, J = 8.4, 3-HAr), 7.30 (1 H, t, J = 8.4, 7-HAr), 7.73 (1 H, d, J = 8.4, 6-HAr), 7.76 (1 H, d, J = 
8.4, 2-HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 56.4, 94.9, 108.7, 109.4, 114.7, 115.2, 125.4, 
125.5, 125.6, 127.9, 151.6, 154.3. IR (ATR): υ (cm-1) 1309, 3100, 3617 (O-H stretch). HRMS 
calcd. for C12H12O3 [M + H]
+
: 205.0859 found: 205.0860. mp: 101-104 °C. 
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1-Methoxymethyleneoxy-5-methoxynaphthalene 198
[122]
 
 
Scheme 97. 
Under nitrogen, at r.t., NaH 60% (71 mg, 1.72 mmol) was slowly added to a solution of 1-
methoxymethyleneoxy-5-hydroxynaphthalene 197 (350 mg, 1.72 mmol) in DMF (20 mL), at 0 
°C and stirred for 10 mins producing a red solution. Methyl iodide (0.11 mL, 1.72 mmol) was 
then added dropwise and mixture stirred for 3 hrs. H2O (30 mL) was added and mixture 
extracted into ethyl acetate (2 x 30 mL). After washing with H2O (3 x 30 mL), NaHCO3 (2 x 
20 mL), drying (MgSO4) and filtration solvent was removed to give desired product 198 as a 
light brown solid (99% 371 mg). Rf = 0.30 (EtOAc/hexanes, 1:8). 
1
H NMR (400 Mz, CDCl3): 
δ (ppm) 3.50 (3 H, s, OCH3), 4.01 (3 H, s, OCH3), 5.39 (2 H, s, CH2), 6.81 (1 H, d, J = 7.6, 8-
HAr), 7.09 (1 H, d, J = 7.6, 8-HAr), 7.34 (2 H, m, 3,7-HAr), 7.82 (1 H, d, J = 8.4, 2-HAr), 7.90 (1 
H, d, J = 8.4, 4-HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 55.7, 56.4, 94.9, 104.5, 108.8, 
114.3, 115.6, 125.4, 125.5, 126.9, 127.1, 152.8, 155.4. IR (ATR): υ (cm-1) 1234, 1343, 1539, 
3100. HRMS calcd. for C13H15O3 [M + H]
+
: 219.1016 found: 219.1016. mp: 75-76 °C, lit. 75-
76 °C. 
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1,4-Methoxymethyleneoxybenzene 200
[123]
 
 
Scheme 98. 
Sodium hydride (5.7 g, 136 mmol, 60% in mineral oil) was added to a solution of 
hydroquinone 199 (5.00 g, 45.5 mmol) in DMF (80 mL) at 0 °C, resulting in a dark yellow 
slurry. MOMCl (65 mL, 136 mmol, 2.1M in toluene) was then added dropwise and the 
solution was stirred at 0 °C for two hrs. The gray reaction mixture was quenched with water 
(100 mL) and extracted into EtOAc (3 x 100ml). The combined organic fractions where 
washed with NaHCO3 (2 x 50 mL), dried (MgSO4), filtered and solvent removed under 
reduced pressure. Purification by silica gel chromatography (EtOAc/hexanes, 1:9) gave bis-
protected product 200 as colourless oil (92% 8.25 g). Rf = 0.35 (EtOAc/hexanes, 1:9) 
1
H NMR 
(400 Mz, CDCl3): δ (ppm) 3.42 (6 H, s, OCH3), 5.07 (4 H, s, CH2), 6.94 (4 H, s, HAr). 
13
C 
NMR (100 Mz, CDCl3): δ (ppm) 55.9, 95.2, 117.5, 152.4. IR (ATR): υ (cm
-1
) 1289, 1531, 
3200. HRMS calcd. for C10H9O4 [M + NH4]
+ 
: 216.2130 found: 216.2131.  
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N-isopropyl-1,4-bismethoxymethyleneoxy-2-benzamide 201 
 
Scheme 99. 
At −55 °C and under an atmosphere of nitrogen, TMEDA (1.5 mL, 10.1 mmol) was added to a 
solution of 1,4-methoxymethyleneoxybenzene 200 (1.00 g, 5.0 mmol) in THF (60 mL) 
followed by slow addition of 
t
BuLi (5.9 mL, 10.1 mmol, 1.6 M in pentane) resulting in a 
yellow solution. Isopropylisocyanate (0.25 mL, 5.30 mmol) was then added to the yellow 
solution dropwise, and the mixture was stirred for 1 hr. The reaction mixture was quenched at 
0 °C with H2O (50 mL) and extracted into EtOAc (2 x 40 mL). The combined organic 
fractions were then washed with NaCl (30 mL) and NaHCO3(40 mL). After drying (MgSO4), 
the solution was filtered and concentrated under reduced pressure. Purification by alumina gel 
chromatography (EtOAc/hexanes, 1:4) gave benzamide 201 as a green oil. (71%, 1.008 g). Rf 
= 0.22 (EtOAc/hexanes, 1:4). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.21 (6 H, d, J = 7.2, CH3), 
3.43 (3 H, s, OCH3), 3.48 (3 H, s, OCH3), 4.24 (1 H, m, CH), 5.12 (2 H, s, CH2), 5.21 (2 H, s, 
CH2), 7.02 (2 H, br s, HAr), 7.64 (1 H, br s, HAr), 7.80 (1 H, s, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 22.3, 45.4, 55.0, 55.8, 94.9, 96.8, 111.0, 115.4, 119.1, 121.7, 151.1, 153.7, 
164.6. IR (ATR): υ (cm-1) 1240, 1444, 1532, 1632 (C=O stretch), 2978, 3180 (N-H stretch), 
3275. HRMS calcd. for C14H21NO5 [M + H]
+ 
: 284.1492 found 284.1491. 
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N,N-dimethyl-1,4-methoxymethyleneoxy-2-benzamide 202 
 
Scheme 100. 
At −55 °C and under an atmosphere of nitrogen, TMEDA (1.5 mL, 10.1 mmol) was added to a 
solution of 1,4-methoxymethyleneoxybenzene 200 (1.00 g, 5.0 mmol) in THF (60 mL) 
followed by slow addition of 
t
BuLi (5.9 mL, 10.1 mmol, 1.6M in pentane) resulting in a 
yellow solution. N,N-dimethylcarbamyl chloride (0.48 mL, 5.3 mmol) was then added to the 
solution dropwise and the reaction mixture was stirred for 3 hrs. The reaction mixture was 
quenched with H2O (50 mL) and extracted into EtOAc (2 x 40 mL). The combined organic 
fractions were then washed with NaCl (30 mL) and NaHCO3 (40 mL) followed by drying 
(MgSO4), filtration and removal of solvent under reduced pressure. Purification by alumina 
gel chromatography (EtOAc/hexanes, 1:2) gave desired benzamide 202 as a pale green oil. (84 
%, 1.11 g). Rf = 0.25 (EtOAc/hexanes, 1:2). 
1
H NMR (400 Mz, CDCl3): 1.21 (6 H, br s 
NCH3), 3.23 (3 H, s, OCH3), 3.41 (3 H, s, OCH3), 4.86 (2 H, s, CH2), 5.07 (2 H, s, CH2), 7.01 
(1 H, s, HAr), 7.04 (1 H, d, J = 2.9, HAr), 7.14 (1 H, d, J = 2.9, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 38.8, 39.9, 51.7, 95.5, 95.9, 112.2, 114.4, 119.7, 123.3, 151.0, 152.8, 170.8. 
IR (ATR): υ (cm-1) 1262, 1501, 1555, 1700 (C=O), 3212. HRMS calcd. for C12H19NO5 [M + 
H]
+ 
: 270.1336 found 170.1337. 
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(±)-2-Bromosuccinic acid 195
[54]
 
 
Scheme 101. 
To a solution on (±)-aspartic acid 194 (2.5 g, 18.8 mmol) in H2O/H2SO4 (50 mL/6.65 mL, 125 
mmol) was added KBr (10 g, 85 mmol) followed by the dropwise addition of NaNO2(2.30 g, 
34 mmol) in H2O (4.5 mL) at −5 °C over 20 mins. During the addition of NaNO2 a brown gas 
was evolved. The yellow mixture was then stirred at 0 °C for 3 hrs. After extraction into 
EtOAc (3 x 50 mL) solvent was removed to produce a white solid to give 2-bromosuccinic 
acid 195 in quantitaitive yield (3.70 g). Rf = 0.50 (AcOH/EtOAc/hexanes, 1:20:20). 
1
H NMR 
(400 Mz, D2O): δ (ppm) 2.92 (1 H, dd, J = 6.2, CH2), 3.13 (1 H, dd, J = 8.7, CH2), 4.54 (1 H, 
dd, J = 6.2, CH). 
13
C NMR (100 Mz, D2O): δ (ppm) 40.9, 42.2, 173.3, 174.3. IR (ATR): υ 
(cm
-1
) 1404, 1700 (C=O stretch), 1742 (C=O stretch), 3001 (O-H stretch br). mp: 163-166 °C, 
lit. 163-164 °C. 
(S)-2-bromosuccinic acid (S)-195
[124]
 
[α]D
25
: −43.5° (c 1g/100mL, H2O). lit.: −42.7° (c 1g/100mL, H2O).   
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(±)-2-Bromo-1,4-butandiol 196
[125]
 
 
Scheme 102. 
Under an atmosphere of nitrogen at −5 °C (ice/NaCl water bath), BH3
 
(45.7 mL, 45.7 mmol, 
1M THF complex) was added over a period of 1 hr, via dropping funnel, to a solution of (±)-
bromosuccinic acid 195 (3.0 g, 15.2 mmol) in THF (50 mL) and the reaction mixture was 
stirred for 1 hr at this temperature resulting in a cloudy suspension. The cooling bath was 
removed and stirring continued for 1.5 hrs at r.t. H2O (3 mL) was added followed by K2CO3 
(5.5 g) and the mixture stirred at 0 °C for a further 20 mins. After filtration, solvent was 
removed and purification by silica gel chromatography (MeOH/EtOAc, 1:50) gave the desired 
diol 196 as a colourless oil (88%, 2.26 g over 2 steps from aspartic acid). Rf = 0.45 
(MeOH/EtOAc, 1:50). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 2.00 - 2.10 (2 H, br m, CH2), 2.42 
(2 H, br s, OH), 3.78 (4 H, m, CH2), 4.23 (1 H, m, CH). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 
37.6, 55.0, 60.0, 67.0. IR (ATR): υ (cm-1) 1420, 2859, 2930, 3107 (O-H stretch), 3399 (O-H 
stretch).  
(S)-2-Bromo-1,4-butandiol (S)-196
[124]
 
[α]D
25
: −23.0° (c 1.05g/100mL, CHCl3). lit.: −26.2° (c 1.05g/100mL, CHCl3).  
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(±)-
t
Butyl-(2-(oxiran-2-yl)ethoxy)diphenylsilane 197
[54]
 
 
Scheme 103. 
To a suspension of NaH 60% (1.53 g, 39.7 mmol) in THF (30 mL) was added (±)-2-bromo-
1,4-butanediol (2.24 g, 13.2 mmol) in THF (10 mL) over 20 mins. at −16 °C and under an 
atmosphere of nitrogen. TBDPS-Cl (3.61 mL, 13.92 mmol) in THF (10 mL) was then slowly 
added at −10 °C and the mixture was stirred for 30 mins. after which stirring was continued 
for 45 mins. At r.t. H2O (20 mL) and NH4Cl (20 mL) were then added and mixture extracted 
into ethyl acetate (3 x 50 mL). The combined organic fractions were then dried (MgSO4), 
filtered, solvent evaporated and compound was purified by silica gel chromatography 
(EtOAc/hexanes, 1:20) to give the desired epoxide 197 as a colourless oil (61%, 2.76 g). Rf = 
0.40 (EtOAc/hexanes, 1:20). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.09 (9 H, s, 
t
Bu), 1.79 (2 H, 
m, CH2), 2.50 (1 H, m, CH2), 2.78 (1 H, m, CH2), 3.10 (1 H, m, CH), 3.89 (2 H, m, CH2), 7.45 
(6 H, m, HAr), 7.70 (4 H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 20.1, 27.0, 36.1, 47.4, 
50.6, 61.3, 128.8, 131.0, 133.8, 133.9, 136.0, 136.7. IR (ATR): υ (cm-1): 1197, 1305, 1466, 
1483, 3050.  
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2-(2,5-Dimethoxyphenyl)ethanol 210
[126, 127]
 
 
Scheme 104. 
To a solution, cooled to 0 °C, of dimethoxybenzene 209 (6.9 g, 50 mmol) in THF (100 mL) 
was added 
n
BuLi (20 mL, 50 mmol, 2.5 M in hexane) resulting in a pale yellow solution and 
the reaction mixture stirred at this temperature for 30 mins. Neat ethylene oxide 359, cooled to 
below −20 °C, was then added in one portion and mixture stirred at r.t. for 2 hrs. Reaction was 
then quenched at 0 °C with 50% saturated solution NH4Cl (50 mL) and extracted with EtOAc 
(3 x 40 mL). The combined organic extracts were then dried (MgSO4), filtered and 
concentrated under reduced pressure. Purification by silica gel chromatography 
(EtOAc/hexanes, 1:5) gave pure alcohol 210 as a yellow oil (54%, 4.8 g). Rf = 1.5 
(EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 2.81 (2H, t, J = 6.4, CH2), 3.69 
(3H, s, OCH3), 3.72 (3H, s, OCH3), 3.76 (2H, m, CH2), 6.64-6.74 (3H, m, HAr). 
13
C NMR (100 
Mz, CDCl3): δ (ppm) 34.2, 55.7, 55.9, 62.9, 111.42, 111.72, 111.74, 128.3, 151.9, 153.6. IR 
(ATR): υ (cm-1) 1046, 1501, 1590, 1741, 2938, 3386 (O-H stretch br). LRMS C10H14O3 [M + 
H]
+
: 182.02. HRMS calcd. for C10H14O3 [M + Na]
+
: 205.0835 found 205.0833. 
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2-(2,5-Dimethoxyphenyl)acetaldehyde 211
[128]
 
 
Scheme 105. 
To a solution of the alcohol 210 (500 mg, 3.30 mmol) in CH2Cl2 (10 mL) and DMSO (5 mL) 
was added 
i
Pr2NEt (2.86 mL, 16.20 mmol) at 0 °C and the reaction mixture was stirred for 20 
mins. A solution of sulfur trioxide pyridine complex (1.59 g, 9.98 mmol) in DMSO (2 mL) 
was then slowly added, maintaining low temperature. Reaction was stirred at this temperature 
for 30 mins and at r.t. for a further 30 mins before being diluted with CH2Cl2 (30 mL), washed 
with CuSO4 (2 x 30 mL), NaHCO3 (30 mL) and brine (30 mL). The organic phase was then 
dried (MgSO4), filtered and concentrated to give pure aldehyde 211 as an orange oil (99%, 
574 mg). Rf = 0.33 (EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.64 (2H, d, J = 
2.1, CH2), 3.79 (3H, s, OCH3), 3.80 (3H, s, OCH3), 6.74-6.85 (3H, m, HAr), 9.96 (1H, t, J = 
2.1, CHO). 
13
C NMR (100 Mz): δ (ppm) 45.5, 55.8, 55.9, 111.4, 113.1, 117.4, 122.2, 151.9, 
153.7, 200.0. IR (ATR): υ (cm-1) 1523, 1588, 1720 (C=O stretch), 1751, 2835 (C-H aldehyde 
stretch), 2948. HRMS calcd. for C10H12O3 [M - H]
+
: 179.0703 found 179.0698. 
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(4S-benzyl-thio-oxo-oxazolidin-3-yl)-ethanone 218
[90]
 
 
Scheme 106. 
To a solution, cooled to −78 °C, of the oxazolidinthione 224 (200 mg, 1.04 mmol) in THF (10 
mL) was added 
n
butyllithium (0.416 mL, 1.04 mmol, 2.5 M in hexanes) dropwise and mixture 
stirred at this temperature for 20 mins. Acetic anhydride (0.1 mL, 1.14 mmol) was then slowly 
added and the mixture was stirred for 30 mins. at r.t. A 50% saturated solution of NaHCO3 (20 
mL) was used to quench the reaction at 0 °C and the THF evaporated. The remaining 
suspension was then extracted into CH2Cl2 (2 x 20 mL), dried (MgSO4) and concentrated 
under reduced pressure to give the acylated compound 218 as a pure white solid (99%, 231 
mg). Rf = 0.50 (EtOAc/hexanes, 1:4) 
1
H NMR (300 Mz, CDCl3): δ (ppm) 2.80 (1H, dd, J = 
9.0, 13.3, CH2), 2.88 (3H, s, CH3), 3.32 (1H, dd, J = 9.0 13.3, CH2), 4.34 (2H, m, CH2), 4.96 
(1H, m, CH), 7.23-7.39 (5H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 26.2, 37.5, 59.8, 
70.3, 127.4, 129.4, 135.2, 171.1, 185.8. IR (ATR): υ (cm-1) 1170, 1290, 1460 (C=S stretch), 
1690 (C=O stretch).  mp: 163-166 °C, lit. 163-164 °C. [α]D
25
: +25.0° (c 0.40/100mL, CDCl3). 
lit.: +26.3° (c 0.40g/100mL, CDCl3). 
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L-Valine methyl ester hydrochloride 226
[91]
 
 
Scheme 107. 
L-valine 225 (5.00g, 42 mmol) as a suspension in MeOH (50 mL) was treated with thionyl 
chloride (9.23 mL, 127 mmol) dropwise over 5 minutes at 0 °C and stirred at r.t. for 17 hrs. 
The reaction mixture was then concentrated and washed with Et2O to give methyl ester 226 as 
a solid yellow hydrochloride salt (98%, 6.90 g). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 1.16 (6H, 
d, J = 6.8, CH3), 2.47 (1H, m, CH), 3.84 (3H, s, CO2CH), 3.93 (1H, d, J = 4.4, CH). 
13
C NMR 
(100 Mz, CDCl3): δ (ppm) 17.7, 18.3, 29.0, 38.9, 57.2, 170.1. IR (ATR): υ (cm
-1
) 1235, 1766 
(C=O stretch), 2899, 3345 (N-H stretch). mp: 171-173 °C, lit. 171-173 °C. [α]D
25
: +25.0° (c 
1.00/100mL, MeOH). lit.: +24.2° (c 1.00g/100mL, MeOH). 
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(S)-1,1-Diphenylvalinol 227
[92, 93, 130]
 
 
Scheme 108. 
Bromobenzene (21.6 mL, 206 mmol) was added dropwise to a three necked round bottom 
flask charged with Mg turnings (5.00 g) and Et2O (50 mL) at a rate to maintain gentle reflux. 
After addition was complete the dark brown coloured mixture was diluted more with Et2O (30 
mL) and stirred for 30 mins. before the slow addition of methyl ester hydrochloride 226 (6.7 g, 
40 mmol) which also resulted in gentle reflux over 30 min. After stirring at r.t. for 17 hrs. The 
yellow reaction mixture was poured onto 2 M NaOH (200 mL), filtered through a pad of 
Celite and the aqueous phase was extracted into CH2Cl2 (4 x 40 mL). The combined organic 
fractions were then dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification by silica gel chromatography (EtOAc/hexanes, 1:4) gave pure compound 227 as a 
pale yellow solid (44%, 4.56 g). Rf = 0.15 (EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, CDCl3): δ 
(ppm) 0.69 (3H, d, J = 6.9, CH3), 0.81 (3H, d, J = 6.9, CH3), 1.91 (1H, m, CH), 5.19 (1H, d, J 
= 3.4, CH), 7.19-7.42 (10H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 16.1, 23.0, 27.8, 
60.2, 79.7, 125.5, 125.9, 126.3, 127.6, 128.0, 128.4, 144.9, 148.0. IR (ATR): υ (cm-1) 1601, 
3017, 3261 (N-H stretch), 3607 (O-H stretch). LRMS C17H21NO [M + H]
+
: 238.13. mp: 99-
101 °C, lit. 98-99 °C. [α]D
25
: −124.0° (c 1.10/100mL, CHCl3). lit.: −130.2° (c 1.10g/100mL, 
CHCl3). 
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(4S)-isopropyl-(3,3-diphenyl)-thio-oxo-oxazolidinone 228
[89]
 
 
Scheme 109. 
To a solution of amino alcohol 227 (1.00 g, 4.10 mmol) in THF (30 mL) was added Et3N (1.70 
mL, 12.3 mmol) and CS2 (0.74 mL, 12.3 mmol) respectively before being refluxed for 14 hrs. 
The reaction was then cooled to r.t., quenched with saturated NH4Cl (20 mL) and extracted 
into EtOAc (2 x 20 mL). The combined organic fractions were then dried (MgSO4), filtered 
and concentrated under reduced pressure. Purification by silica gel chromatography (4:1 
hexanes:EtOAc) gave the oxazolidinthione 228 as a pale yellow solid (85%, 1.05 g). Rf = 0.20 
(EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 0.70 (3H, d, J = 6.7, CH3), 0.90 
(3H, d, J = 6.7, CH3), 1.90 (1H, m, CH), 4.48 (1H, d, J = 4.4, CH), 7.30-7.38 (8H, m, HAr), 
7.50 (2H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 16.3, 20.9, 29.7, 69.6, 95.7, 125.8, 
126.6, 128.2, 128.7, 138.1, 142.4, 187.9. IR (ATR): υ (cm-1) 1170, 1177, 1509 (C=S stretch), 
2910 (N-H stretch). LRMS C18H19NOS [M + H]
+
: 298.07. mp: 220-223 °C, lit. 223 °C. [α]D
25
: 
−310.0° (c 0.50g/100mL, MeOH). lit.: −295.0° (c 0.50g/100mL, MeOH). 
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(4S)-isopropyl-(3,3-diphenyl)-oxazolidinone 230
[89, 95]
 
 
Scheme 110. 
To a suspension of the amino alcohol 228 (1.00 g, 4.10 mmol) in toluene (20 mL) and 10% 
aqueous KOH (20 mL) was added triphosgene (4.19 g, 14.1 mmol) at r.t. and the slurry stirred 
for 2 hrs. The newly formed white solid was then filtered, washed with toluene and cold water 
before being recrystalised from cyclohexane to give desired oxazolidinone 230 as white 
crystals (65%, 760 mg). Rf = 0.35 (EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 
0.66 (3H, d, J = 6.6, CH3), 0.87 (3H, d, J = 6.9, CH3), 1.85 (1H, m, CH), 4.33 (1H, d, J = 3.6, 
CH), 5.72 (1H, br s, NH), 7.24-7.39 (8H, m, HAr), 7.52 (2H, m, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 15.6, 20.8, 29.5, 65.7, 89.3, 125.7, 126.3, 128.1, 128.8, 158.2, 196.8. IR 
(ATR): υ (cm-1) 1185, 1217, 1759 (C=O stretch), 3079, 3315 (N-H stretch) LRMS C18H19NO2 
[M + H]
+
: 282.07. mp: 252-255 °C, lit. 252-253 °C. [α]D
25
: −255.1° (c 0.50g/100mL, CDCl3). 
lit.: −263.4° (c 0.50g/100mL, CDCl3). 
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(4S-isopropyl-(3,3-diphenyl)-thio-oxo-oxazolidin-3-yl)-ethanone 229
[89, 93]
 
 
Scheme 111. 
To a solution of the oxazolidinthione 228 (1.00 g, 3.36 mmol) in THF, at 0 °C was added oil 
free NaH and stirred for 20 mins. Acetic anhydride (0.34 mL, 3.69 mmol) was then added 
dropwise and reaction mixture was stirred at r.t. for 17 hrs. NH4Cl (20 mL) was then added 
and the mixture extracted into EtOAc (2 x 20 mL). The combined organic fractions were then 
washed with NaHCO3 (40 mL), dried (MgSO4), filtered and concentrated. Silica gel 
chromatography (EtOAc/hexanes, 1:8) gave acylated compound 229 as a white powder (61%, 
674 mg). Rf = 0.45  (EtOAc/hexanes, 1:6).
1
H NMR (300 Mz, CDCl3): δ (ppm) 0.79 (3H, d, J = 
6.0, CH3), 0.84 (3H, d, J = 6.0, CH3), 2.03 (1H, m, CH), 2.69 (3H, s, CH3), 5.59 (1H, d, J = 
3.0, CH), 7.29-7.49 (10h, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 17.0, 21.5, 25.7, 30.0, 
68.0, 93.3, 125.4, 126.1, 128.4, 137.4, 141.6, 171.0, 185.4. IR (ATR): υ (cm-1) 1220, 1334 
(C=S stretch), 1374, 1703, 1756 (C=O stretch), 3016. LRMS C20H21NO2S [M + H]
+
: 340.00. 
mp: 90-92 °C, lit. 89-90 °C. [α]D
25
: −201.1° (c 0.50g/100mL, CDCl3). lit. −192.0° (c 
0.50g/100mL, CDCl3). 
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(4S-isopropyl-(3,3-diphenyl)-oxazolidin-3-yl)-ethanone 231
[96]
 
 
Scheme 112. 
At −78 °C, nBuLi (0.71 mL, 1.79 mmol, 2.5 M in hexanes) was added to a solution of 
oxazolidinone 230 (505 mg, 1.79 mmol) in THF (20 mL) and stirred at this temperature for 20 
mins. Freshly distilled acetic anhydride (0.18 mL, 2.00 mmol) was then added and the reaction 
mixture temperature warmed to 0 °C. After stirring for 2 hrs, 50% aqueous NH4Cl (20 mL) 
was added and the mixture was extracted into EtOAc (3 x 20 mL). The combined organic 
fractions were then washed with saturated NaHCO3 (30 mL). After drying (MgSO4), filtration 
and concentration under reduced pressure the acetylated oxazolidinone was recrystalised from 
cyclohexane to give a white solid of 231 (98%, 576 mg). Rf = 0.40 (EtOAc/hexanes, 1:6). 
1
H 
NMR (300 Mz, CDCl3): δ (ppm) 0.69 (3H, d, J = 6.8, CH3), 0.77 (3H, d, J = 6.0, CH3), 1.91 
(1H, m, CH), 2.36 (3H, s, CH3), 5.29 (1H, d, J = 3.4, CH), 7.14-7.31 (8H, m, HAr), 7.41 (2H, 
m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 16.4, 21.7, 23.4, 29.9, 64.4, 89.3, 125.6, 125.9, 
128.4, 128.9, 138.2, 142.3, 153.2, 170.1. IR (ATR): υ (cm-1) 1450, 1706 (C=O stretch), 1787 
(C=O stretch), 2994. LRMS C20H21NO3 [M + H]
+
: 324.07. mp: 121-123 °C, lit. 121-122 °C. 
[α]D
25
: −261.5° (c 1.33g/100mL, CDCl3). lit. −252.5° (c 1.33g/100mL, CDCl3). 
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2,5-Dimethoxybenzaldehyde 134
[131]
 
 
Scheme 113. 
To a solution, cooled to 0 °C, of 1,4-dimethoxybenzene 209 (4.00 g, 28.98 mmol) in THF (60 
mL) was added 
n
BuLi (15.0 mL, 37.7 mmol, 2.5 M in hexanes) dropwise and the solution was 
stirred for 20 mins. Freshly distilled DMF (2.90 mL, 37.7 mmol) was then added in one 
portion and mixture was stirred for 1 hr at 0 °C. 50% aqueous NH4Cl (50 mL) was then added 
and mixture extracted into EtOAc (3 x 30 mL), washed with saturated NaHCO3 (30 mL) 
before being dried (MgSO4). After filtration, solvent was evaporated under reduced pressure 
and the crude mixture was purified by silica gel chromatography (EtOAc/hexanes, 1:4) to give 
2,5-dimethoxybenzaldehyde 134 as a yellow crystalline solid (84%, 3.94 g). Rf = 0.30 
(EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.80 (3H, s, OCH3), 3.89 (3H, s, 
OCH3), 6.93 (1H, d, J = 9.1, HAr), 7.14 (1H, dd, J = 9.1, HAr), 7.33 (1H, d, J = 3.3, HAr), 10.44 
(1H, s, CHO). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 55.8, 56.1, 110.4, 113.4, 123.5, 124.9, 
153.6, 156.7, 189.6. IR (ATR): υ (cm-1) 1224, 1300, 1592, 1599, 1710 (C=O stretch), 2891 (C-
H stretch aldehyde), 3076. LRMS C9H10O3 [M + H]
+
: 167.14. mp: 46-48 °C, lit. 46-48 °C. 
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(E)-Methyl-4-(2,5-dimethoxyphenyl)but-3-enoate 137
[70]
 
 
Scheme 114. 
To a stirred solution of 3-triphenylphosphonium bromide propanoic acid 233 (3.74 g, 9.0 
mmol) in THF (40 mL) at 0 °C was added 2,5-dimethoxybenzaldehyde 134 (730 mg, 4.5 
mmol) followed by the dropwise addition of a solution of 
t
BuOK (2.0g, 18.0 mmol) in THF 
(40 mL) over 1 hr. This mixture was stirred for 30 mins at 0 °C and a further 2 hrs at r.t. 
before the addition of dimethylsulfate (1.14ml, 12.0 mmol). After stirring for 1 hr H2O (40 
mL) was added and the reaction mixture extracted into EtOAc (2 x 30 mL). After washing 
with saturated NaHCO3 (30 mL) and saturated NaCl (30 mL) the solution was dried (MgSO4), 
filtered and solvent removed. Purification by silica gel chromatography (EtOAc:pentane, 1:5) 
gave β,γ-unsaturated ester 137 as a colourless oil (37%, 387 mmol). Rf = 0. 25 
(EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.27 (2H, d, J = 6.1, CH2), 3.72 
(3H, s, OCH3), 3.78 (3H, s, OCH3), 3.80 (3H, s, CO2CH3), 6.29 (1H, dt, J = 7.2 16.0, CH), 
6.78 (1H, dd, J = 7.2 16.0, CH). 6.87-7.00 (3H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 
39.0, 52.1, 55.9, 56.3, 112.0, 112.0, 113.9, 122.7, 126.8, 128.2, 150.7, 154.1, 172.3. IR (ATR): 
υ (cm-1) 1040, 1179, 1212, 1433, 1751 (C=O stretch), 2845 (C-H stretch alkene), 2995 (C-H 
stretch alkene), 3000. LRMS C13H16O4 [M + H]
+
: 238.86. 
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2,5-Dimethoxy-4-bromobenzaldehyde 242
[100, 132]
 
 
Scheme 115. 
To a stirred solution of 1,4-dibromo-2,5-dimethoxybenzene 241 (2 g, 6.7 mmol) in THF (20 
mL) at 0 °C under an atmosphere of argon was added dropwise 
n
BuLi (2.8 mL 7.1 mmol, 2.5 
M in hexanes) and the mixture was stirred for 5 mins. DMF (0.67 mL, 8.8 mmol) was then 
added and mixture allowed to warm to r.t. over 10 mins and then refluxed for 10 mins. H2O 
(20 mL) was then added and mixture extracted into EtOAc (2 x 20 mL). The combined 
organic fractions were then washed with NaHCO3 (10 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. Purification by flash chromatography (EtOAc/hexanes, 
1:6) gave the desired substituted benzaldehyde 242 as a yellow solid (90%, 1.46 g). Rf = 0.35 
(EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.83 (3H, s, OCH3), 3.84 (3H, s, 
OCH3), 7.19 (1H, s, HAr), 7.27 (1H, s, HAr), 10.33 (1H, s, CHO). 
13
C NMR (100 Mz, CDCl3): 
δ (ppm) 56.4, 56.7, 109.6, 117.7, 120.3, 124.1, 150.4, 156.2, 188.8. IR (ATR): υ (cm-1) 1393, 
1448, 1485, 1600, 1677 (C=O), 2890, (C-H stretch aldehyde), 3076. mp: 129-130 °C, lit. 132-
134 °C. 
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5,8-Dimethoxy-1,4-dihydro-1,4-epoxynaphthalene 235
[119]
 
 
Scheme 116. 
At −20 °C under an atmosphere of argon was added nBuLi (0.92 mL, 2.3 mmol, 2.5 M in 
hexanes) to a stirred solution of diisopropylamine (0.32 mL, 2.3 mmol) in THF (10 mL) and 
briefly warmed to r.t. The resulting solution of LDA was then cooled to −78 °C and furan 
slowly added over 30 minutes. A solution of 2,5-dimethoxybromobenzene 90 (0.34 mL, 2.3 
mmol) in THF (10 mL) was then added over 15 minutes and the reaction mixture was stirred 
for a further 30 mins at −78 °C. At this temperature H2O (20 mL) was added and the solution 
allowed to warm to r.t. before being extracted into EtOAc (3 x 20 mL). The combined extracts 
were then washed with saturated NaHCO3 (30 mL) and brine (30 mL), dried (MgSO4), filtered 
and concentrated under reduced pressure. Silica gel chromatography (EtOAc/hexanes, 1:4) 
gave cycloaddition adduct 235 (99%, 455 mg). Rf = 0.20 (EtOAc/hexanes, 1:6). 
1
H NMR (300 
Mz, CDCl3): δ (ppm) 3.79 (6H, s, OCH3), 5.92 (2H, t, J = 1.0, CH), 6.54 (2H, s, HAr), 7.06 
(2H, t, J = 1.0, CH). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 56.4, 80.4, 111.6, 137.4, 143.0, 
147.9. IR (ATR): υ (cm-1) 1177, 1254, 1495, 1614, 2835, 2941. LRMS C12H12O3 [M + H]
+
: 
205.06. mp: 85-87 °C, lit. 86-87 °C. 
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1,4-Dihydroxy-5,8-dimethoxynaphthlene 236
[101]
 
 
Scheme 117. 
To a solution of diisopropylamine (0.42 mL, 3 mmol) in THF (3 mL) was added 
n
BuLi (1.2 
mL, 3 mmol, 2.5 M in hexanes) dropwise at 0 °C and the reaction mixture was stirred for 10 
mins. The resulting LDA solution was then cooled to −78 °C and 2-siloxyfuran 213 (0.67 mL, 
4 mmol) was then added in one portion followed by the slow addition of 2-bromo-1,4-
dimethoxybenzene 90 (3.02 mL, 2 mmol) in THF (10 mL) over 20 minutes. After addition 
was complete the reaction mixture was stirred for 30 minutes at −78 °C and quenched with 
water (10 mL) at this temperature. The biphasic solution was allowed to warm to r.t. and 1 M 
HCl (20 mL) was added producing a yellow solution. The mixture was extracted into EtOAc 
(4 x 10 mL), washed with NaHCO3 (20 mL), dried (MgSO4) and filtered before being 
concentrated under reduced pressure. Silica gel chromatography (EtOAc/hexanes, 1:2) gave 
the aromatised adduct as an orange solid 236 (77%, 333 mg). The compound readily oxidised 
in air/silica gel to naphthoquinone 181. Rf = 0.40 (EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, 
CDCl3): δ (ppm) 3.99 (6H, s, OCH3), 6.61 (2H, s, HAr), 6.82 (2H, s, HAr), 9.08 (2H, s, OH). 
13
C NMR (100 Mz, CDCl3) δ (ppm) 56.4, 56.9, 112.6, 114.6, 146.9, 154.0. HRMS calcd. for 
C12H12O4 [M + H]
+
: 221.0812 found 221.0810.  
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O,O-dimethoxynaphthazarin 181
[102, 103]
 
 
Scheme 118. 
Acetonitrile (4 mL) and H2O (1 mL) were added to 1,4-dihydroxy-5,8-dimethoxynaphthalene 
236 (90 mg, 0.41 mmol) followed by the addition of ceric ammonium nitrate (914 mg, 1.66 
mmol) at 0 °C, and the reaction mixture was stirred for 10 minutes. The solution was then 
diluted with H2O (10 mL), extracted into EtOAc (4 x 5 mL) and the combined organic 
fractions washed with H2O (3 x 10 mL). The bright orange solution was then dried (MgSO4), 
filtered and concentrated under reduced pressure to give naphthazarin analogue 181 in 
quantitative yield as red crystals (89 mg). Rf = 0.22 (EtOAc/hexanes, 1:4). 
1
H NMR (300 Mz, 
CDCl3): δ (ppm) 3.96 (2H, s, OCH3), 6.78 (2H, s, HAr), 7.33 (2H, s, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 56.9, 120.3, 138.4, 153.7, 184.9. IR (ATR): υ (cm
-1
) 964, 1652 (C=O 
stretch), 2848, 2933. HRMS calcd. for C10H10O4 [M + Na]
+
: 219.0555 found 219.0553. mp: 
157-160 °C, lit. 157-159 °C. 
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2,5-Dibromo-1,4-dimethoxybenzene 241
[104, 133]
 
 
Scheme 119. 
1,4-Dimethoxybenzene 209 (5 g, 69 mmol) was dissolved in chloroform (50 mL) at 0 °C and 
bromine (8.9 mL, 172.5 mmol) was slowly added to the solution over 1 hr. The reaction 
mixture was stirred at this temperature for 3 hrs and quenched with saturated Na2SO4 solution 
(50 mL). After extraction with CH2Cl2 (3 x 30 mL), drying (MgSO4), filtration and 
concentration under reduced pressure the brominated compound 241 was recrystallised from 
EtOH to give yellow plates (47%, 9.5 g). Rf = 0.45 (EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, 
CDCl3): δ (ppm) 3.85 (6H, s, OCH3), 7.11 (2H, s, HAr). 
13
C NMR (300 Mz, CDCl3): δ (ppm) 
57.0, 110.4, 117.1, 150.5. IR (ATR): υ (cm-1) 1237, 1599, 3047. mp: 139-141 °C, lit. 144-145 
°C. 
 
  
123 
 
2,5-Dimethoxy-4-bromobenzaldehyde 242
[104, 132]
 
 
Scheme 120. 
To a stirred solution of 2,5-dimethoxybenzaldehyde 134 (5 g, 30 mmol) in AcOH (50 mL) 
was added bromine (4.6 mL, 90 mmol) dropwise at r.t. and solution stirred for 48 hrs. The 
reaction mixture was then concentrated under reduced pressure and the brominated compound 
242 was crystallised at −20 °C form EtOAc as bright yellow plates (53%, 3.83 g). Rf = 0.35 
(EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.83 (3H, s, OCH3), 3.84 (3H, s, 
OCH3), 7.19 (1H, s, HAr), 7.27 (1H, s, HAr), 10.33 (1H, s, CHO). 
13
C NMR (300 Mz, CDCl3): 
δ (ppm) 56.4, 56.7, 109.6, 117.6, 120.3, 124.1, 140.4, 156.2, 188.8. IR (ATR): υ (cm-1) 1393, 
1448, 1485, 1600, 1677 (C=O), 2890, (C-H stretch aldehyde), 3076. HRMS calcd. for 
C9H9O3Br [M + H]
+
: 244.9808, 246.9787 found 244.9804, 246.9782. mp: 129-130 °C, lit. 
132-134 °C. 
 
 
  
124 
 
(4R,5S)-5-(4-bromo-2,5-dimethoxyphenyl)-4-hydroxydihydrofuran-2(3H)-one 244 
 
Scheme 121. 
To a solution of 4-bromo-2,5-dimethoxybenzaldehyde 242 (612 mg, 2.50 mmol) and 3-
triphenylphosphonium bromide propanoic acid 233 (1.55 g, 3.75 mmol) in THF (20 mL) was 
added a solution of 
t
BuOK (0.841 g, 7.49 mmol) in THF (20 mL) at 0 °C over a period of 1 hr. 
And the reaction mixture was then stirred at this temperature for an additional 2 hrs. Me2SO4 
(0.356 mL, 3.75 mmol) was then added and reaction brought to r.t. After stirring for 2 hrs the 
reaction was quenched with HCl (1 M, 40 mL) and extracted into EtOAc (3 x 20 mL) before 
being washed with NaHCO3 (30 mL). The solution was dried (MgSO4), filtered, concentrated 
and 243 was used as a crude mixture. Rf = 0.25 (EtOAc/hexanes, 1:6). 
Methane sulfonamide (49 mg, 0.51 mmol) and AD-mix-α (510 mg) were dissolved in tBuOH 
(3 mL) and H2O (3 mL) and cooled to 0 °C. The crude Wittig adduct 243 (161 mg, 0.15 
mmol) was then added in solution 
t
BuOH/H2O (2 mL/2 mL) and the reaction mixture stirred 
for 14 hours. The temperature was then increased to r.t. and mixture stirred for an additional 
10 hrs. A saturated solution of Na2SO4 (5 mL) was then added and the solution stirred for 1 hr 
at ambient temperature before being extracted into EtOAc (6 x 10 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash chromatography (EtOAc/hexane, 1:1 
to 1:2) on silica gave the desired lactone product 244 as a yellow solid (90%, 140 mg). Rf = 
0.25 (EtOAc/hexane, 1:1). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 2.70 (1H, d, J = 17.5, CH2), 
2.87 (1H, dd, J = 5.3, 17.5, CH2), 3.83 (3H, s, OCH3), 3.88 (3H, s, OCH3), 4.80 (1H, m, CH), 
5.68 (1H, d, J = 3.2, CH), 7.08 (1H, s, HAr), 7.13 (1H, s, HAr). 
13
C NMR (100 Mz, CDCl3): δ 
(ppm) 38.2, 56.2, 57.0, 68.7, 81.6, 111.4, 111.7, 115.9, 121.6, 149.6, 150.6, 175.3. IR (ATR): 
υ (cm-1) 1031, 1279, 1390, 1464, 1497, 1778 (C=O stretch), 2940, 3454 (O-H stretch br). 
HRMS calcd. for C12H13O5Br [M + H]
+
: 317.0019, 318.9999 found 317.0024, 319.0003. mp: 
65-67 °C. [α]D
25
: +49.0° (c 1.00g/100mL, CHCl3).  
125 
 
Methyl 2-((4R,5S)-5-(4-bromo-2,5-dimethoxyphenyl)-2-methyl-1,3-dioxolan-4-yl)acetate 
252 
 
Scheme 122. 
To a solution of lactone 243 (100 mg, 0.32 mmol) in MeOH (0.19 mL, 5.12 mmol) and 1,1-
dimethoxyethane (0.34 mL, 3.2 mmol) was added Amberlyst resin at r.t. The mixture was 
stirred for 3 days. The Amberlyst resin was then filtered and all volatile materials evaporated 
to give desired acetal methyl ester. Purification by silica gel chromatography (EtOAc/hexanes, 
1:9) gave an inseperable mixture of isomers of 252 at the acetal position (33%, 40 mg). Rf = 
0.20 (EtOAc/hexanes, 1:6). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.14 (3H, d, J = 3, CH3 
(minor)), 1.45 (3H, d, J = 3, CH3 (major)), 2.63-2.69 (1H, m, CH2), 2.81-2.85 (1H, m, CH2), 
3.62 (3H, s, OCH3), 3.70 (3H, s, OCH3), 3.80 (3H, s, CO2Me (minor)), 3.81 (3H, s, CO2Me 
(major)), 4.14-4.21 (1H, m, CH), 4.89 (1H, d, J = 3, CH, (minor)), 4.94 (1H, d, J = 3, CH 
(major)), 5.26 (1H, q, J = 3, 6, CH (major)), 5.33(1H, q, J = 3, 6, CH (minor)), 6.98 (2H, m, 
HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 20.0 (major), 20.5 (minor), 37.8 (major), 37.9 
(minor), 51.8, 56.0 (minor), 56.1 (major), 56.9 (major), 57.0 (minor), 77.5, 79.5 (major), 80.3 
(minor), 101.0 (major), 102.2 (minor), 110.5, 110.6, 110.8, 115.8, 116.0, 127.4, 127.5, 150.4, 
150.6, 150.8, 171.1 (major), 171.2 (minor). IR (ATR): υ (cm-1) 1211 (C-O stretch), 1492, 1739 
(C=O stretch), 2999. HRMS calcd. for C15H19O6Br [M + NH4]
+
: 392.0703, 394.0683 found 
392.0706, 394.0685. mp: 161-165 °C.   
  
126 
 
3-triphenyl phosphonium bromide propanoic acid 233 
 
Scheme 123. 
Under an atmosphere of argon, triphenylphosphine (8 g, 30.5 mmol) was added to a solution 
of 3-bromopropanoic acid 232 (5.60 g, 36.6 mmol) in toluene (90 mL) and the mixture was 
refluxed for 24 hrs. The cloudy solution was then allowed to cool to r.t. resulting in the 
formation of a white solid. The toluene was removed under reduced pressure and the residue 
was dissolved in CH2Cl2 (50 mL) before being filtered. The filtrate was concentrated to give 
phosphonium salt 233 in quatative yield as a white solid (15.2 g). 
1
H NMR (400 Mz, CDCl3): 
δ (ppm) 3.11 (2H, m, CH2), 3.77 (2H, m, CH2), 7.75 (15H, m, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 18.8 (d), 28.2, 117.1 (d), 130.6, 133.6, 135.4, 171.2. IR (ATR): υ (cm
-1
) 
1212, 1455, 1765 (C=O stretch), 3345 (O-H stretch).  HRMS calcd. for C21H20O2BrP [M - 
H]
+
: 413.0312, 415.0291 found 413.0310, 415.0289. mp: <300 °C.  
  
127 
 
benzyl but-3-enoate 275
[110]
 
 
Scheme 124. 
To a solution of vinyl acetic acid 274 (500 mg, 5.81 mmol) in CH2Cl2 (30 mL) was added 
pyridine (0.934 mL, 11.60 mmol) followed by a solution of benzyl chloroformate (0.912 mL, 
6.40 mmol) in CH2Cl2 (10 mL) and reaction mixture stirred at r.t. for 17 hrs. Saturated NH4Cl 
(50 mL) was then added and organic phase was separated. The solution was then washed with 
CuSO4 (2 x 40 mL), NaHCO3 (2 x 40 mL), brine (2 x 40 mL) before drying (MgSO4), 
filtration and concentration under reduced pressure. Silica gel chromatography 
(EtOAc/hexanes, 1:9) gave benzyl ester 275 as a clear oil (98%, 1.02 g). Rf = 0.4 
(EtOAc/hexanes, 1:9). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 3.16 (2H, dt, J =  1.4, 7.2, CH2), 
5.15 (2H, s, PhCH2), 5.20 (2H, m, CH2), 5.95 (1H, dt, J = 7.2, 17.4, CH), 7.35 (5H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 39.1, 66.5, 118.7, 128.2, 128.3, 128.6, 130.2, 135.9, 
171.3. IR (ATR): υ (cm-1) 1160, 1685 C=C stretch,1730 (C=O stretch), 3158. 
  
128 
 
Benzyl-(2-oxiran-2-yl)acetate 276
[111]
 
 
Scheme 125. 
Benzyl ester 275 (1.84 g, 10.4 mmol) was dissolved in CH2Cl2 (100 mL) and NaHCO3 (3.51 
g, 41.8 mmol) added at 0 °C followed by mCPBA (6.54 g, 41.8 mmol) and the reaction 
mixture was stirred at r.t. for 24 hrs. Organic phase was then washed with H2O (3 x 50 mL), 
dried (MgSO4) and filtered before being concentrated under reduced pressure. Silica gel 
chromatography (EtOAc/hexanes, 1:9) gave epoxide 276 as a colourless oil (35%, 725 mg). Rf 
= 0.20 (EtOAc/hexanes, 1:6). 
1
H NMR (300 Mz, CDCl3): δ (ppm) 2.56 (1H, m CH), 2.61 (2H, 
m, CH2), 2.80 (2H, m, CH2), 5.20 (2H, s, PhCH2), 7.35 (5H, m, HAr). 
13
C NMR (100 Mz, 
CDCl3): δ (ppm) 38.4, 47.1, 48.4, 67.7, 128.9, 128.9, 129.1, 136.1, 170.6. IR (ATR): υ (cm
-1
) 
1208, 1765 (C=O stretch), 3039. HRMS calcd. for C11H12O3 [M + H]
+
: 193.0859 found 
193.0857. 
  
129 
 
(S)-2-((2-pivaloyloxy)ethyl)oxirane 326 
 
Scheme 126. 
Under an atmosphere of argon, at 0 °C, was slowly added NaH (3.20g, 80 mmol, 60% in 
mineral oil) to a solution of bromo-diol (S)-196 (4.50g, 26.6 mmol) in THF (100 mL). The 
cloudy solution was then allowed to stir at this temperature for 2 hrs. Pivaloyl chloride (4.9 
mL, 40 mmol) was then added dropwise over 15 mins maintaining 0 °C. After stirring for a 
further 5 hrs the reaction mixture was then quenched at 0 °C with H2O (50 mL) and extracted 
into EtOAc (2 x 50 mL). The combined organic fractions were washed with saturated 
NaHCO3 (2 x 30 mL), dried (MgSO4), filtered and evaporated to dryness under reduced 
pressure. Purification by silica gel chromatography (EtOAc/hexanes, 1:10) gave desired 
epoxide 326 as a colourless oil (83.1%, 3.811 g). Rf = 0.28 (EtOAc/hexanes, 1:6). 
1
H NMR 
(500 Mz, CDCl3): δ (ppm) 1.24 (9H, s, CH3), 1.86 (2H, m, CH2), 2.55 (1H, dd, J = 5.0, 2.7, 
CH2), 2.82 (1H, m, CH), 3.05 (1H, ddd, J = 11.4, 5.3, 3.7, CH2), 4.25 (2H, t, J = 6.3, CH2). 
13
C 
NMR (500 Mz, CDCl3): δ (ppm) 27.1, 32.0, 38.7, 46.9, 49.6, 60.9, 66.9, 68.9, 178.4. IR 
(ATR): υ (cm-1) 1158, 1285, 1366, 1398, 1461, 1481, 1731 (C=O stretch), 2931. HRMS calcd. 
for C9H16O3 [M + H]
+
: 173.1168 found 173.1168. [α]D
25 
= + 4.4° (c 1.00 g/100mL CHCl3). 
  
130 
 
(S)-2-((2-p-methoxybenzyloxy)ethyl)oxirane 301
[113]
 
 
Scheme 127. 
To a suspension of NaH (60%, 370 mg, 8.9 mmol) in THF (30 mL) was added a solution of 
diol (S)-196 (454 mg, 2.9 mmol) at 0 °C and stirred for 5 hrs at r.t. P-methoxybenzyl bromide 
(500 mg, 2.9 mmol) in DMF (10 mL) was then added at r.t. and the reaction stirred for a 
further 3 hrs. The mixture was then quenched with saturated NH4Cl (50 mL), extracted into 
EtOAc (2 x 30 mL) and washed with saturated NaHCO3 (2 x 20 mL). The solution was dried 
(MgSO4), filtered and concentrated under reduced pressure. Flash chromatography 
(EtOAc/hexanes, 1:6) gave desired epoxide as clear oil 301 (77%, 469 mg). Rf = 0.25 
(EtOAc/hexanes, 1:4). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.75 (1 H, m, CH2), 1.85 (1 H, m, 
CH2), 2.52 (1 H, m, CH), 2.76 (1 H, m, CH2), 3.06 (1 H, m, CH2), 3.59 (2 H, mCH2), 3.81 (3 
H, s, OCH3), 4.45 (2 H, s, ArCH2), 6.87 (2 H, d, J = 9.0, HAr), 7.26 (2 H, d, J = 9.0, HAr). 
13
C 
NMR (400 Mz,. CDCl3): δ (ppm) 32.8, 47.0, 55.2, 66.7, 72.7, 113.8, 129.3, 130.4, 159.3. IR 
(ATR): υ (cm-1) 1178, 1201, 1366, 1308, 1454, 1467, 2999. [α]D
25
 = + 10.5°. (c = 1.05 
g/100mL, CHCl3) lit. +12.1° (c = 1.05 g/100mL, CHCl3). 
  
131 
 
(S)-4-para-methoxybenzyl-1-(2,5-dimethoxyphenyl)butan-2-ol 298 
 
Scheme 128. 
To a solution of 2-bromo-1,4-dimethoxybenzene 90 (473 mg, 2.18 mmol) in Et2O (20 mL) 
was added 
n
BuLi (0.300 mL, 2.40 mmol, 1.6 M in hexanes) dropwise and the mixture was 
stirred for 20 minutes at −78 °C resulting in a pale yellow solution of the transmetallated 
compound. Freshly distilled BF3
.
Et2O (0.300 mL, 2.40 mmol) was then added slowly. PMB 
protected epoxyalcohol 301(500 mg, 2.40 mmol) was then added as a dilute solution in Et2O 
(10 mL) over 40 minutes at −55 °C and reaction mixture stirred at this temperature for 2 hrs. 
Mixture was then quenched at 0 °C with 50% aqueous NH4Cl (40 mL), extracted into EtOAc 
(3 x 20 mL) and the combined organic fractions were washed with NaHCO3 (30 mL). After 
drying (MgSO4), filtration and concentrating under reduced pressure. Purification by silica gel 
chromatography (EtOAc/hexanes, 1:4 to 1:2) to give a clear oil of 298 (87%, 656 mg). Rf = 
0.25 (EtOAc/ hexanes, 1:2). 
1
H NMR. (400 Mz, CDCl3): δ (ppm) 1.76 (2H, m, CH2), 2.77 
(2H, m, CH2), 3.59-3.68 (2H, br m, CH2), 3.75 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.79 (3H, 
s, OCH3), 4.04 (1H, m, CH), 4.44 (2H, s, ArCH2), 6.73 (3H, m, HAr), 6.78 (2H, d, J = 9.0, 
HAr), 7.23 (2H, d, J = 9.0, HAr). 
13
C NMR (400 Mz, CDCl3): δ (ppm) 36.0, 38.5, 55.2, 55.5, 
55.8, 68.5, 70.8, 72.8, 111.4, 111.7, 113.8, 117.6, 128.3, 129.4, 130.3, 151.9, 153.5, 159.3. IR 
(ATR): υ (cm-1) 1019, 1201, 1457, 3117, 3609 (O-H stretch). HRMS calcd. for C20H26O5 [M + 
H]
+
: 347.1850 found 347.1851. [α]D = + 39.7° (c 1.00 g/100mL, CHCl3). 
  
132 
 
(S)-2-((2-benzyloxy)ethyl)oxirane 303
[114, 124]
 
 
Scheme 129. 
Oil free NaH (3.92 g, 98 mmol) was added slowly to a solution of diol (S)-196 (5.52 g, 32.7 
mmol) in THF (90 mL) and stirred for 2 hrs at 0 °C. BnBr (11.8 mL, 98 mmol) in THF (10 
mL) was then added at this temperature and reaction warmed to r.t. After stirring for 5 hrs, 
saturated NH4Cl (100 mL) was added and the reaction mixture was extracted into EtOAc (3 x 
40 mL). The combined organic fractions were washed with NaHCO3 (50 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure. Silica gel chromatography (EtOAc/hexanes, 
1:19) gave pure epoxide 303 as a yellow oil (73%, 4.24 g). Rf = 0.30 (EtOAc/hexanes, 1:19). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 1.81 (1 H, m, CH2), 1.91 (1 H, m, CH2), 2.51 (1 H, 
mCH2), 2.78 (1 H, mCH2), 3.08 (1 H, m, CH), 3.63 (2 H, m, CH2), 4.53 (2 H, s, PhCH2), 7.34 
(5 H, m, HAr). 
13
C NMR (400 Mz, CDCl3): δ (ppm) 32.9, 47.0, 50.1, 67.0, 76.7, 127.6, 128.4, 
138.2. IR (ATR): υ (cm-1) 1229., 1470, 1607, 2984, 3049. HRMS calcd. for C11H13O2 [M + 
NH4]
+
: 226.1438 found 226.1436. [α]D
25
 = +15.8° (c = 1.05 g/100mL, CHCl3), lit. +14.6° (c = 
1.05 g/100mL, CHCl3). 
  
133 
 
(S)-4-benzyloxy-1-(2,5-dimethoxyphenyl)butan-2-ol 304 
 
Scheme 130. 
To a solution of 2-bromo-1,4-dimethoxybenzene 90 (546 mg, 2.55 mmol), at −78 °C in Et2O 
(30 mL) was added 
n
BuLi  (1.75 mL, 2.81 mmol, 1.6 M in hexanes) and stirred for 20 mins. 
BF3
.
Et2O (0.34 mL, 2.81 mmol) was then added and a solution of epoxide 303 in Et2O (5 mL) 
was added dropwise over 20 minutes. Mixture was then stirred at −55 °C for 2 hrs before 
quenching with a 50% aqueous solution of NH4Cl (50 mL) at 0 °C, extracting into Et2O (2 x 
20 mL) and washing the combined organic fractions with NaHCO3 (50 mL). After drying 
(MgSO4), filtration and concentrating under reduced pressure, the compound was purified by 
silica gel chromatography (EtOAc/hexanes, 1:4 to 1:2) to give essentially pure alcohol 304 as 
a pale yellow oil (88%, 705 mg). Rf = 0.30 (EtOAc/hexanes, 1:2). 
1
H NMR (400 Mz, CDCl3): 
δ (ppm) 1.78 (2H, m, CH2), 2.79 (2H, m, CH2), 3.70 (2H, br m, CH2), 3.75 (3H, s, OCH3), 
3.77 (3H, s, OCH3), 4.11 (1H, m, CH), 4.51 (2H, s, PhCH2), 6.76 (3H, m, HAr), 7.30 (5H, m, 
HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 22.5, 25.1, 31.7, 36.3, 37.3, 55.5, 56.5, 60.2, 71.4, 
101.8, 104.2, 111.5, 127.7, 128.5, 138.0. IR (ATR): υ (cm-1) 1116, 1499, 2899, 3077, 3643 
(O-H stretch). HRMS calcd. for C19H24O4 [M + H]
+
: 317.1747 found 317.1749.  [α]D
25
 = 
+45.5° (c = 1.00 g/100mL, CHCl3).  
134 
 
(1S,3R)-3-(2-(benzyloxy)ethyl)-5,8-dimethoxy-1-methylisochromane 305 
 
Scheme 131. 
BF3
.
Et2O (0.14 mL, 1.12 mmol) was added at 0 °C, to a solution of alcohol 304 (306 mg, 1.12 
mmol) in CH2Cl2 (10 mL) followed by dimethyl acetaldehyde (0.12 mL, 1.12 mmol) and 
stirred at r.t. for 17 hrs. The reaction was then quenched with saturated NaHCO3 (20 mL) and 
extracted into CH2Cl2 (2 x 20 mL) before being dried (MgSO4), filtered and concentrated 
under reduced pressure to give isochromane 305 as a mixture of diastereoisomers (98%, 333 
mg, 1:2.7 cis:trans). Purification by silica gel chromatography (EtOAc/hexanes, 1:9) gave the 
desired trans isomer as a yellow solid (61%, 205 mg). Rf = 0.60 (EtOAc/hexanes, 1:4). 
1
H 
NMR (400 Mz, CDCl3): δ (ppm) 1.40, (3H, d, J = 3, CH3), 1.84 (2H, m, CH2), 2.62 (1H, dd, J 
= 3, 6, CH2), 2.67 (1H, dd, J = 3, 6, CH2), 3.61 (2H, m, CH2), 3.69 (H, s, OCH3), 3.70 (3H, s, 
OCH3), 4.66 (2H, s, ArCH2), 5.00 (1H, qd, J = 6, 4, CH), 6.54 (2H, m, HAr), 7.25 (5H, m, 
HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 19.5, 28.9, 36.4, 55.5, 55.6, 63.3, 66.9, 68.3, 73.1, 
107.2, 107.5, 123.5, 127.5, 127.7, 128.4, 129.4, 138.6, 149.5, 151.0. IR (ATR): υ (cm-1) 1075, 
1094, 1256, 1437, 1453, 1482, 2935. HRMS calcd. for C21H26O4 [M + H]
+
: 343.1904 found 
343.1904. mp: 145-147 °C. [α]D
25
 = +77.7° (c = 1.00 g/100mL, CHCl3).  
 
  
135 
 
(±)-(1S, 3R)-5,8-dimethoxy-1,3-dimethylchroman 267
[108, 109]
 
 
Scheme 132. 
2-bromo-1,4-dimethoxybenzene 90 (500 mg, 2.30 mmol) was added to a flame dried round 
bottom flask followed by THF (20 mL). 
n
BuLi (1.51 mL, 2.42 mmol, 1.6 M in hexanes) was 
then added at −78 °C and warmed to −40 °C before the addition of propylene oxide (0.169 
mL, 2.42 mmol) and BF3
.
Et2O (0.299 mL, 2.42 mmol). Mixture was then stirred for 3 hrs. The 
reaction was quenched at 0 °C with 50% aqueous NH4Cl, (30 mL) extracted into EtOAc (2 x 
20 mL) and washed with NaHCO3 (2 x 30ml). Solution was dried (MgSO4) and concentrated 
under reduced pressure. Compound (±)-266 was taken forward without further purification. 
Under an atmosphere of argon, at 0 °C, was added MeCH(OMe)2 (2.01 mL, 18.41 mmol) 
followed by BF3
.
Et2O (2.27 mL, 18.41 mmol) to a solution of alcohol 266 (1.777 g, 9.21 
mmol) in CH2Cl2 (50 mL). The mixture was then warmed to r.t. and stirred for 4 hrs. Saturated 
NaHCO3 (40 mL) was then added and the mixture was extracted into CH2Cl2 (2 x 40 mL), 
dried (MgSO4) and concentrated under reduced pressure to give isochromane 267 as a mixture 
of diastereoisomers (98 %, 2.00 g, 2.7:1 trans:cis determined by 
1
H NMR NOESY). Silica gel 
chromatography (EtOAc/hexanes, 1:19) afforded the trans isochromane as a yellow solid 
(65% over 2 steps, 1.26 g). Rf = 0.25 (EtOAc/hexanes, 1:9). 
1
H NMR (400 Mz, CDCl3): δ 
(ppm) 1.66 (3H, d, J = 6.0, CH3), 1.50 (3H, d, J = 6.0, CH3), 2.30 (1H, dd, J = 15.0, 9.0, CH2), 
2.76 (1H, dd, J = 15.0, 3.0, CH2), 3.77 (3H, s, OCH3), 3.78 (3H, s, OCH3), 4.05 (1H, m, CH), 
5.09 (1H, m, CH), 6.67 (2H, m, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 19.4, 21.9, 30.2, 
55.3, 62.2, 68.2, 107.2, 107.5, 114.7, 123.5, 129.2, 149.5, 150.9. IR (ATR): υ (cm-1) 1060, 
1127, 1456, 1481, 1459, 2965. HRMS calcd. for C13H18O3 [M + H]
+
: 222.1328 found 
222.1328. mp: 65- 66 °C. [α]D
25
 = +40.8 (c = 1.00 g/100mL, CHCl3) lit. +32.8° (c = 1.00 
g/100mL, CHCl3). 
  
136 
 
(1S, 3R)-5,8-dimethoxy-1,3-dimethylchroman quinone 268
[110]
 
 
Scheme 133. 
To a solution of isochromane 268 (752 mg, 3.39 mmol) in MeCN:H2O (20 mL:5 mL) was 
added ceric ammonium nitrate (5.57 g, 10.1 mmol) in one portion and solution stirred at r.t. 
for 17 hrs. Reaction mixture was then extracted into EtOAc (5 x 20 mL) and the combined 
organic fractions were washed with NaHCO3 (2 x 20 mL). Solution was then dried (MgSO4), 
filtered and concentrated under reduced pressure to give the quinine 268 as a bright yellow 
solid (99%, 647 mg). Rf = 0.45 (EtOAc/hexanes, 1:9). 
1
H NMR (400 Mz, CDCl3): δ (ppm) 
1.31 (3H, d, J = 6.2, CH3), 1.45 (3H, d, J = 6.8, CH3), 2.12 (1H, ddd, J = 19.2, 10.1, 2.2, CH2), 
2.52 (1H, ddd, J = 19.2, 3.4, 0.8, CH2), 3.94 (1H, m, CH), 4.83 (1H, m, CH), 6.71 (2H, dq, J =  
10.1, HAr). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 19.7, 21.6, 29.4, 62.6, 67.0, 136.2, 136.7, 
139.5, 144.3, 185.9, 186.5. IR (ATR): υ (cm-1) 1130, 1303, 1332, 1490, 1667 (C=O stretch), 
1689, (C=O stretch). HRMS calcd. for C11H12O3 [M + H]
+
: 193.0857 found 193.0859. mp: 
122-123 °C. lit. 122-123. [α]D
25
 = +177.0 (c = 1.00 g/100mL, CHCl3), lit. +178.1° (c = 1.00 
g/100mL, CHCl3). 
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(±)-1,3-Dimethyl-5,8-dimethoxy-6-bromoisochromane 337/(±)-1,3-dimethyl-5,8-
dimethoxy-6-bromoisochromane 338 
 
Scheme 134. 
(±)-isochromane 267 (444 mg, 2.0 mmol) was dissolved in AcOH (10 mL) at 0 °C. Bromine 
(0.11 mL, 2.2 mmol) was then slowly added and the reaction mixture stirred at this 
temperature for 5 hrs. The mixture was then diluted with H2O (30 mL) and extracted into 
EtOAc (4 x 10 mL). The combined organic fractions were then sequentially washed with 
NaHCO3 (2 x 10 mL), Na2S2O3 (2 x 10 mL) and brine (2 x 10 mL) before being dried 
(MgSO4), filtered and evaporated to dryness under reduced pressure. Purification by silica gel 
chromatography (EtOAc/hexanes, 1:19) gave brominated isochromanes 337/338 as an 
approximate 1:1 mixture of inseperable regioisomers (76%, 457 mg). Rf = 0.35 
(EtOAc/hexanes, 1:9). 
1
H NMR (500 Mz, CDCl3): δ (ppm) 1.24 (3H, d, J = 5, CH3), 1.27 (3H, 
d, J = 5, CH3), 1.39 (3H, d, J = 5, CH3), 1.46 (3H, d, J = 5, CH3), 2.12 (1H, dd, J = 15, 20, 
CH2), 2.35, (1H, dd, J = 15, 20, CH2), 2.75, (1H, d, J = 15, CH2), 2.79 (1H, d, J = 15, CH2), 
3.68 (3H, s, OCH3), 3.69 (3H, s, OCH3), 3.70 (3H, s, OCH3), 3.72 (3H, s, OCH3), 3.94 (1H, m, 
CH), 4.91 (1H, q, J = 5, 15, CH), 4.99 (1H, q, J = 5, 15, CH), 6.74-6.79 (2H, m, HAr). 
13
C 
NMR (100 Mz, CDCl3): δ (ppm) 19.3, 20.4, 21.9, 22.0, 30.0, 31.0, 55.6, 55.7, 62.0, 62.3, 68.1, 
68.7, 112.4, 112.9, 113.5, 113.6, 119.4, 121.9, 128.5, 129.4, 146.7, 148.2, 152.0, 153.5. IR 
(ATR): υ (cm-1) 1230, 1361, 1459, 1471, 1485, 1578, 2934 HRMS calcd. for C13H17O3Br [M 
+ H]
+
: 301.0434, 303.0413 found 301.0434, 303.0413.  
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1,4-Methoxymethyleneoxy-5,8-methoxynaphthalene 334 
 
Scheme 135. 
To a flame dried round bottom flask, under an atmosphere of argon, was added bromo-1,4-
dimethoxybenzene 90 (0.22 mL, 1.5 mmol) and this was then dissolved in freshly distilled 
THF (4 mL). The solution was then cooled to −78 °C and 2-trimethylsiloxyfuran 312 (0.5 mL, 
3 mmol) was slowly added. A solution of freshly prepared LDA (3 mmol) in THF (6 mL) was 
then added dropwise over 1 hr. and the mixture stirred at this temperature for a further 1 hr. 
The reaction was allowed to warm then quenched at 0 °C with H2O (5 mL) before being 
rapidly extracted into EtOAc (10 mL), dried (MgSO4), filtered and evaporated to dryness. This 
crude mixture was then placed under an atmosphere of argon, cooled to −78 °C and dissolved 
in freshly distilled THF (10 mL). 
n
BuLi (1.2 mL, 3 mmol, 2.5 M in hexane) was then added 
dropwise over 5 mins. and mixture stirred for 15 mins. A solution of MOM-Cl (3.14 mL, 6.6 
mmol, 2.1 M in toluene) was then added dropwise over 5 mins and the reaction mixture was 
stirred for 2 hrs. at 0 °C. H2O (10 mL) was then added and the reaction mixture was extracted 
with EtOAc (3 x 10 mL) before being washed with NaHCO3 (2 x 10 mL) and brine (10 mL). 
The combined organic fractions were then dried (MgSO4), filtered and evaporated to dryness 
under reduced pressure. Purification by alumina gel chromatography (EtOAc/hexanes, 1:6) 
gave naphthalene compound 334 as a red powder (67% over 2 steps, 305 mg). Rf = 0.45 
(EtOAc/hexanes, 1:6). 
1
H NMR (500 Mz, CDCl3): δ (ppm) 3.53 (6H, s, OCH3), 3.82 (6H, s, 
OCH3), 5.08 (4H, s, CH2), 6.75 (2H, s, HAr), 6.97 (2H, s, HAr). 
13
C NMR (100 Mz, CDCl3): δ 
(ppm) 56.4, 57.4, 98.0, 108.0, 116.3, 122.0, 149.3, 150.9. IR (ATR): υ (cm-1) 1152, 1265, 
1371, 1456, 1595, 2975. HRMS calcd for C16H20O6 [M + Na]
+
: 331.1155 found 331.1155. mp: 
59-61. 
  
139 
 
6. Appendix 
6.1 Synthesised protecting reagents and reagents to ascertain optical purity 
Methoxymethylenechloride 361
[111]
 
 
Scheme 136. 
A 250 mL three neck round bottom flask flushed with argon was charged with 
dimethoxymethane 362 (17.6 mL, 200 mmol) in anhydrous toluene (53 mL). Zn(OAc)2 (4 mg, 
0.002 mmol, 0.01 mol%) was then added followed by dropwise addition of acetyl chloride 
over 5 mins. The exothermic reaction resulted in the reaction mixture to rise to 50 °C. After 
stirring for 3 hrs the solution was cooled to r.t. and analysis by 
1
H NMR showed 99% 
conversion to methoxymethylene chloride 361 2.1M in toluene. 
1
H NMR (400 Mz, CDCl3): δ 
(ppm) 5.43 (2 H, s, CH2), 3.49 (3 H, s, OCH3). 
13
C NMR (100 Mz, CDCl3): δ (ppm) 51.1, 
59.1. 
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4-Methoxybenzyl bromide 363
[113]
 
 
Scheme 137. 
To a solution of p-methoxybenzyl alcohol 364 (0.498 mL, 4.00 mmol) in CH2Cl2 (20 mL) at 
r.t. was added PBr3 (0.494 mL, 5.20 mmol) under inert atmosphere. The mixture was then 
stirred for 3 hrs before being cooled to 0 °C and quenched with H2O (20 mL). Extraction into 
CH2Cl2 (2 x 20 mL), drying (MgSO4), filtration and concentrating gave pure PMBBr 363 as a 
yellow oil (99%, 0.80 g). 
1
H NMR (400 Mz, CDCl3): 3.81 (3 H, s, OCH3), 4.51 (2 H, s, 
ArCH2), 6.85 (2 H, d, J = 9.0, HAr), 7.34 (2 H, d, J = 9.0, HAr). 
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O-Acetylmandelic acid 248
[105]
 
 
Scheme 138. 
To a solution of mandelic acid 247 (1.52 g, 10 mmol) in Et2O (30 mL) and pyridine (4.02 mL, 
50 mmol) was added acetic anhydride (1.04 mL, 11 mmol) followed by a catalytic amount of 
DMAP at 0 °C under an atmosphere of argon. The mixture was then allowed to warm to r.t. 
and stirred for 8 hrs. H2O (20 mL) was then added and the mixture extracted with EtOAc (2 x 
20 mL). The organic phase was then washed with saturated CuSO4 (2 x 20 mL) then NaHCO3 
(2 x 20 mL) before being dried (MgSO4), filtered and evaporated to dryness to give pure 
acylmandelic acid 248 in quantative yield as a yellow solid (1.860 g). 
1
H NMR (500 Mz, 
CDCl3): 2.13 (3H, s, CH3), 5.86 (1H, s, CH), 7.30-7.48 (5H, m, HAr). 
13
C NMR (500 Mz, 
CDCl3): 20.8, 74.2, 126.0, 127.0, 129.2, 129.5, 133.3, 170.0, 175.0. IR (ATR): υ (cm
-1
) 1210, 
1701, 1688, 1741, 3035. [α]D
25
 = + 149.2. (c = 1.00, MeOH), lit. +152.0 (c = 1.00, MeOH). 
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6.2 Non-isolable compounds  
(E)-methyl-4-(4-bromo-2,5-dimethoxyphenyl)but-3-enoic acid 365 
 
Scheme 139. 
To a solution of 4-bromo-2,5-dimethoxybenzaldehyde 242 (612 mg, 2.50 mmol) and 3-
triphenylphosphonium bromide propanoic acid 233 (1.55 g, 3.75 mmol) in THF (20 mL) was 
added a solution of 
t
BuOK (0.841 g, 7.49 mmol) in THF (20 mL) at 0 °C over a period of 1 hr. 
And the reaction mixture was then stirred at this temperature for an additional 3 hrs. The 
reaction was then quenched with saturated NH4Cl (30 mL) extracted into EtOAc (4 x 40 mL) 
and the combined organic layers were washed with 1 M HCl (30 mL) and saturated NaHCO3 
(30 mL) solutions consecutively. After drying (MgSO4), filtration through a pad of silica 
eluting with EtOAc, the eluent was concentrated under reduced pressure and (E)-365 was used 
without further purification. 
 
Figure 37:  
1
H NMR of crude 365.   
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1-Bromo-(2's,3's)-2-(2'',5''dimethoxyphenyl)-5'-oxotetrahydrofuran-3'-yl-(2s)-2-
(acetyl)phenylacetate 249 
 
Scheme 140. 
To a solution of acylmandelic acid 248 (136 mg, 0.70 mmol) in toluene (10 mL) was added a 
catalytic amount of DMAP and DCC (150 mg, 0.70 mmol) at 0 °C. A solution of β-
hydroxylactone 252 (150 mg, 0.46 mmol) in CH2Cl2 (2 mL) was then added dropwise to the 
suspension at 0 °C and the reaction mixture was stirred for 2 hrs at this temperature. The 
mixture was then diluted with CH2Cl2 (10 mL), washed with H2O (10 mL) and the organic 
phase was dried (MgSO4) and filtered before being concentrated under reduced pressure. 
Analysis by 
1
H NMR of the crude mixture showed little of ester 249 which could not be 
isolated. 
 
Figure 38: 
1
H NMR of crude 249. 
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3-(4-bromo-2,5-dimethoxyphenyl)isopropanol 330
[110]
 
 
Scheme 141. 
 To a solution of 2,5-dibromo-1,4-dimethoxybenzene 241 (1 g, 3.16 mmol) in THF (30 mL) at 
−78 °C under an atmosphere  of argon was added dropwise  nBuLi (1.33 mL, 3.32 mmol, 2.5 
M in hexane) and the reaction mixture was then stirred for 30 mins. At this temperature was 
added BF3.Et2O (0.4 mL, 3.32 mmol) dropwise followed by the slow addition of a solution of 
propylene oxide 360 (183 mg, 3.16 mmol) in THF (10 mL) over 30 minutes. The reaction 
mixture was then allowed to slowly warm to 0 °C and then stirred for a further 3 hrs. The 
mixture was then quenched at 0 °C with H2O (30 mL) and extracted with EtOAc (2 x 30 mL). 
The combined organic fractions were then washed with brine (2 x 30 mL), dried (MgSO4), 
filtered and evaporated to dryness to give crude opened epoxide 330. The crude material was 
used without further purification. HRMS [M − OH + H]+: 259.0151. calc. for C11H15O3Br: 
274.02 
 
Figure 39:  
1
H NMR of crude 330. 
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